More annual reports from Invacare:
2021 ReportPeers and competitors of Invacare:
Itamar Medical Ltd.2020 Annual Report
Resilient operating result 
in a challenging year
,,
  We’re here to support our clients,  
their families and friends, at a pivotal 
time in their lives. We do this by being 
compassionate, exceeding expectations 
and delivering outstanding service.
,,
About this report
InvoCare’s 2020 Annual Report is our primary statutory and regulatory 
reporting disclosure. It comprises information about our activities, strategy, 
our financial and non-financial performance, risk management, remuneration 
and our financial statements. The financial statements are structured to 
provide prominence to the disclosures that are considered most relevant to 
the user’s understanding of the operations, results and financial position.
Corporate reporting suite
InvoCare’s corporate reporting suite brings together the Group’s financial, 
non-financial, risk and sustainability performance for the financial year 
ended 31 December 2020, including:
Investor 
Presentation
Scan QR 
code on your 
smart device 
to download 
from the ASX
Sustainability 
Report
Scan QR 
code on your 
smart device 
to download 
from InvoCare 
website
Our corporate reporting documents are available for download on the 
InvoCare Investor Relations page:
www.invocare.com.au/investor-relations/
Resilient operating resultin a challenging year2020FullYearResults24 February 2021InvoCare FY20 Sustainability ReportNew dimension to sustainabilityContents
InvoCare Limited
ABN 42 096 437 393
Section 1 
Performance 
Overview
Performance highlights
Chairman’s message
Five year financials
Chief Executive Officer’s message
Executive Leadership Team
2020 Sustainability highlights
Managing the impact of COVID-19
Our community
Section 2 
Directors’ Report
Operating and financial review
Remuneration report – audited
Other statutory matters
Auditor’s Independence declaration
Section 3 
Financial Report 
Financial Report Introduction
Consolidated financial statements
Notes to the consolidated financial statements
Directors’ declaration
Independent auditor’s report
Section 4  
Other Information
Shareholders information
Glossary
Corporate directory
InvoCare            Annual Report 2020  | 3
4
6
9
10
12
13
14
16
21
36
60
66
68
69
75
125
126
132
134
135
P
e
r
f
o
r
m
a
n
c
e
R
e
v
e
w
i
D
i
r
e
c
t
o
r
s
’
R
e
p
o
r
t
i
F
n
a
n
c
a
i
l
R
e
p
o
r
t
O
t
h
e
r
I
n
f
o
r
m
a
t
i
o
n
1
2
3
4
 
 
 
 
Performance highlights
Remained focused on our mission and values of care and service
Financial a 
summary
Operating 
revenue b 
$476.2m 
↓  4.7% 
Operating 
EBITDA 
$102.6m 
↓  29%
Reported loss 
($9.2m) 
↓  114%
Operating EPS 
20.4¢
 ↓  61%
Capital  
management
Cash flow 
conversion
107%
↑ 25 ppts 
Leverage  
ratio
1.3x
 ↓  1.1x
 ROCE
8.6%
↓  8.5 ppts
Full year 
dividend
12.5¢
↓  70%
Operating 
EBITDA 
business 
lines
Operational 
and 
sustainability 
metrics
Funeral  
services
$80.1m
↓  26%
Memorial  
Parks
$57.6m
↓  8.7%
Pet  
cremations
$0.5m
 ↑ 141%
Funeral case 
volumes 
44,784
 ↓  3.0%
Funeral case 
average c 
$7,858 
↓  4.5%
Memorialisation 
revenue
+4.4%
 ↑ on PCP
NPS
+79
 ↑ 0.5
LTIFR
12.5
↓  1.6
N.B Variations noted above are versus the prior corresponding period 
a  For reconciliation of operating to statutory results, refer to page 33
b  Includes operating sales revenue and other revenue
c  Gross funeral case average, including disbursements
InvoCare            Annual Report 2020  | 4
Operating sales revenue  
$m
Operating EBITDA  
$m
2016
462.5
2017
2018
2019
2020
470.9
477.3
494.1
2016
2017
2018
2019
115.3
124.3
119.0
144.4
470.2
2020
102.6
450
460
470
480
490
500
90
100
110
120
130
140
150
Operating earnings after tax  
$m
(Loss)/profit after tax attributable to 
members $m
2016
2017
2018
2019
2020
27.5
57.4
63.5
49.5
59.2
2016
2017
2018
2019
2020
(9.2)
70.9
97.4
41.2
63.8
20
30
40
50
60
70
(10)
10
30
50
70
90
Operating earnings per share  
¢ per share
Ordinary dividend (full year)  
¢ per share
2016
2017
2018
2019
2020
20.4
52.4
57.9
45.2
51.7
2016
2017
2018
2019
2020
12.5
42.5
46.0
37.0
41.0
10
20
30
40
50
60
10
20
30
40
50
InvoCare            Annual Report 2020  | 5
Performance Review12Directors’ Report3Financial Report4Other InformationChairman’s message
Dear Shareholder,
On behalf of the Board, we would like to thank you for your support 
in what has been a year of unprecedented disruption.
The Board would also like to extend their thanks and gratitude to 
our employees. In 2020, our teams across our Funeral Services, 
Memorial Parks and Pet Cremations businesses, as well as our 
support office teams, stepped up to the significant challenge of 
the COVID-19 pandemic (COVID-19). They have committed to 
our purpose, serving families when they need us most, focusing 
on high standards of safety and service. They showed resilience, 
agility, and a readiness to do things differently to support families 
across Australia, New Zealand and Singapore. 
In 2020, our client families showed their satisfaction with these 
efforts with a very strong Net Promoter Score of +79, an 
exceptional result in difficult circumstances. We are proud and 
so grateful for everything our teams have achieved in such a 
demanding year.
2020 financial results
InvoCare reported statutory revenue of $477.7 million for the 
year, a decrease of 4.5% on the prior corresponding period 
(PCP). COVID-19 and the associated government restrictions 
had a significant impact on both InvoCare’s ability to deliver 
full-service funeral arrangements and on the mortality rate in 
the countries in which it operates.
The statutory net loss after tax attributed to shareholders 
was $9.2 million for the year. As disclosed to the market 
on 17 February 2021, this 2020 full year result includes the 
impact of net $26.5 million (pre-tax) of significant operating 
and non-operating items. 
The Group delivered an operating earnings per share 
(EPS) of 20.4 cents, 61% below the PCP, driven by the 
decline in operating earnings in the year and the dilutive 
impact of the increased number of shares on issue 
following the successful equity raising completed in 
April and May 2020.
               the Board remains confident 
about the long-term potential of 
the business, with future growth 
supported by both population growth 
,,
and ageing trends in its markets,,
InvoCare            Annual Report 2020  | 6
Impact of COVID-19
Embracing sustainability
The last year has clearly been challenging across the world and 
As Australia, Singapore and New Zealand’s leading operator in the 
the ongoing impact of COVID-19 is the backdrop to our financial 
funeral, cemetery and crematoria sector, InvoCare has a responsibility 
performance. While the strategies employed by various governments 
to both our shareholders and the communities we serve to lead the way 
in our part of the world to control the spread of COVID-19 have been 
in defining standards of excellence in the sustainability of our industry’s 
successful, they have led to softer market conditions in the Funeral 
environmental, social and governance (ESG) practices.
Services sector in particular.
2020 was the second year in our initial three-year plan, with a focus 
In 2020 our people were truly able to live our mission to support 
on developing the operational and reporting model ideal for our 
families at the most pivotal time of their lives. They have done so 
core sectors, and building on established and globally recognised 
by being compassionate, exceeding expectations and delivering 
frameworks such as the GRI Index. Further information is provided in 
outstanding service and by setting the highest standards in safety 
our separate Sustainability Report issued on 31 March 2021, which is 
and business practice. They were able to support families through 
available on our website.  
situations where they either couldn’t hold a funeral or were not able to 
attend in person because of government restrictions.
Despite the disrupted year hampering our ability to pursue some of 
their intended sustainability initiatives, the team’s response has been 
We implemented a detailed and comprehensive COVID-19 response 
to increase the focus on areas such as the health and safety of our 
plan. This involved additional measures in each business to protect 
employees and client families and expanding digital accessibility to 
the health and safety of our teams and customers, while supporting 
funeral events, which required the accelerated deployment of digital 
government efforts to limit the spread of the virus. These important 
capabilities at our funeral and memorial park locations. 
measures resulted in additional costs. I should note that our 
businesses in Australia did not benefit from JobKeeper assistance. 
There was also a measured approach to cost control in order to 
Leadership changes
maintain uncompromised service levels and this was a deliberate 
The InvoCare Board established and executed a leadership transition 
decision of the Board and Management given the important role our 
plan during the year. Adrian Gratwicke was appointed as InvoCare’s 
teams play in the community and in helping our client families farewell 
new Chief Financial Officer (CFO) from 3 August 2020. Adrian is 
their loved ones.
The impacts from COVID-19 have mostly been experienced in our 
core Funeral Services businesses where restrictions on gathering 
an experienced public company CFO, having worked across a 
broad range of sectors stretching into Oil & Gas, Mining, FMCG and 
Agriservices. 
limits impacted our ability to provide our full range of services. Rules 
Additionally, as announced on 19 November 2020, Olivier Chretien 
differed between geographies and states and changed multiple times 
joined the Company on 1 January 2021 as InvoCare’s new Managing 
Director and Chief Executive Officer (CEO). Olivier has a proven 
record of value creation, strategic design and execution, and he has 
pleasingly hit the ground running. Along with his refreshed Executive 
Leadership Team (see page 12), he has been working on the details of 
the InvoCare strategy for the next five years. 
over the year.  
A common trend seen across all markets has been an increase 
in direct cremations during the height of lockdowns as family and 
friends were unable to attend a ceremony in person. However, we 
have observed how important the ‘gathering’ element of a funeral 
arrangement to celebrate a loved one’s life was to client families. Even 
though the rise in digital solutions assisted families during lockdown, 
we have seen a progressive return to traditional arrangements when 
restrictions have lifted. Additionally, the breadth of our brand portfolio, 
particularly in Australia, has helped the business manage the shift to 
direct cremation and back to traditional services. Either way, digital 
solutions will continue to be needed and we have ensured our funeral 
homes and memorial park chapels have the appropriate technology.
InvoCare            Annual Report 2020  | 7
Performance Review12Directors’ Report3Financial Report4Other InformationChairman’s message
continued
Remuneration activities
Capital management
Robyn Stubbs resigned as an independent Non-Executive Director 
In response to the uncertain impact of COVID-19 and to ensure 
effective 1 February 2021. Robyn has been a valued member of the 
the continued positive momentum of growth initiatives through 
Board since her appointment in 2017, especially in her role as Chair 
an environment of temporary restrictions on the funeral industry, 
of the People, Culture & Remuneration Committee (Committee). 
InvoCare successfully completed a $274 million capital raise in April 
On behalf of the Board we thank her for her commitment and 
and May 2020 via an institutional placement and share purchase plan. 
contributions to the business.
We are delighted with the strong support shown by participants in the 
Our 2020 Remuneration Report is contained in this Annual Report. 
raise, which positioned the Group to maintain momentum to deliver 
Led by Robyn, the main activities of the Committee during the year 
long-term value for its shareholders and I thank our shareholders on 
were highly influenced by COVID-19, which provided a back drop for 
behalf of the Board for their continued support.
its assessments of both the STI and LTI outcomes for the year but also 
in assessments of base salary and director fees. Key remuneration 
outcomes in the year included: 
• •  The financial performance in 2020 did not meet the agreed financial 
targets, and as a result the full financial portion (50%) of STI has 
been forfeited by the Executive Key Management Personnel (KMP). 
The average STI outcome for 2020 for Executive KMP was 27% 
based on their balanced scorecard
• •  The Return on Invested Capital (ROIC) gateway was not met for 
the 2017 and 2018 LTI grants that were tested in the year. None of 
these awards therefore vested in 2020 in accordance with the plan 
rules
The net proceeds of the capital raise have been used to reduce 
net debt, increase liquidity, and provide balance sheet flexibility for 
acquisitions and ongoing capital investment. Management also 
successfully re-negotiated an extension of the undrawn $200 million 
debt tranche due to mature in February 2021. This funding line, 
along with the additional capital is expected to provide InvoCare with 
increased flexibility to further strengthen its balance sheet, accelerate 
the roll out of Enhance and Growth projects in the NBO program, and 
in taking advantage of new growth opportunities that may arise.
Notwithstanding the earnings reduction, the Group was able to 
maintain strong cash conversion and that in turn has enabled the 
Board to determine a final fully franked dividend of 7 cents per share, 
• •  From 1 August to 30 November 2020, the Non-Executive Directors 
which brings the full year dividend to 12.5 cents per share. The 
took a 25% base fee reduction (COVID-19 related)
reduction in dividend payout ratio to 61% reflects an appropriately 
The Committee also undertook a review of the LTI arrangements in 
place and a new LTI plan was introduced during the year for the 2020 
grant with a particular focus on its ability to attract and retain senior 
management to ensure they are focused on delivering sustainable 
long term growth. Key features of the 2020 LTI plan include:
• •  Introduction of two performance hurdle measures weighted 50% 
on compound annual growth of EPS and 50% on average ROIC 
over the three-year performance period with no ROIC gateway and 
the testing point for vesting being at the end of this performance 
period only
• •   Participants are able to choose a mix of options and performance 
rights based on their personal risk profile
• •   Vested options or performance rights are subject to a further  
12- month restriction period
• •   The performance rights are entitled to dividends, if determined, 
prudent approach to capital management given ongoing short-term 
outlook uncertainty and another year of heightened capital spend as 
the Group seeks to complement its commitment to the NBO program 
of works with other growth initiatives.
Outlook
Short-term market conditions are still being impacted by COVID-19 
restrictions and the timing and extent of the unwind of related 
impacts remains hard to predict. Notwithstanding this, the Board 
remains confident about the long-term potential of the business, 
with future growth supported by both population growth and 
ageing trends in its markets. The refreshed Executive Leadership 
Team and the appointment of Olivier as CEO sets the Company up 
for its next phase in meeting the evolving needs of client families.
paid in the form of shares but no voting rights attach to the options 
Bart Vogel  Chairman
or performance rights awarded
               The Board would also like to extend their thanks and gratitude to our 
employees... They have committed to our purpose, serving families when they 
need us most, focusing on high standards of safety and service. They showed 
,,
resilience, agility, and a readiness to do things differently to support families,,
InvoCare            Annual Report 2020  | 8
Five year financials 
$’000 
Operating sales revenue a  
Operating EBITDA  
Operating EBITDA margin  
Operating earnings after tax b 
Operating earnings per share (cents) 
(Loss)/profit after tax attributable to members  
Earnings per share (cents) 
Dividend paid in respect of the financial year (cents) 
2020
2019
2018
 2017 
 2016 
 470,232 
 494,112 
 477,337 
 470,852 
 462,476 
 102,565 
 144,433 
 118,998 
 124,316 
 115,344 
22%
29%
25%
26%
25%
 27,478 
 59,202 
 49,496 
 63,526 
 57,417 
 20.4 
 (9,242)
(6.9)
 12.5 
 51.7 
 45.2 
 57.9 
 52.4 
 63,752 
 41,224 
 97,439 
 70,949 
 55.8 
 41.0
 37.8 
 37.0
 88.8 
 46.0
 64.7 
 42.5 
Ungeared, tax free operating cash flow 
 109,324 
 118,776 
 104,222 
 116,891 
 105,007 
Proportion of EBITDA converted to cash  
107%
82%
88%
94%
91%
Actual capital expenditure 
 68,136 
 65,289 
 84,120 
 47,471 
 30,321 
Net debt  
 137,468 
 349,968 
 393,469 
 227,547 
 222,927 
Operating EBITDA/Net interest (times) 
Net debt/EBITDA (times) 
Funeral homes (number) 
Memorial Parks (number) 
 8.3 
 1.3 
 278 
 17 
 10.1 
 2.4 
 280 
 17 
 9.6 
 3.3 
 255 
 16 
 13.8 
 1.8 
 228 
 16 
 11.0
 1.9 
 233 
 16 
a  Operating sales revenue excludes other revenue including rent and sundry revenue
b   Operating earnings after tax excludes the net gain/(loss) on pre-paid contracts, costs associated with the administration of pre-paid contracts, 
commissions received,  gain/(loss) on sale, disposal or impairment of non-current assets and non-controlling interests  
Le Pine Funerals / White Lady Funerals, Kew Victoria
InvoCare            Annual Report 2020  | 9
Performance Review12Directors’ Report3Financial Report4Other Information 
Chief Executive Officer’s message
Dear Shareholder,
I have only been here a short time but from the site visits I’ve 
done and employees I have met with, I am impressed and proud 
of their professionalism, flexibility, and work ethic. Echoing the 
Chairman’s message, I would like to thank all our employees in 
Australia, New Zealand and Singapore for their tireless efforts this 
last year to support each other and our client families to ensure 
they were provided with the best care and service at all times, 
notwithstanding the very difficult conditions they faced.  
During the past year, we completed 63 NBO projects across Australia 
and New Zealand. We also welcomed to our Group the team of 
Galaxy Funerals in NSW and two well-established Pet Cremations 
businesses in Australia, Family Pet Care and Pets in Peace, providing 
strong platforms for growth.
We delivered full year operating revenue of  
$476.2 million and an operating EBITDA of 
$109.6 million after excluding the impact of 
some significant items captured in our results, 
which was in line with market expectations. 
This is pleasing in what was a very difficult 
year where all our businesses faced 
significant operating constraints, changes 
in consumer behaviours and demand, as well 
as increased price competition, especially at the 
height of the lockdowns. But that was the past and 
we need to focus on the future. 
We are still living with a level of uncertainty and ever-changing 
restrictions across our three countries. This simply means that we 
need to continue to adapt and be nimble. I am delighted to have joined 
a team who is extremely passionate about what they do every day. 
With drive, expertise and commitment, there is so much more we can 
do for our client families in the year ahead.
Refreshed Executive Leadership Team
We recently announced a leadership restructure of the business 
where I confirmed several recent executive promotions and made 
additions and changes to accountabilities to align with our strategic 
focus areas and my strong commitment to diversity. 
This new ‘leaner’, flat structure will enable me as CEO to have direct 
oversight of our operations and I am pleased to have the leadership 
accountabilities in place to deliver on our strategic plan for the next five 
years. In addition, my Executive Leadership Team and I are committed 
to doing all we can to ensure that over the coming years we 
build an even safer, inclusive and rewarding place to 
work, so that all our employees can be proud to 
work here.
InvoCare            Annual Report 2020  | 10
InvoCare 2025
As the Chairman touched on, my team and I are in the process of 
Leveraging stronger foundations, we can then really grow our market 
evaluating some elements of our five-year strategic plan.
share in value – several avenues for growth exist across pre, at and 
The guiding principle for this next stage of our strategy is to leverage our 
core assets and recent investments in our properties (the NBO program) 
and IT systems, and to optimise their potential to meet the evolving 
needs of our client families through an expanding value proposition.
Our key focus will be on enhancing the experience we provide to both 
our client families and teams to position our business for success today 
and for sustainable growth in the future. Our purpose is to honour life 
and celebrate memories for generations. This means considering our 
lifetime customer journey, where we can really leverage our pre, at and 
post-need offerings, through our Pre-paid Funerals, Funeral Services, 
Memorial Parks and Crematoria, as well as Pet Cremations services. 
We will also focus on expanding our service offering for targeted 
customer segments – rather than taking a generic approach to market 
share in case volume. This will require a progressive shift in our business 
post-need including expanding our provision of value-add services to 
customers. We will also continue to seek to expand our addressable 
market. This includes further growth in our Pet Cremation business, 
expanding digital channels and being a partner of choice. Work is also 
underway to assess and prioritise other growth opportunities. 
Last but not least, I believe we can and have a duty to extend our 
industry leadership across a number of dimensions – our commitment 
to service excellence; our safety standards and performance; 
developing talent; our sustainability commitments; digital, data and 
innovation investments; as well as our community support and a 
more proactive stakeholder engagement, including with our industry 
associations.
Outlook
focus with a greater emphasis on innovation, flexibility, and diversity. 
I am energised by the quality of our teams, services, brands and 
First and foremost – we are a service business, so the core foundation 
of the strategy will be a relentless focus on our client families and our 
teams to meet and exceed customer needs. This includes a focus on 
our service excellence and customer metrics, and ensuring we provide 
a safe, inclusive, and rewarding workplace.
assets across Australia, New Zealand and Singapore. In the years 
ahead, I really look forward to providing an increased quality of care 
and excellence in service to our client families and communities;  
a safe, inclusive and rewarding workplace to our employees; 
industry stewardship, notably through our commitments to 
sustainability, innovation and proactive stakeholder engagement; 
To succeed, we need to simplify our approach. We need to put our 
and delivering value to our shareholders through a relentless 
attention on what matters by empowering our local leaders and 
commitment to profitable growth and satisfactory returns on 
supporting our frontline teams to do the best they can. My commitment 
capital employed. 
as CEO is that we will remain focused on achieving better experiences 
for our teams and client families.
We have already initiated a review of our operating model and will look 
for opportunities to variabilise more of our cost base over the long term. 
Finally, I too would like to thank all our shareholders for their 
ongoing support.
Some areas of focus here will include our funeral network performance 
Olivier Chretien Managing Director & Chief Executive Officer
and strategy; the value propositions of our leading brands; our capital 
deployment; as well as more efficient support services.
,,
            ...we will also focus 
on expanding our service 
offering for targeted 
customer segments... 
this will require a 
progressive shift in our 
business focus with a 
greater emphasis on 
innovation, flexibility, and 
diversity ,,
Beth Shan Funerals, Taradale New Zealand
InvoCare            Annual Report 2020  | 11
Performance Review12Directors’ Report3Financial Report4Other InformationExecutive Leadership Team
Chief Executive Officer
Chief Financial Officer
Olivier Chretien
Adrian Gratwicke
Executive General Manager 
 – Australian Funerals
Lynne Gallucci
Executive General Manager 
 – Cemeteries & Crematoria
Executive General Manager 
– Customer
Executive General Manager  
– Stakeholder Engagement
Steve Nobbs 
Victoria Doidge
Fergus Kelly
Executive General Manager 
– Health, Safety and Sustainability
Executive General Manager  
– Human Resources
Grace Westdorp
Amanda Tober
Company Secretary
Heidi Aldred
InvoCare            Annual Report 2020  | 12
2020 Sustainability highlights
Health & Safety
InvoCare was very pleased to have remained 
operational throughout the 2020 COVID-19 
Local empowerment and rewards
A significant component of 2020’s COVID-19 
driven cost control was to substantially reduce the 
lockdowns without any recorded cases of workplace-
level of centrally located operational management, 
acquired infections.
delegating more authority and responsibility to local 
Heightened awareness of safety, backed by increased 
leaders and teams. 
resources around safety risk evaluation and best 
The quarterly Net Promoter Score incentives for 
practices were realised through online safety training 
our customer-facing employees were deferred 
and incentive initiatives. These initiatives contributed to 
during 2020. However in recognition of the critical 
a 11.6% reduction in Lost Time Injury Frequency Rates 
roles they had in maintaining excellent client service 
(LTIFR) from 2019 to 2020, which was ahead of our 
and satisfaction, an end of year incentive was paid in 
proposed target (10.0%). 
December 2020.
Digital accessibility
Another key achievement in 2020 was to provide our 
client families and others much greater online access 
to our employees, product and service information and 
live events. 
Accelerated due to COVID-19 lockdowns, digital 
platform innovations were a key outcome of the 
increased focus on positive customer engagement. 
More accessible and transparent information was 
provided which  contributed to positive Net Promoter 
Score outcomes.
Modern slavery statement
A significant milestone at the end of the 2020 year was 
the development of our Modern Slavery Statement, 
which sets out our process to identify, prevent, mitigate 
and address modern slavery risks in our supply chain. 
The Statement reflects our commitment to 
understanding and addressing the social and ethical 
challenges associated with our business and to 
promoting high standards of ethics and integrity.
Building on the success of the ongoing Aspire 
Leadership program, these initiatives have supported 
the maintenance of very high Net Promoter Score 
levels (+79) despite the frustrations and uncertainties 
associated with COVID-19 lockdown regulations.
Gender-balanced senior  
leadership team
At the end of 2020 our Executive Leadership Team, 
including the CEO, was equally gender balanced 
with four females and four males. Normally reported 
without the CEO (who is counted with the Board) this 
is a significant improvement on last year.
Diversity and inclusion leadership
In 2020, InvoCare was included as one of only nine 
Australian listed corporations in the world’s top 100 
companies by the Refinitiv Diversity and Inclusion 
Index. 
As one of the top 100 international organisations from 
over 9,000 assessed globally, that places InvoCare 
in the top 1% of the world’s listed organisations on 
Diversity and Inclusion.
Download the full 2020 
Sustainability Report
Scan this QR code on your smart 
device to access the full report
InvoCare            Annual Report 2020  | 13
InvoCare FY20 Sustainability ReportNew dimension to sustainabilityPerformance Review12Directors’ Report3Financial Report4Other InformationManaging the impact of COVID-19
The Company’s response to the  
COVID-19 pandemic revolved around  
four key principles:
• •  Safety  
of our staff, suppliers and client families
• •  Retention of key talent   
measured approach to cost control, retaining frontline 
field staff expertise to ensure uninterrupted support to 
client families
The operation and financial performance of all InvoCare business units 
was substantially impacted by the COVID-19 pandemic, due both to 
a decline in the number of deaths in the communities we serve, and to 
the restrictions placed on our ability to host funeral gatherings.
Preliminary indications of partial data from the ABS for doctor certified 
deaths in Australia covering the 52 weeks ending 31 December 2020 
are that social isolation, social distancing, face masks and hygiene 
awareness has contributed to the number of deaths reducing by 
around 2.3% relative to the comparable period in 2019. In New 
Zealand, full-year data shows that the number of deaths has declined 
• •  Maintain customer service standards   
by 4.8% year on year.
innovative and digitally focused solutions allowed 
families to continue to arrange a service which 
honoured their loved ones
• •  Strong balance sheet   
The decline in the number of deaths is reflected in both funeral 
and cremation case volumes, which were down 3% and 3.8% 
respectively. During the winter flu season, which is normally the 
busiest time of the year (Q2/3), the Group’s funeral case volumes were 
capital raise and extension of debt maturity allowed 
down by 6%.
the Group to deleverage the balance sheet and 
maintain the momentum of its growth initiatives. 
The nature and impact of government restrictions varied from time to 
time and place to place, as circumstances changed. The overall result 
was a substantial shift towards simpler funeral ceremonies and an 
increase in cremations and direct cremations in all three countries.
InvoCare            Annual Report 2020  | 14
The financial impact on our funeral businesses was relatively greater 
government cost relief to cover the cost of PPE and it did not qualify 
in Singapore, where full-service offerings on farewells which normally 
for JobKeeper. Wage subsidies were received in the New Zealand and 
last from three to seven days were severely affected by prolonged 
Singaporean businesses contributing $2.3 million to other income in 
government restrictions and ongoing bans on catered indoor wakes 
the year.
and gatherings. New Zealand, where traditionally most people are 
embalmed, was also badly impacted. In Australia, we were able 
to leverage our Simplicity and Value Cremations brands to meet 
the market demand for affordable arrangements that combined a 
memorial event with a cremation, reducing the relative severity of the 
financial impact.
On the positive side, InvoCare was able to sustain its very high NPS 
(+79) over the course of the year, in part due to our ability to provide 
online video access to funeral ceremonies, which was offered to 
clients free of charge. We were also able to manage the relatively high 
risks of COVID-19 infections associated with serving many families 
affected by the disease, with no recorded cases of work-related 
Social distancing measures also impacted on the performance 
infections amongst staff or customers throughout the year.
of our Memorial Parks business, albeit to a lesser extent. Chapels 
had reduced capacities due to the two and four-square metre rules 
restricting our full range of services. Offsetting an initial reduction 
in revenue during March and April due to reduced attendance at 
our parks, we have seen strong revenue performance from the 
Memorial Parks business in the second half of the year, particularly 
The majority of our staff voluntarily chose to take one day a week leave 
for several weeks during the first wave of lockdowns in April and May, 
a testament to the One Team culture embedded within the business. 
The Non-Executive Directors also chose to reduce their fees by 25% 
for a period of four months this financial year. 
in memorialisation sales. Also, digital investment was accelerated 
The extraordinary challenges and stresses placed on our staff by 
to ensure our parks had the appropriate AV technology to be able to 
the need to manage COVID-19 restrictions and remain operational 
conduct live streamed funeral services.
With the easing of COVID-19 related restrictions all markets have seen 
a return to more typical patterns of demand for face-to-face services 
and larger funeral gatherings.
despite risks of exposure to the disease have been acknowledged 
and addressed via a heightened focus on mental wellbeing and social 
support. An important challenge for the coming year will be to mitigate 
the cumulative effects of these human impacts while ensuring that we 
sustain high levels of service quality and continue to reduce voluntary 
Operating expenses for the Group included $1.9 million of incremental 
turnover rates.
costs associated with live streaming, cleaning, and personal 
protection equipment (PPE). The ability to travel remains volatile and 
specific safety measures remain necessary. In addition, the funeral 
services industry in Australia was not considered to be an ‘essential 
service’ and therefore the business did not receive any Australian 
Photographs courtesy of Billy Foster Photography
InvoCare            Annual Report 2020  | 15
Performance Review12Directors’ Report3Financial Report4Other InformationOur community
The Queen of Nurses  
Louise Thomson, 1960 – 2021
Our ladies were honoured to farewell an incredible woman, Louise 
Thomson, who dedicated her life to bettering the nursing community. 
Working in consultation with her husband Steve Thomson, White 
Lady Funerals in Melbourne ensured that Louise was farewelled in 
the grandeur befitting her larger-than-life personality and her long and 
accomplished career.
Louise, or Louy as she was affectionately known, left an enduring 
mark on our communities through her work to empower women 
to progress their careers or enrich their personal lives. She was 
farewelled in style in a sea of her favourite colours – hot pink and red – 
with eight adorned horses leading the procession and guard  
of honour.
The Queen of Queensland 
Mabel Crosby, 1909 – 2021
The team at George Hartnett Metropolitan Funerals were 
honoured to host a celebration of the life of Mabel Crosby, 
Australia’s oldest resident, who passed following a brief 
illness at the age of 111.
Mabel’s own desire was for a simple service with just one 
hymn and a single red rose for her coffin, requesting that 
people should honour her passing with donations to 
Vision Australia rather than flowers. 
Farewelled by her three surviving children, 10 
grandchildren, 20 great grandchildren and 9 great, great 
grandchildren, Mabel’s long life was a testament to 
the tough and pioneering spirit that has 
been so important to the development of 
Australia as we know it today.
InvoCare            Annual Report 2020  | 16
Making it personal 
Life Art
An area of focus is to increase the variety of ways in which customers 
might choose to memorialise a life; Life Art is a business that offers 
personalised artwork on coffins that reflect the special character or 
passion of the loved one whose life is being celebrated.
LifeArt predesigned  
or customised coffins
Making it personal  
Luteru Reupena
A personal passion for honouring the 
end of life is part of the vocation that calls 
people of all ages and cultures to work in our 
industry. From a Samoan heritage and trained 
as a carpenter, Luteru first learned his carving 
skills working with a professional Samoan carver 
to carving the lecterns, pulpits and icons for his 
church.
In 2017, more than a decade after Luteru chose 
to become a mortician, his skills were called 
upon to carve the coffin of a fellow church 
member. Since then, Luteru has accepted many 
requests for personalised carvings of coffins and 
grave markers. 
                Combining the roles of contemporary funeral professional, traditional 
cultural craftsman and dedicated local community member, Luteru epitomises 
,,
the personal passion that we share for celebrating the end of life.,,
InvoCare            Annual Report 2020  | 17
Performance Review12Directors’ Report3Financial Report4Other InformationInvoCare            Annual Report 2020  | 18
Directors’ Report
InvoCare            Annual Report 2020  | 19
Directors’ Report
Your directors present their report, together with the consolidated financial report 
of InvoCare Limited (the Company) and its subsidiaries (together referred to as 
InvoCare or the Group) for the financial year ended 31 December 2020, along with 
the independent audit report.
The flow of the information in the Directors’ report is outlined in the table below.
Information is only being included in the 2020 Annual 
PAGE 
INFORMATION
Operating and financial review
Report to the extent it has been considered material 
and relevant to the understanding of the financial 
performance and financial position of the Group.
21 
21 
21 
21 
21 
25 
25 
27 
28 
30 
31 
33 
34 
36 
60 
60 
60 
61 
64 
64 
64 
65 
65 
65 
65 
65 
65 
65 
66 
Company overview and principal activities
A disclosure is considered material and relevant if,  
for example:
• •  The dollar amount is significant in size (quantitative 
factor)
• •  The dollar amount is significant by nature 
(qualitative factor)
• •  The Group’s results cannot be understood without 
the specific disclosure (qualitative factor)
• •  It is critical to allow a user to understand the impact 
of significant changes in the Group’s business 
during the period such as business acquisitions 
(qualitative factor)
• •  It relates to an aspect of the Group’s operations 
that is important to its future performance
Review of financial performance
Generating long term shareholder returns 
Profit performance
Portfolio management
Balance sheet
Cash flow
InvoCare business strategy update
2021 outlook
Risks
Reconciliation of financial information
Glossary for operating and financial review
Remuneration report – audited
Other statutory matters
Directors
Directorships of other listed companies
Directors’ profiles 
Meetings of directors
Company secretary
Significant changes in the state of affairs
Dividends
Subsequent events
Indemnification and insurance of officers
Environmental regulation and performance
Corporate governance
Non-audit services
Rounding of amounts
Auditor’s independence declaration
InvoCare            Annual Report 2020  | 20
Directors’ Report
Operating and financial review
Company overview and principal activities
Profit performance
InvoCare Limited (listed on the Australian Securities Exchange, 
The year ended 31 December 2020 has been a year of unprecedented 
ASX:IVC), headquartered in Sydney, is a leading provider of  
disruption. Whilst the success that countries like Australia, New 
at-need and pre-need funeral services in Australia, New Zealand 
Zealand and Singapore have had in controlling COVID-19 has kept 
and Singapore operating a portfolio of national and local brands in its 
their populations safe, the travel restrictions and social distancing 
network of over 278 locations. It also owns and operates 17 private 
initiatives combined with government imposed funeral attendee limits, 
memorial parks providing burial, memorialisation and cremation 
have led to a softening of the funeral services sector.
services respectively. Following acquisitions in 2020, InvoCare is now 
also a leading provider of Pet Cremation services in Australia.
Review of financial performance
To grow earnings per share and total shareholder returns, we seek 
to complement operational execution of our strategy with financial 
discipline, strong portfolio management, balance sheet strength and 
cash flow generation. Set out below is a description of these areas and 
the financial tools we use to measure success:
The Group delivered Operating net profit after tax of $27.3 million 
for the year, a 54% decline on the PCP driven both by a decrease 
in funeral case volume and case average in Australia, New Zealand 
and Singapore and an $18.5 million increase in operating costs. The 
latter includes $5.3 million of significant items arising from reviews of 
carrying values undertaken at the year-end of aged debtors and slow 
moving inventory and $1.7 million of costs associated with the change 
in senior leadership that was announced in the second half. It also 
reflects increased costs of working such as COVID-19 driven PPE 
and live streaming costs and EBA award increases to wages that were 
• •  Financial discipline – Focus on cost control and efficiency to drive 
unavoidable.
positive operating leverage
• •  Balance sheet strength – Maintain funding flexibility and disciplined 
capital management to support growth aspirations
Reported loss for the year attributable to shareholders of $9.2 million 
reflects the impact of $25.5 million of impairments recognised 
with respect to the Group’s goodwill arising from its New Zealand 
• •  Portfolio management – Acting decisively on the allocation of 
operations and of capitalised IT development costs relating to certain 
capital and managing returns from investments
• •  Cash flow generation – Pursue working capital efficiency and 
realisation of profits into cash to reinvest in the business
The Group’s performance in these areas during the financial year ended 
31 December 2020 (2020) is set out on the following pages. The prior 
corresponding period (PCP) is the year ended 31 December 2019. 
Generating long term shareholder returns 
InvoCare seeks to optimise shareholder’s returns through earnings 
per share (EPS) and dividend growth which, if delivered, should 
support share price performance. The Board determined a fully 
franked final dividend of 7.0 cents per share for 2020, taking the 
full year ordinary dividend to 12.5 cents per share (fully franked), 
representing a dividend payout ratio of 61% of Operating EPS. 
The final dividend is payable on 22 April 2021 to shareholders who 
were on the Company’s register as at 4 March 2021, the record date 
for the final dividend. The Dividend Reinvestment Plan continues to 
operate in respect of the final dividend.
2020 
cents
2019 
cents
Movement 
%
Basic earnings per share 
(EPS)
Operating EPS
Final dividend
Total dividend for the 
financial year
Dividend payout ratio (%)
(6.9)
20.4
7.0
12.5
61%
55.8
51.7
23.5
41.0
79%
(112)
(61)
(70)
(70)
modules of the Oracle Enterprise Resource Planning (ERP) system 
rolled out in the PCP. The impairment of goodwill related to the New 
Zealand operations (which represents less than 10% of Group 
Operating EBITDA) reflects the disruption caused by COVID-19 
and the subsequent restrictions imposed by the New Zealand 
government that hampered the Group’s ability to operate as planned. 
New Zealand’s financial performance was significantly impacted 
as a consequence and this has been reflected in long term financial 
projections used to support carrying value testing. The $6.2 million 
partial impairment of certain modules of the Oracle ERP system 
reflects significant remediation in 2020 and the replacement of certain 
functionality that has rendered some elements of the IT platform 
obsolete.
Partially offsetting the impact of these impairments, an assessment 
of carrying values of our memorial parks and crematoria during the 
year has identified an impairment reversal of $6 million with respect 
to Allambe Memorial Park following remediation works undertaken 
over the last two years enabling a gradual return to successful sales 
performance.
Also reflected in the reported loss for the year is a $16.6 million loss 
arising from the mark-to-market accounting for pre-paid funeral 
contracts with a $3.7 million gain on the revaluation of pre-paid funds 
under management (FUM) offset by a $20.3 million increase in the 
associated provision for pre-paid contract liabilities. It should be 
noted that the provision for pre-paid contract liabilities has increased 
in line with expected change in costs to fulfil the contracts. The 
corresponding value of the (independently controlled) funds under 
management reflects the gradual recovery in equities and asset values 
(18 ppts)
over the year from the significant equity market volatility experienced 
in the first half of 2020. This net movement compares unfavourably 
InvoCare            Annual Report 2020  | 21
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Operating and financial review continued
to the PCP where a large $45.6 million net gain on the revaluation of 
Despite such a challenging year, the resilient nature of the funeral 
pre-paid FUM assets was recognised driven by strong returns from 
services industry is reflected in the operating revenue results, with a 
the equities market and property investment revaluations. Importantly, 
stronger Q4 in funeral case volume and case averages stemming the 
the headroom between pre-paid contract FUM assets and pre-paid 
full year operating revenue decline to 4.7%.
contract liabilities remains healthy at $71.8 million at 31 December 2020.
Operating results for 2020
InvoCare considers Operating earnings before interest, tax, 
depreciation and amortisation and business acquisition costs 
(Operating EBITDA) and Operating earnings before interest and tax 
(Operating EBIT) as key performance measures.
Operating EBITDA, EBIT and net profit after tax exclude the following 
items:
• •  The financial impacts of the pre-paid funerals business
A high proportion of our sales are driven through referrals and 
therefore maintaining the quality of our service standards is critical. 
It was a deliberate management decision to maintain full service 
levels at a time of heightened anxiety amongst our client families. 
With employee costs a large proportion of OPEX this meant that 
fluctuations in revenue had a consequential impact on Operating 
EBITDA, which reduced 29% on the PCP and is reflected in the  
7.1 ppts increase in OPEX to sales % metric to 54%.
Cost savings achieved in employee expenses from leave initiatives, 
reduction in temporary labour and restructuring activities undertaken 
in response to COVID-19 have been offset by a number of additional 
• •  Other non-operating activities, including asset sale gains/losses, 
expenses including contractual wage increases of c.3%, $5.3 million 
impairment losses and restructuring costs as relevant
• •  Net finance costs associated with the pre-paid funerals business
• •  The tax effect of the above items
A reconciliation of operating to statutory financial results is included on 
page 33.
Set out in the table below is the operating result and key performance 
metrics:
Revenue
Expenses
EBITDA
Depreciation and 
amortisation
2020 
$’000
2019 
$’000
Movement 
%
476,249
499,665
(373,684)
(355,232)
102,565
144,433
(44,280)
(36,973)
Business acquisition costs
(1,918)
(2,021)
EBIT
56,367
105,439
Net finance costs
(20,484)
(23,213)
Profit before income tax
35,883
82,226
Income tax expense
(8,405)
(23,024)
Non-controlling interest
(167)
(136)
Operating net profit after 
income tax
27,311
59,066
(4.7)
(5.2)
(29)
(20)
5.1
(47)
12
(56)
63
(23)
(54)
of costs arising from the increases in provisions for aged debtors and 
slow moving inventory and $1.7 million of costs associated with the 
change in senior leadership announced in the second half.
Depreciation and amortisation expense increased $7.3 million or 
20% on the PCP driven by increased depreciation of leasehold 
improvements arising from completed Network and Brand 
Optimisation (NBO) projects and amortisation of captialised IT 
costs relating to the implementation of the Oracle ERP system. The 
impairment of the latter as previously disclosed, has been recognised 
within non-operating expenses.
Net finance costs have declined $2.7 million reflecting the benefit of 
repaying $111.8 million of borrowings following the successful capital 
raising in April and May 2020.
Operating revenue by region
By regions
Australia
New Zealand
Singapore
Total
2020 
$’000
2019 
$’000
Movement 
%
404,855
421,863
51,990
56,579
19,404
21,223
476,249
499,665
(4.0)
(8.1)
(8.6)
(4.7)
OPEX to sales %*
EBITDA margin (%)
EBIT margin (%)
Operating EPS (cents per 
share)
53%
22%
12%
46%
29%
21%
(7.1 ppts)
(7.4 ppts)
(9.3 ppts)
20.4
51.7
(61)
*    OPEX excludes finished goods, consumables and funeral 
disbursements.
InvoCare            Annual Report 2020  | 22
Operating EBITDA and EBIT by region
By regions
Australia
New Zealand
Singapore
Total
Operating results by revenue type
2020
Case volumes (number)
Revenue
EBITDA
EBITDA margin (%)
EBIT
2019
Case volumes (number)
Revenue
EBITDA
EBITDA margin (%)
EBIT
Australia
Funeral services
The Australian funeral services business experienced challenging 
market conditions, notably in Q2 and Q3. It finished the year with 
a 7.2% decrease in revenue overall attributed primarily to a 4.5% 
reduction in funeral case average and to a lesser extent a reduction in 
volume, which had recovered in most states by the end of the year and 
grew 3% on the PCP in Q4.
Despite decreases in revenue earned from professional service 
fees and items such as catering and transport services, which were 
unable to be provided in a lot of instances in line with social restriction 
requirements, the business also observed changes in category spend 
by client families, with the inability to hold in-person farewells driving 
an increase in coffin and floral arrangement spend, particularly at the 
height of lock downs.
The trend observed in the first half of an increase in demand for simpler 
funerals and direct cremations continued into Q3 as travel restrictions 
and attendee limits hampered the ability for client families to conduct 
full service farewells, but, as restrictions eased demand for full service 
offerings has slowly recovered.
Operating EBITDA
Operating EBIT
2020 
$’000
2019 
$’000
Movement 
%
2020 
$’000
2019 
$’000
Movement 
%
84,395
121,627
8,778
9,392
12,889
9,917
102,565
144,433
(31)
(32)
(5.3)
(29)
44,746
88,868
3,416
8,205
7,855
8,716
56,367
105,439
Funeral  
services 
$’000
44,784
349,297
80,035
23%
49,673
46,171
377,525
107,853
29%
81,813
Memorial  
Parks 
$’000
Pet  
cremations 
$’000
Support  
office 
$’000
122,310
57,632
47%
51,661
121,324
63,150
52%
57,275
4,642
502
11%
(301)
816
(1,239)
(152%)
(1,580)
-
(35,604)
-
(44,666)
-
(25,331)
-
(50)
(57)
(5.9)
(47)
Total 
$’000
44,784
476,249
102,565
22%
56,367
46,171
499,665
144,433
29%
(32,069)
105,439
The business was also able to respond to this change in market 
demand notably with our Simplicity brand, which offers client families 
an arrangement that combines a memorial event and cremation 
at an affordable price. In addition, despite a weaker April and May, 
packages put together in our White Lady and traditional brand 
locations meant we could still provide client families with higher 
service arrangements that were meaningful farewells but just of a 
smaller size. Live streaming was also provided to client families at no 
additional charge. This continuation of high-quality service has been 
reflected in the business’ NPS score of +79 for the year.
Overall funeral case volume in Australia declined 2.5% compared to 
the PCP with a strong second half in both New South Wales and West 
Australian businesses partially offsetting declines experienced in 
Victoria and Queensland. Victoria notably was hard hit by lockdowns 
in Q3 compared to other states.
As noted previously, the focus on maintaining client service 
throughout the pandemic and the fixed cost nature of the funeral 
services business has meant that the revenue decline has been 
transmitted directly to Operating EBITDA, which has decreased by 
27%, and EBITDA margin has dropped 5.5 ppts. Despite actions 
taken during the year to reorganise the business on a regional basis 
InvoCare            Annual Report 2020  | 23
Performance Review12Directors’ Report3Financial Report4Other Information 
Directors’ Report
Operating and financial review continued
and to remove layers of middle management that resulted in second 
half employee cost savings, increased marketing costs in the first 
half to protect volumes in a market where we couldn’t offer our usual 
product and services, the increase in facilities costs arising from NBO 
locations, the impact of incremental COVID-19 driven costs and the 
increase to provisions for aged debtors noted previously, have driven 
a 5.8% increase in operating expenses for the year.
Pre-paid funerals
The recognition of a reported loss for the year partly reflects the 
impact of non-cash movements in our pre-paid funerals business’ 
funds under management (FUM). Reported profit of $63.8 million in 
the PCP included a net $45.6 million mark-to-market (MTM) gain on 
the revaluation of undelivered pre-paid FUM and contract liabilities. 
New Zealand
Total revenue for the New Zealand business declined 8.1% on the 
PCP driven primarily from a 6.7% decline in case average and to a 
lesser extent volume decline.
The restrictions placed on funeral services in New Zealand were more 
extreme than in Australia with no funerals or tangihanga permitted 
in late March into April (direct cremation or burials only). This led to a 
25% decline in Q2 funeral case averages alone in this business.
Similar trends to Australia were observed in revenue drivers of case 
average decline with a reduction in professional service fees the main 
contributor but reduced catering services have had a greater impact 
on case average than in Australia, as attendee limits reduced demand 
Market volatility (particularly in equity markets) in 2020 arising from 
for this service significantly.
COVID-19 uncertainty has held asset valuations relatively flat, 
resulting in a net $17 million MTM loss for 2020 (which reflects a 
material improvement on the $39.5 million half year net loss recorded 
at 30 June 2020). It is primarily for this reason that the Company has 
historically distinguished its results on an operating versus non-
Despite restrictions on the level of service that was able to be provided 
to client families, the hard work and dedication of our employees to 
support our client families through these difficult periods was reflected 
in growth in the business’ NPS score by 2 ppts to +86.
operating basis to exclude the impact of such material, non-cash 
Overall, the New Zealand funeral case volume declined 4.9% 
movements. Importantly, FUM asset headroom (defined as pre-paid 
compared to the PCP driven primarily by a weaker Q2 and Q3 with the 
contract assets less liabilities) at 31 December 2020 remains strong at 
country experiencing a benign winter flu season (like Australia), but 
approximately $72 million.
Memorial Parks
COVID-19 led to reduced patronage at the parks with the cancellation 
of many community events, particularly in the first half of the reporting 
period. Despite this, the Memorial Parks business recorded strong 
growth in memorialisation sales in the second half of the year, 
notably from sales from deepening relationships with local religious 
communities at some of our largest parks. This growth, together 
with a favourable release of revenue deferred on transition to  
AASB 15 Revenue from Contracts with Customers as instalment 
payers completed their plans, drove an overall increase in revenue of 
1% against the PCP.
Operating EBITDA was down 8.7% on the PCP as operating costs 
increased with the shift to live streaming of memorial services, 
increased cleaning to protect client families and employees, and 
increased grounds maintenance costs. An additional provision for 
slow moving inventory of $2.5 million has also been recognised 
following a review of slow-moving inventory items. The provision mainly 
relates to single-site niche walls and specific memorial developments 
that have not achieved expected sales since construction.
Pet cremations
The pet cremations business in Australia continued to grow and was 
largely untouched by COVID-19. The greenfield development on the 
existing NSW Lakeside Memorial Park continued to ramp up and 
the second greenfield development on the NSW Central Coast had 
reached practical completion in June.
In November, the Group acquired two pet cremations businesses, 
Family Pet Care and Pets in Peace, representing a strategic expansion 
of the Group’s existing pet cremations business. Both of these 
businesses contributed only one month of trading results in the year.
volumes have slowly recovered over Q4.
The New Zealand funeral services market remains fragmented across 
regional areas and competition, particularly on price, has been 
increasing along with an observed increase in client family preference 
for simpler funerals and cremations for their loved ones. COVID-19 
has accelerated this change, with government restrictions on the 
number of funeral attendees and economic pressure on household 
incomes. This trend has a greater impact in New Zealand, where 
traditionally most people are embalmed, and the business does not 
currently have the breadth of brand portfolio in every local market 
to the extent we do in Australia, to quickly meet such changes in 
consumer demand. As a result, a review of the assumptions used 
in the long-term modelling to support the carrying value of the New 
Zealand group of cash generating units (CGUs) was made at the 
balance date and an impairment of $19.3 million of the goodwill 
allocated to this group of CGUs was recognised.
Singapore
Total revenue for the Singaporean business declined 8.6% with the 
funerals market negatively impacted by prolonged funeral attendance 
restrictions, a ban on catering and a general economic downturn 
in the country all of which has heightened price competition and 
reduced discretionary spend attached to higher service offerings. 
Declines in revenue have been driven both by funeral case average 
and volume declines.
InvoCare            Annual Report 2020  | 24
Funeral case average has declined 6.5% for the year with an 
increase in consumer preference for direct cremations as higher 
service, catered wakes and gatherings not permitted by government 
authorities. Similarly, funeral case volume has declined 5.3% on the 
PCP with an increase in competition observed in the market due to the 
low barriers of entry to the lower service, and direct cremation.
Disciplined cost control in the Singaporean business has held OPEX 
as a % of sales to 32% and improved EBITDA margin 3 ppts to 51% in 
the year despite a decline in Operating EBITDA to $9.4 million.
Balance sheet
InvoCare successfully deleveraged its balance sheet during the 
year via a successful $274 million institutional placement and share 
purchase plan and continues to maintain a strong balance sheet with 
a disciplined focus on working capital management. The Group’s capital 
employed excluding net debt items is comprised of the following.
Total capital employed as at 31 December
2020 
$’000
2019 
$’000
Movement 
%
Support office
InvoCare’s support office includes the centralised costs of 
Procurement as well as Information and Technology (IT), Finance, 
Marketing, Safety, Sustainability, Human Resources and the costs 
Trade and other receivables
82,582
82,794
Inventories
44,117
45,117
Trade and other payables
(60,514)
(60,810)
associated with the CEO, Company Secretary and Board. The 
Net working capital
66,185
67,101
increase in support office costs is attributed to a step up in IT related 
software license costs incurred by the Group following system 
investments in the current and prior year and $1.7 million of  
one-off transition costs incurred as a result of the appointment of  
new executive leadership during the year.
Portfolio management
Decisive action to invest, restructure or divest non-core operations 
while fulfilling the Company’s investment and strategic priorities is vital 
to managing InvoCare’s portfolio of operations.
Acquisitions
In July, the Group acquired Galaxy Funerals for $5.9 million,  
$5.3 million of which is deferred as it is contingent on achieving 
earnings targets over the next two years. Galaxy Funerals is a Sydney 
based funeral business with two locations that specialise in serving 
the Asian community. The acquisition represents an investment in the 
strategic priority of growing presence in the inclusive funerals market.
In November, the Group acquired two pet cremation businesses as 
noted previously for $49.8 million, $11.9 million of which was deferred 
and is contingent on achieving earnings targets over the next two 
years. These acquisitions represent a strategic expansion of the 
Group’s existing pet cremation businesses in NSW, positioning the 
Company to be Australia’s leading provider of pet cremation services 
in a growing industry.
Disposals
As part of the NBO project, sites that have been identified as non-core 
(0.3)
(2.2)
0.5
(1.4)
8.7
16
24
5.5
37
(73)
1.1
3.2
Property, plant and 
equipment
464,277
426,955
Intangibles
243,515
210,724
Net pre-paid funds under 
management/contract 
liabilities
71,822
94,006
Deferred selling costs
37,712
39,928
Deferred contract assets
4,066
6,449
Net right of use asset and 
lease liabilities a
(11,346)
(6,561)
Deferred revenue
(137,718)
(139,300)
Net tax items
Other items b
(34,513)
(35,639)
(34,632)
(16,716)
(107)
Total capital employed
669,368
646,947
Net debt
Net assets
(137,468)
(349,968)
531,900
296,979
3.5
61
79
Average working capital % 
of sales c
ROCE % d
14%
8.6%
10%
17%
4.0 ppts
(8.5 ppts)
a    Excludes certain finance leases which are considered ‘debt-like’ and 
included in net debt balance.
b    Includes assets held for sale, other financial assets, derivative financial 
instruments, provisions for employee entitlements and deferred 
consideration.
c    Represents the average working capital for the reporting period 
(average of opening and closing) divided by revenue for the same 
period.
are sold to realise their value. During the year the Group disposed of 
d    ROCE = Operating EBIT/(Average total equity + Average net debt).
six locations, four in Australia and two in New Zealand for combined 
proceeds of $11.9 million giving rise to a gain on disposal recognised 
through non-operating profit of $7.4 million.
Disciplined working capital management and the $5.3 million impact 
from the review of trade receivable and inventory carrying values at 
year end held working capital relatively steady on the PCP. Despite 
this, average working capital as a % of sales has increased 4 ppts in 
the year as the nature of inventory balances (primarily memorialisation 
items like crypts) do not fluctuate materially in response to revenue.
InvoCare            Annual Report 2020  | 25
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Operating and financial review continued
Total capital employed has increased by 3.5% reflecting the continued 
After accounting for borrowings, capitalised loan establishment costs, 
capital investment in property, plant and equipment arising primarily 
finance leases and a cash position of $118.8 million the Group’s net 
from the NBO program, an increase in intangibles arising from the 
debt as at 31 December 2020 was $137.5 million, a 61% decrease on 
acquisitions and continued capitalisation of IT development costs.
the PCP.
ROCE has deteriorated, reducing 8.5 ppts to 8.6%. This reflects 
InvoCare successfully deleveraged its balance sheet during the year 
reduced Operating EBIT in the year (as explained above) and an 
and undertook two key initiatives:
enlarged capital base driven by the equity raise. The $274 million of 
funds raised from the institutional placement and share purchase plan 
in April/May has been used to continue the roll out of NBO, shared 
service centres and IT projects and fund the acquisitions conducted 
during the year.
Included in the increase of property, plant and equipment is  
$39.5 million associated with the continuation of the NBO project as 
well as IT development costs. It was also impacted by the $6 million 
increase in the value of cemetery land reflecting a reversal of a portion 
of the previous impairment at Allambe Memorial Park (refer to  
Note 11 Non-current operating assets).
The net $32.8 million increase in intangible assets is net of the 
$52 million impact of acquisitions in the year and the $25.5 million 
impairment of the goodwill relating to the New Zealand business and 
of capitalised IT development costs previously referred to in this report 
(refer to Note 12 Intangibles).
The decrease in net pre-paid funds under management/contract 
liabilities of $22.2 million is driven by higher redemptions following 
service delivery and an increase in the provision for pre-paid contract 
liabilities of $20.3 million (2019: $20.3 million) reflecting the financing 
charge recognised on the liability. The 2019 net pre-paid funds 
under management of $94 million reflected a net $45.6 million gain 
on the revaluation of these balance sheet items. Equity market 
volatility, particularly in the first half due to uncertainties regarding 
COVID-19, have stabilised in the second half resulting in a significantly 
lower gain of $3.7 million from the mark-to-market revaluation 
of these independently controlled funds at 31 December 2020. 
Notwithstanding this impact in 2020, significant headroom  
between the asset and liability remains healthy at $71.8 million at  
31 December 2020.
Net debt as at 31 December
2020 
$’000
2019 
$’000
Movement 
%
Cash and cash equivalents
118,781
19,560
Borrowings
(246,039)
(357,189)
Net right of use asset and 
lease liabilities
(10,210)
(12,339)
Net debt
(137,468)
(349,968)
Total shareholders’ equity
531,900
296,979
507
31
17
61
79
Gearing ratio (spot) %
Leverage ratio (times)
Interest cover ratio (times)
21%
1.3
8.3
54%
2.4
10.1
(34 ppts)
1.1
1.8
• •  Conducted a well-supported institutional placement and share 
purchase plan that raised $274 million of capital in April/May with a 
small discount to prevailing share price ($270.9 million net of raise 
costs)
• •  On 19 June 2020, the Group successfully renegotiated its three 
year $200 million revolving debt facility, extending its maturity 
to February 2023, as it was due to expire in February 2021. This 
facility remains undrawn
Both these measures provide the Group with balance sheet flexibility 
to support the business during the period of economic uncertainty 
and to fund growth initiatives, and also allowed repayment of  
$111 million of borrowings during the year.
The Group has access to $452.5 million of loan facilities at  
31 December 2020 as follows:
• •  10 year $100 million Note Purchase Agreement with Metlife,  
fully drawn at 31 December 2020 and due for repayment in 
February 2028
• •  5 year Syndicated Facility Agreement supported by ANZ, HSBC, 
Westpac, Mizuho and SMBC providing $152.5 million (fully drawn) 
and $200 million (undrawn) due for repayment in February 2023. 
The facilities are multi-currency with NZ$50 million drawn with 
respect to New Zealand and SG$35 million drawn with respect to 
Singapore
The foreign currency drawings naturally hedge InvoCare’s 
investments in the Singapore and New Zealand markets.
The financial covenant ratios included on the debt facilities differ from 
the calculations included in the table above as they are calculated on 
an adjusted Operating EBITDA basis (primarily to include the proforma 
earnings contributions from acquisitions and to adjust for costs arising 
from restructuring initiatives). The covenant target ratios are as follows:
• •  Leverage ratio (being net debt to adjusted Operating EBITDA) must 
be no greater than 3.5x
• •  Interest cover ratio (being adjusted Operating EBITDA to net 
interest adjusted to remove interest related to AASB 16 lease 
accounting) must be greater than 3.0x
The above ratios continued to be met as at 31 December 2020, being 
1.3x and 8.3x, respectively (2019: 2.4x and 10.1x, respectively).
To maintain certainty over cash flows, the Group also has financial risk 
management policies limiting exposure to interest rate fluctuations. In 
accordance with InvoCare’s policy, at 31 December 2020, 58% (2019: 
94%) of the debt principal was at fixed interest rates through using 
either floating to fixed interest rate swaps or fixed rate debt (notably 
the $100 million Note Purchase Agreement).
InvoCare            Annual Report 2020  | 26
Due to the level of stability of Singaporean interest rates and its 
The Group ended the period with cash on hand of $118.8 million and 
quantum, Singapore dollar debt is not covered by interest rate swaps. 
improved its cash conversion to 107% (2019: 82%).
Additionally, due to low volatility of interest rates the Group’s policy has 
been amended and no new interest rate swaps will be taken out whilst 
low interest rates continue. Existing swaps in place will be allowed to 
expire.
Despite a reduction in business activity during the year, a disciplined 
focus on current year cash collections and a reduction in tax and 
finance costs paid has led to growth in operating cash flows of 7.6%. 
This has also led to improved cash conversion and realisation ratios as 
While there is the ability to pay down an additional, material amount 
more earnings were converted into cash.
of debt, the fixed term nature of these drawn facilities means that 
repayment would result in retirement of such debt. A review will 
be undertaken in the first half of 2021 to determine an appropriate 
structure and tenure of the Group’s debt facilities.
Cash flow
Investing cash flows for the year of $84 million includes $38.5 million 
for the purchase of the two pet cremation businesses and the Galaxy 
Funerals business (excluding the amounts deferred as previously 
noted) and proceeds of $11.9 million from the disposal of certain 
properties as part of our ongoing portfolio management activities.
Capital expenditure (CAPEX) of $68.1 million in the year included 
InvoCare aims to use cash generated from operations to pay down 
$39.5 million of NBO related expenditure and $16.2 million of 
borrowings, fund capital expenditure and bolt-on acquisitions and 
IT related projects. The remainder relates primarily to annual 
return dividends to shareholders.
maintenance CAPEX of the Group’s facilities.
Net financing cash flows includes the impact of the $270.9 million 
capital raise net of raise costs, the subsequent $111.8 million 
repayment of debt and $3.1 million of payments made to exit related 
interest rate swaps early following repayment of a debt as noted 
previously. In addition, the deferred 2019 final dividend was paid in 
October 2020.
Cash conversion % calculation
Operating cash flows
2020 
$’000
2019 
$’000
63,568
59,070
Add back: Net finance costs paid
17,046
20,803
Add back: Tax paid
14,424
20,631
Net funds from pre-paid contracts
12,857
15,866
Other cash flows related to pre-paid 
contracts
1,429
2,406
Ungeared, tax free operating cash flows
109,324
118,776
Operating EBITDA
Cash conversion %
102,565
144,433
107%
82%
The conversion ratio calculation and the line items as shown in the 
table above are all non-IFRS information, however, all financial data is 
based on the information disclosed in the audited financial statements 
and notes to the financial statements and follow the recognition 
requirements of Australian Accounting Standards.
Abridged cash flow for the year ended 31 December
Movement 
%
2020 
$’000
2019 
$’000
Operating EBITDA
102,565
144,433
Net change in working 
capital
(7,527)
(43,929)
Net finance costs paid
(17,046)
(20,803)
Tax paid
(14,424)
(20,631)
Operating cash flows
63,568
59,070
Acquisitions
(40,581)
(15,187)
Divestments/sale of assets
11,908
6,550
Capital expenditure
(68,136)
(65,289)
Net funds from pre-paid 
contracts
12,857
15,866
Investing cash flows
(83,952)
(58,060)
Dividends paid
(29,514)
(32,863)
(29)
(83)
18
30
7.6
(167)
82
(4.4)
(19)
(45)
10
Equity raise (net of raise 
costs)
270,875
85,787
216
Net draw down/repayment 
of borrowings
(106,761)
(53,103)
Net lease payments
(11,599)
3,625
Other
(3,184)
258
Financing cash flows
Change in cash held
Cash conversion %a
Cash realisation %b
119,817
99,433
107%
89%
3,704
4,714
82%
62%
(101)
420
(1,334)
(3,135)
2,009
25 ppts
27 ppts
a  Cash conversion % calculated as per table below.
b    Cash realisation % means Operating cash flows as a % of operating 
profit after income tax for the period adjusted to remove depreciation 
and amortisation expense.
InvoCare            Annual Report 2020  | 27
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Operating and financial review continued
InvoCare business strategy update
In 2016 the InvoCare Board recognised that acquisitions alone  
could not continue to drive EPS growth at the same level as  
historically achieved. Regulatory limits on further acquisitions in 
Australian metropolitan markets imposed by the ACCC and the 
growing demand for personalised funeral celebrations in modern,  
non-religious surroundings led to a shift in focus to updating existing 
facilities, products and service capabilities to meet contemporary 
expectations.
During 2016 and 2017, comprehensive plans were developed for 
a major transformation of the Group’s physical network to ensure 
that the Group’s facilities and product offerings were appropriate 
to drive organic growth into the future. The rollout of this Protect & 
share decline, increasing revenue by providing increased product 
offerings to meet the changing needs of client families and creating 
opportunities to drive operational efficiencies. The rollout of this 
strategy continued in 2020.
Network and brand optimisation (NBO)
A core focus of the Protect & Grow strategy has been the NBO 
program which is transforming InvoCare’s unrenovated, out-of-date 
and underperforming funeral homes into modern, contemporary 
locations with new capabilities that allow for additional service levels 
that are in-tune with client families’ needs and preferences. The 
following tables provide a summary of the completed projects since 
the commencement of the project in 2017 and the projects planned 
Grow strategy was started in 2017, with a focus on reversing market 
for completion in 2021.
Year completed/due
2017
2018
2019
2020
Refresh
Enhance
Growth
Total
CAPEX ($m)
Acquired properties ($m)
Sites sold (Number)
Proceeds ($m)
26
-
4
30
(21.0)
(8.3)
2
6.1
32
7
16
55
(39.2)
(1.2)
1
0.7
15
2
4
21
54
7
2
63
Total
127
16
26
169
(26.5)
(39.5)
(126.2)
-
3
3.1
-
6
12.0
(9.5)
12
21.9
2021 
estimate
40-50*
~2
*  Number of projects is approximate and subject to change
The total amount of capital deployed for NBO sites is $126.2 million 
As noted at half year, the restrictions and social distancing have had 
by the end of the four years to date. Offsetting this is $21.9 million of 
a greater impact on the renovated locations than the unrenovated 
proceeds from the sale of identified non-core sites as a result of this 
locations due to the low attendance at funerals negatively impacting 
program.
As part of the Group’s response to COVID-19 earlier in the year, 
CAPEX was delayed or deferred until such time as the full impact on 
the business was known. Despite a resumption of NBO activity in 
the second half, some projects have been delayed and are due to be 
the locations that are able to provide a wider range of services. 
Therefore, when assessing performance of NBO locations, 2020 
provides an abnormal trading year for comparison. It also makes it 
difficult to ascertain the drag on earnings that may have come from 
closed sites due to renovation and construction.
completed in early 2021. Notwithstanding the COVID-19 driven delay, 
The first cohort of 48 sites that were completed between June 2017 
a total of 63 projects were completed during the year. A further 40-50 
and July 2018 have now had two years of post completion trading for 
sites are planned for works in 2021, subject to business case and DA 
comparability purposes. Projects completed post that date have the 
approval.
abnormal 2020 trading conditions to cycle in their post completion 
returns assessments. 
It should be noted that there are around 50 to 60 locations remaining 
that do not form part of the NBO program of works. These are 
locations that either do not require renovation or are intended to be 
sold. Additionally, future Refresh renovation type activity will form part 
of the annual maintenance CAPEX budgets of the network from 2021.
Work will continue Enhance and Grow projects, to be categorised as 
Growth CAPEX and subject to disciplined capital approval processes.
InvoCare            Annual Report 2020  | 28
When comparing the growth in net sales of this cohort and growth in EBITDA margin (both pre NBO to now), those sites that were Enhance 
or Growth locations continue to outperform other locations both in volumes and sales. This is shown in the graph below.
Positive
EBITDA 
margin
(2016 – 
2020) 
versus 
Average
Average
Enhance/Growth 
location (first cohort)
Refresh location  
(first cohort)
Unrenovated 
location (as of 
December 2020)
Negative
Negative
Average
Positive
Net sales  (2016 – 2020) versus Average
How to read the above graph:
Operational efficiencies
• •  Locations plotted include unrenovated sites (as of December 
2020) and the 48 Refresh and Enhance/Grow NBO sites that were 
completed in the first cohort (2017 to July 2018)
As noted at half year, the roll out of the Oracle ERP system for the 
funeral services businesses in Australia and New Zealand is now 
complete (except for acquisitions and the Memorial Parks business, 
• •  Bubble size reflects NBO CAPEX spend per location
which is a focus in 2021). Initial implementation issues are being 
• •  Average is the average of all funerals locations in Australia and New 
Zealand including those that have been renovated after July 2018 
and those identified as not requiring NBO investment
• •  The horizontal axis is the growth in revenue (excluding 
disbursements) for a location relative to the average
• •  The vertical axis is the change in EBITDA margin of that location 
over the same period relative to the average
• •  The closer a bubble appears towards the top right of the chart, the 
better it has performed relative to the average for the same period.
addressed and the current year remediation activities undertaken 
is what has driven the $6.2 million of impairment of capitalised IT 
development costs.
In addition, four shared service centre projects were completed in 
the year with a further six to eight planned for 2021. A summary of the 
amount spent on IT investment and shared service centre projects 
from 2017 to 2020 is included in the table below.
CAPEX spend
Information technology ($m)
Shared service centres ($m)
2017
(6.7)
-
2018
(12.4)
(2.2)
2019
(7.6)
(7.9)
2020
(8.6)
(1.2)
Total
(35.3)
(11.3)
2021 
estimate
6-8 sites*
*  Number of projects is approximate and subject to change
InvoCare            Annual Report 2020  | 29
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Operating and financial review continued
People & Culture
2021 outlook
InvoCare is acutely aware of the additional pressures our employees 
InvoCare remains cautious in its outlook with short term market 
faced throughout the COVID-19 crisis. Working with grieving families 
conditions still being impacted by COVID-19 restrictions and the 
is highly emotional and demanding. In a COVID-19 impacted world, 
timing and extent of the unwind of related impacts remains hard to 
our team have strived to meet and exceed government guidelines to 
predict.
ensure the safety of themselves and their client families and friends. 
Those guidelines impact many aspects of the way funerals are 
planned and managed including restrictions on the attendance at 
funerals.
The Group remains nevertheless confident about the long term 
potential of this business with future growth underpinned by 
population and ageing trends in its markets, and management 
have initiated an operating model and cost efficiency review to 
NPS is a our key measure of customer satisfaction and the fact that 
further strengthen the business foundations. With an experienced 
the Group overall (excluding Singapore, which is not measured by 
team, strong national and local brands, a modernised asset base 
this metric) has been able to maintain or grow their NPS scores during 
and leading market position, the Company’s management see 
the year is a testament to the quality of the service that our employees 
many opportunities to leverage and optimise the foundations 
provide. The NPS result of +79 in 2020 also compares favourably to 
of the business to meet the evolving needs of client families and 
the NPS achieved at the beginning of the Protect & Grow strategy 
communities with an expanding value proposition. The Company will 
in 2017 of +74, a 5 point increase over the three years. This reflects 
also look to extend its industry leadership through increased focus 
the investment in leadership and management training alongside 
on talent, safety, sustainability, innovation, and proactive stakeholder 
the Group’s cultural and community engagement initiatives and the 
management.
positive impact these are having on both employee and client family 
experiences.
Ensuring the health and safety of our employees and client families 
is our highest priority. At the onset of the COVID-19 pandemic, 
InvoCare created a COVID-19 Taskforce focused on creating safe 
work practices, including infection control procedures, adequate 
personal protective equipment (PPE) availability and usage, cleaning 
guidelines, supporting remote working practices and general 
principles of COVID-19 safety.
Lost time injury frequency rate (LTIFR) is a key metric to measure the 
safety performance of the Group. The LTIFR in 2020 was 12.5, which 
reflects a 1.6 ppts improvement since the renewed strategic focus 
began in 2017. The recent appointment of a new EGM of Health, 
Safety and Sustainability in early 2021 reflects the continued focus on 
safety in our organisation.
Additionally, InvoCare took a proactive approach to the 
implementation of a paid pandemic leave policy in March 2020. We 
have also worked hard to support the new ways of working that have 
come with COVID-19, not only how we engage with each other, 
but also how we engage with our client families. In response, the 
Learning & Development team have delivered many training initiatives 
to employees via virtual platforms this year in order to upskill their 
capabilities in this changing environment.
The focus in 2019 shifted towards training our field team to become 
strong local leaders with a focus on providing the leadership required 
to elicit high levels of discretionary effort which is essential to delivering 
the highest levels of customer service. While this training has been 
put on hold in 2020 due to budgetary and travel constraints imposed 
by COVID-19, it is our intention to resume this program in 2021 as 
high performing, empowered local leaders are an essential part of our 
service proposition.
InvoCare            Annual Report 2020  | 30
Risks
The Company has in place an Enterprise Risk Management Framework. As part of the framework the Group maintains an extensive risk register. 
The most significant risk for annual financial performance is the number of deaths occurring in the markets in which we operate.
The key areas of identified risks are summarised below.
Risk
Description
Risk management mitigation
Number of deaths
• •  Change in mortality rates 
• •  BDM data monitoring and analysis
• •  Relocation of population to areas 
• •  Workforce flexibility
outside InvoCare business operating 
• •  Geographic footprint
regions
• •  Service offerings
• •  Data analytics
Strategic risk
• •  The risk that the Company’s 
• •  Experienced executive team
strategies and growth initiatives 
are not successfully executed or 
integrated or deliver the expected 
returns
• •  Board and CEO sign-off of individual business cases with process in place to 
monitor performance post execution
Competitive risk
• •  Risk from existing and new market 
• •  Focus on client satisfaction via continuous improvements in delivery of 
entrants
customer required products and services
• •  Competitors may offer/develop 
• •  Leveraging existing brands in local markets with strategies to expand market 
superior products/services
share locally
• •  Delivery of superior products/services to exceed customer expectations and 
competitors’ products/services offerings in same operating regions
• •  Focus on local community engagement and relationship to maintain or 
improve competitive advantage
Loss of key brand 
• •  Failure to maintain brand reputation 
• •  Continued investment in customer research to sustain market leading 
reputation/customer 
in market
position
relationships
• •  Failure to react to changes in 
• •  Customer feedback surveys and complaints monitoring
customers’ needs/trends
• •  Products and/or services do not 
keep pace with developments in 
market needs or technological 
advancements
• •  Customers/media complaints
• •  Net promoter score reporting or tracking
• •  Close monitoring of market developments
• •  NBO renovations and transformations of locations and facilities to exceed 
customer expectations
Regulatory risk
• •  Environmental regulations risks
• •  Sustainability plan and commitments
• •  Perpetual care
• •  Consumer Act training for employees
• •  Australian Competition and  
• •  Aligned accountabilities at executive level
Customer Act 2010 (Consumer Act) 
and other related legislations
Safety risk
• •  Occupational, health and safety risks
• •  Behavioural-based safety programmes
• •  Lost Time Injury Frequency Rate metrics reported monthly by business
People risk
• •  Loss of key executives
• •  Appropriate incentives and career development opportunities for key 
• •  Loss of key individuals in operating 
executives and senior management
businesses with consequential 
• •  Identification and management of high potential employees
material business interruption
InvoCare            Annual Report 2020  | 31
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Operating and financial review continued
Risk
Description
Risk management mitigation
Information 
• •  Risk of targeted cyber-attack against 
• •  Cyber-security training
technology (IT) risk – 
Company assets
• •  Dedicated internal resources to monitor and address cyber and information 
cyber risk, privacy  
and data sovereignty
• •  Unauthorised access to or loss of 
risks
customer data including personally 
identifiable data
• •  Risk of data loss/fraud, system 
breakdown
• •  ERP implementation risk
• •  Monitoring and prevention of unauthorised access to IT assets
• •  Code of Conduct is set up and relevant employee training is conducted
• •  Disaster Recovery Plan
• •  Penetration Testing
Reliance on single 
• •  Unable to supply products to deliver 
• •  Dedicated internal resources to monitor supply agreement contracts
point of failure in 
services for families
supply chain
• •  Commercial tendering processes to identify alternative suppliers
• •  Inventory management
Working capital
• •  The risk that the Company cannot 
• •  Six monthly reporting to funding providers on covenant compliance
meet its financial obligations
• •  Quarterly reforecasting and annual budget requiring Board sign off
• •  Regular monitoring and reporting on debtors
Investment risk –  
• •  Potential escalation in service/
• •  Control our cost of service at below 4% inflation factor applied to liability 
pre-paid funeral 
product costs
revaluation annually
contracts
• •  Volatility of investment returns on 
• •  Maintain Board representation in the Over Fifty Guardian Friendly Society, the 
pre-paid funds under management 
main investment portfolio for over 85% of the pre-paid funeral contracts
fluctuation
• •  Ensure the pre-paid funeral contracts are invested in diversified asset classes 
to maximise returns without exceeding risk levels as specified in accordance 
with the Fund investment policy and guidelines
Investment risk – 
• •  Deficiencies in due diligence
• •  Balance sheet management
acquisitions
• •  Potentially unknown or contingent 
• •  Investment Committee scrutinises investment proposals and provides 
liabilities
recommendations to the Board on acquisition decisions
• •  Reliance on previous owners 
• •  Post-acquisition reviews conducted to ensure performance in line with 
performing satisfactorily
expectation
• •  No guarantee of continued 
successful performance of acquired 
businesses
Financing risk
• •  Insufficient funding to capitalise on 
• •  Monthly reporting of financial metrics to the Board and Executive Leadership 
opportunities
Team
• •  Business unit performance reviews and monitoring against budget and 
forecasts
• •  Monitoring of debt covenants and monthly cashflow statements
Lease arrangements
• •  The risk that existing lease 
• •  Monthly reporting to executive on leases due for renewal
agreements are not renewed or not 
renewed at satisfactory levels
• •  Legal review for all lease contracts
A crisis occurs 
• •  A pandemic
• •   Pandemic and Epidemic Diseases Plan in place
threatening the 
Company, our 
stakeholders or the 
general public
• •  Natural disaster occurs such as 
• •  Infectious Disease procedure in place
fire, floods impacting significant 
operations
• •  IT system breakdown
• •  Emergency Management Plans, developed locally with clear escalation 
guidelines to Corporate Emergency Management Plan (EMP)
• •  Disaster Recovery Plan (DRP) in place to manage IT risks
• •  Above plans linked to Business Continuity Plan (BCP) with identified 
processes, roles and responsibilities to mitigate disruption to the business 
and community
InvoCare            Annual Report 2020  | 32
Reconciliation of financial information
The Company results are reported under Australian Accounting 
Standards (AASB). This report and associated market releases 
include certain non-IFRS measures including reference to operating/
non-operating measures of profitability and associated performance 
measures that are used internally to assess the performance of the 
business.
The Company considers Operating EBITDA and Operating profit 
after income tax as key performance measures. These measures 
are considered to provide more useful indications of the Group’s 
recurring earnings base and exclude the impact of significant items 
such as material impairments, asset sales gains/losses and costs 
of restructuring operations. Operating measures also exclude the 
impact of accounting for the Group’s funds under management and 
pre-paid funerals business which requires net gains and losses from 
undelivered pre-paid contracts to be included in reported profit. These 
gains and losses are non-cash and do not impact on the Company’s 
business operations.
The table below presents a reconciliation of statutory results as 
disclosed in the consolidated statement of comprehensive income 
and operating results in Note 1 Operating segments.
Year ended 31 December
Revenue
Expenses
EBITDA
Depreciation and amortisation
Business acquisition costs
Net gain/(loss) on pre-paid contracts
Asset sales gain/(loss)
Impairment loss on intangibles
EBIT
Net finance costs
Tax
Non-controlling interest
2020
Non-
operating 
results 
$’000
Operating 
results 
$’000
Statutory 
results 
$’000
Operating  
results 
$’000
2019
Non-
operating 
results 
$’000
Statutory 
results 
$’000
476,249
1,403
477,652
499,665
683
500,348
(373,684)
(6,350)
(380,034)
(355,232)
(8,026)
(363,258)
102,565
(4,947)
97,618
144,433
(7,343)
137,090
(44,280)
(1,918)
(12)
(44,292)
-
(1,918)
(36,973)
(2,021)
(13)
(36,986)
-
(2,021)
-
-
-
(16,618)
(16,618)
7,383
7,383
(19,500)
(19,500)
-
-
-
45,550
45,550
2,404
2,404
(24,404)
(24,404)
56,367
(33,694)
22,673
105,439
16,194
121,633
(20,484)
(3,386)
(23,870)
(23,213)
(1,247)
(24,460)
(8,405)
(167)
527
-
(7,878)
(167)
(23,024)
(10,261)
(33,285)
(136)
-
(136)
Net profit/(loss) after income tax attributable to 
equity holders of InvoCare Limited
EPS (cents per share)
OPEX to sales %
EBITDA margin (%)
EBIT margin (%)
27,311
(36,553)
(9,242)
59,066
4,686
63,752
20.4
53%
22%
12%
(27.3)
(6.9)
54%
20%
4.7%
51.7
46%
29%
21%
4.1
55.8
48%
27%
24%
The table above summarises the key reconciling items between 
The Directors also consider that the presentation of all activities 
net profit after tax attributable to the Company’s equity holders 
related to the mark-to-market fair value movements in the 
and operating EBITDA and EBIT. The operating EBITDA and EBIT 
independently controlled funds under management and pre-paid 
information included in the table above has not been subject to any 
contract liabilities as non-operating in nature and therefore these are 
specific audit or review procedures by the auditor but has been 
also excluded from Operating EBIT and Operating profit after income 
extracted from the accompanying financial report.
tax. This is considered to provide a better reflection of the Company’s 
As well as impairments and gains or losses arising from disposals 
of assets, items included in the non-operating column include the 
financial consequences of all activities related to the administration and 
financial impacts of the pre-paid funerals business. This has resulted in 
normalisation adjustments to revenue and operating expenses to reflect 
the exclusion of the financial impact of the business.
core business performance and results. It also removes volatility from 
the reported profit and loss that arises from the fair value activities 
required by accounting standards on these pre-paid funerals business 
related assets and liabilities.
InvoCare            Annual Report 2020  | 33
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Operating and financial review continued
Glossary for operating and financial review
Term
AV
Description
Term
Description
Audio visual equipment including technology to 
Interest cover 
Calculated as Operating EBITDA/Net finance 
facilitate live streaming of funeral services
ratio
costs. Interest cover calculation used for bank 
Average capital 
Average of opening and closing capital 
employed
employed
Average working 
Average of opening and closing working capital
capital
Average working 
Average working capital divided by Operating 
capital % of 
Revenue for a 12 month period
sales
B2B/B2C
Business to business/Business to consumer
Compound annual growth rate
Capital expenditure
CAGR
CAPEX
Capital  
employed
covenant testing purposes uses an Adjusted 
EBITDA measure (primarily adjusted to include 
proforma earnings from acquisitions and 
costs arising from restructuring initiatives) and 
adjusted net finance costs to exclude interest 
arising from AASB 16 lease accounting
Leverage ratio
Calculated for disclosure purposes as Net debt/
Operating EBITDA. Leverage calculation used 
for bank covenant testing purposes uses an 
Adjusted EBITDA measure (primarily adjusted to 
include proforma earnings from acquisitions and 
costs arising from restructuring initiatives)
As used in ROCE % calculation. Calculated as 
LTIFR
Lost time injury frequency rate
Total equity + Net debt
Maintenance 
Recurring annual CAPEX required to maintain 
Cash conversion 
Ungeared, tax free operating cash flows divided 
CAPEX
facilities
%
by Operating EBITDA
Memorialisation 
Revenue earned from the sale of memorials, 
Cash realisation 
Calculated as Operating cash flow/ (Operating 
revenue
plaques, burial plots etc. in the Memorial Parks 
%
NPAT + Depreciation and amortisation expense)
COVID-19
COVID-19 pandemic
Dividend payout 
Dividend per share/Operating EPS
MTM
NBO
ratio
business
Mark-to-market
Network & Brand Optimisation program of 
projects as part of Protect & Grow Strategy
EBITDA margin
Operating EBITDA/ Operating revenue
Net debt
Cash and cash equivalents + Borrowings + 
EGM
EPS
Executive General Manager
Earnings per share, calculated as Reported 
profit/(loss)/ weighted average number of 
shares
ERP
Enterprise Resource Planning, the main Oracle 
general ledger financial system used by the 
business
Funeral case 
Calculated as funeral gross revenue (including 
average
disbursements)/funeral case volume
Funeral case 
Number of funeral services undertaken
volume
FUM
Funds under management in the pre-paid 
funerals business
Gearing ratio
Calculated as Net debt / (Net debt + Total 
shareholder’s equity)
Growth CAPEX
CAPEX undertaken to expand existing 
operations or further growth prospects
Finance leases
NPS
Net Promoter Score, calculated based 
on customer feedback with Group score 
representative of Australia and New Zealand 
only
Operating 
Reported profit excluding non-operating items 
earnings after 
and associated tax
tax
Operating 
EBITDA
Operating earnings before business acquisition 
costs, interest, tax, depreciation and 
amortisation
Operating EBIT
Operating earnings before interest and tax
Operating EPS
Operating net profit after tax/weighted average 
number of shares
Operating 
leverage
Means the percentage growth in Operating 
EBITDA divided by the percentage growth in 
Operating revenue
Operating 
revenue
Revenue for the Group excluding revenue 
earned from pre-paid funerals business
OPEX % sales
Operating expenses / Operating revenue
InvoCare            Annual Report 2020  | 34
Term
PCP
PPE
Pet case 
average
Description
Prior corresponding period
Personal protective equipment
Pet cremation revenue/pet cremation volume
Pet cremation 
The number of pets cremated
volumes
Reported profit/
Net profit/(loss) attributed to shareholders of 
(loss)
InvoCare Limited
ROCE %
Calculated as Operating EBIT/Average capital 
employed
Ungeared, tax 
Calculated as operating cash flow excluding 
free cash flows
net finance costs paid and tax paid adjusted by 
net funds from pre-paid contracts (Payments 
to funds under management for pre-paid 
contract sales and receipts from funds under 
management for pre-paid contracts performed) 
sourced from investing cash flows and other 
cash flows related to pre-paid contracts
WFH
Work from home
Working capital
Inventories + Trade and other receivables + 
Trade and other payables
InvoCare            Annual Report 2020  | 35
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited
The Board presents the 2020 Remuneration Report for InvoCare in accordance with 
the Corporations Act 2001 and its regulations. This report outlines the key remuneration 
policies and practices for the year ended 31 December 2020. It highlights the link between 
remuneration and corporate performance and provides detailed information on the 
remuneration for Key Management Personnel (KMP).
The Remuneration Report is set out under the following main headings:
PAGE 
SECTION  WHAT IT COVERS 
36 
A 
Who is covered by the report –  
Key Management Personnel 
A.  Who is covered by the report –  
Key Management Personnel
For the purposes of this report, the Key Management Personnel 
37  
39  
41  
47  
57  
59  
B 
C 
D 
E 
F 
G 
Remuneration snapshot 2020 
(KMP) are those persons who have the authority and responsibility 
2020: How did we perform? 
Remuneration governance and framework
Executive KMP remuneration 
Non-Executive Director remuneration 
Additional information 
for planning, directing and controlling the activities of the Group or a 
major operation within the Group as listed in Tables 1 and 2 below.
Table 1 – Independent Non-Executive Directors (NED)
Name
Role
Date  
appointed
Date  
resigned
Bart Vogel
Chairman  
1 October 
N/A
of the Board
2017
Richard Davis
Non-Executive 
21 February 
N/A
Director
2012
Jackie McArthur
Non-Executive 
1 October 
N/A
Director
2018
Megan Quinn
Non-Executive 
1 October 
N/A
Director
2018
Keith Skinner
Non-Executive 
1 September 
N/A
Director
2018
Robyn Stubbs
Non-Executive 
1 January  
1 February 
Director
2017
 2021
Table 2 - Executive Key Management Personnel (Executive KMP)
Name
Role
Martin Earp
Damien MacRae
Managing 
Director and 
Chief Executive 
Officer (MD and 
CEO)
Deputy Chief 
Executive 
Officer (Deputy 
CEO)
Date  
appointed  
as KMP
Date  
ceasing  
as KMP
1 May  
2015
31 December 
2020
5 February  
2018
31 December 
2020
Adrian Gratwicke
Chief Financial 
Officer (CFO)
3 August  
2020
N/A
Josée Lemoine
Former CFO
8 September 
2016
3 August  
2020
InvoCare            Annual Report 2020  | 36
 
 
Management of the Group is delegated to the Executive Leadership 
Team (ELT) comprising Martin Earp’s direct reports. The Board has 
determined that not all members of the ELT are considered Executive 
KMP other than those listed in Table 2 above, as they do not have 
B. Remuneration snapshot 2020
Total fixed 
remuneration 
(TFR)
STI outcome
LTI outcome
NED 
remuneration
responsibility for planning, directing and controlling a substantial part 
The CEO 
The average 
2015 –  
The NEDs 
of the operations of the Company. Periodically, changes are made to 
and the COO 
STI outcome 
100% vested 
received a 3% 
the ELT to reflect the evolving strategy and structure of the Group.
Changes to Executive KMP
During 2020, the Company had the following Executive KMP 
changes:
• •  Martin Earp – Mr Earp determined not to seek re-appointment 
upon conclusion of his six year contract on 31 March 2021.  
On 19 November 2020, the Company announced the appointment 
of Olivier Chretien, as the new Managing Director and Chief 
Executive Officer (MD and CEO) effective 1 January 2021. Mr Earp 
stepped down to support Mr Chretien’s transition into his role from  
1 January 2021. Therefore, Mr Earp ceased as Executive KMP from 
31 December 2020.
• •  Damien MacRae – In support of succession planning for the CEO, 
Mr MacRae was appointed to the role of Deputy CEO on  
1 July 2020, previously from the role of Chief Operations Officer 
(COO). Following the appointment of Mr Chretien, the role of 
Deputy CEO ceased from 1 January 2021. Therefore, Mr MacRae 
ceased as Executive KMP from 31 December 2020.
received a 3% 
for the 2020 
increase to  
year for 
TFR effective  
Executive 
2016 –  
100% vested 
increase to the 
Board base fee 
effective  
1 January 2020
KMP was 
2017 –  
1 January 2020 
27% based on 
0% vested 
their balanced 
scorecard
2018 –  
0% vested
From 1 August 
to 30 November 
2020, the NEDs 
took a 25% 
Board base 
fee reduction 
(COVID-19 
related)
I. 2020 Target pay mix
CEO – Target pay mix
• •  Josée Lemoine – Ms Lemoine resigned from her position of  
36%
Chief Financial Officer and stepped down to assist with the 
transition of her responsibilities to Mr Gratwicke from  
3 August 2020. Ms Lemoine ceased as Executive KMP from  
3 August 2020.
Fixed
remuneration
42%
STI – Cash
STI – Restricted
shares
LTI
8%
14%
Other Executive KMP – Target pay mix
29%
10%
19%
42%
Fixed
remuneration
STI – Cash
STI – Restricted
shares
LTI
InvoCare            Annual Report 2020  | 37
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited continued
II. 2020 Remuneration outcome vs financial performance
Element
Purpose
Link to performance
2020 changes and outcome
FIXED REMUNERATION
Total fixed 
TFR (base salary plus fixed cost 
TFR is benchmarked to be competitive to 
There was a 3% TFR increase to the CEO 
remuneration 
benefits) is targeted at the median of 
attract and retain experienced individuals 
and COO (effective 1 January). 
(TFR)
the market for expected performance 
to drive the Company’s strategy. 
with the opportunity to earn above 
median remuneration for exceptional 
performance.
AT RISK REMUNERATION
Promotion of the COO to Deputy CEO 
Changes to TFR are linked to a 
(Effective 1 July) resulted in a 22.7% 
combination of rewarding high 
increase to TFR. For further details, see 
performance, and the capacity to pay.
Section E. II. 
Short term 
STI is awarded for achievement of pre-
The following factors are among those 
Promotion of the COO to Deputy CEO 
incentive (STI)
determined financial and non-financial 
considered by the People, Culture 
(effective 1 July) resulted in an increased 
objectives. This element of remuneration 
& Remuneration Committee (PCR 
STI from 45% to 70% of TFR. For further 
constitutes part of a market competitive 
Committee) in making its assessment on 
details see Section E. III.
total remuneration package and aims 
the achievement of the STI opportunity: 
to provide an incentive for eligible roles 
to deliver annual business plans that will 
lead to sustainable superior returns for 
shareholders. 
STI for Executive KMP is delivered 
through cash with a potential portion that 
can be deferred to be settled in the form 
of restricted shares. 
A deferral STI was introduced to the 
Executive KMP and ELT with the purpose 
to aid retention and align to market 
practices.
For 2020 Executive KMP outcome was 
• •  Financial performance
27% of target. 
There were no deferrals for 2020 as 
total STI payments did not exceed the 
threshold of $150,000. 
For further details of 2020 STI outcome 
refer to Table 6 in Section E.III.
• •  Our customers
• •  Our people
• •  Our safety 
The STI is measured over a one year 
performance period and paid in cash 
with a potential portion subject to deferral 
paid in the form of restricted shares. The 
shares will be held in trust for 12 months. 
Refer to Section D. IV. Remuneration 
framework for further information.
Long term 
The LTI plan is aimed at attracting, 
The Company utilises incentives to align 
Promotion of the COO to Deputy CEO 
incentive (LTI)
rewarding and retaining high performing 
the long-term interests of Executive KMP 
(effective 1 July) resulted in an increased 
Executive KMP, ELT and other nominated 
with those of equity holders and to ensure 
target LTI from 45% to 70% of TFR. 
participants who contribute to the overall 
that the participants are rewarded in line 
medium and long term success of the 
with the economic value created. 
A new LTI plan was introduced for 
2020. For further details of the changes 
Company.
LTI granted are in the form of a 
introduced refer to Section D. IV. 
combination of options and performance 
rights. 
Introduction of two performance 
hurdles – earnings per share (EPS) with 
Participants can choose the mix of 
a weighting reduced to 50% of the LTI 
vehicles that has most appeal to them. 
and the introduction of return on invested 
The value of LTI awards offered in 2020 
was up to a maximum of 85% of TFR for 
capital (ROIC) as a measure rather than a 
gate with a weighting of 50% of the LTI. 
the CEO and up to a maximum of 70% for 
For further details on LTI vesting outcome 
other Executive KMP.
for 2020 refer to 2020 LTI outcome below 
and Table 10 in Section E.VI.c.
InvoCare            Annual Report 2020  | 38
a. 2020 STI outcome
C. 2020: How did we perform?
In the second half of 2020 the PCR Committee reviewed the impact 
that COVID-19 was having on both the short term and long term 
incentives. This required careful and diligent consideration to ensure 
the plans continued to engage and drive performance. As such, the 
decision was made to adjust our financial focus for the remainder of 
2020 and set separate financial STI targets for the second half of the 
year.
All non-financial components of the STI remained unchanged, and 
therefore applied across the full year.
In what has been a year of unprecedented disruption, the Company 
has reported a net loss after income tax attributed to equity holders 
of $9,242,000 for 2020. COVID-19 and the associated government 
restrictions had a significant impact on both the Company’s ability to 
deliver full-service funeral arrangements and on the mortality rate in 
the countries in which its businesses operate.
The Group delivered an Operating EPS of 20.4 cents, 61% below 
the prior year, driven by the decline in operating earnings in the year 
and the dilutive impact of the increased number of shares on issue 
Despite this, business performance in 2020 did not meet agreed 
following the equity raising completed in April 2020.
Further details of the analysis of our financial performance for 2020  
are provided in the Operating and financial review section.
97.4
57.9
70.9
52.4
63.8
51.7
45.2
41.2
54.5
54.8
45.1
42.2
20.4
2020
(9.2)
2014
2015
2016
2017
2018
2019
Reported profit after income tax ($m)
Operating earnings per share (cents)
financial targets and as a result, the full financial portion of STI has 
been forfeited by the Executive KMP.
In the table below, financial targets are set with reference to the annual 
budget for the financial year. Refer to Table 6 in Section E.III for details 
of STI outcome for each Executive KMP.
Component
Financial 
performance
Our  
customer
Our  
people
Our  
safety
2020 
performance 
targets
Group EBIT
Net Promoter 
Score (NPS)
Market share 
growth – year on 
year
Employee 
turnover < 12 
month tenure
Lost time injury 
frequency rate 
(LTIFR)
Weight
50%
10% 
2020 
performance 
outcome
Target was not 
met
Target was 
partially met 
10%
Target was not 
met
10%
Target was not 
met
20% Target was met
b. 2020 LTI outcome
Grant year
2015
2016
2017
2018
Performance 
measure
7-10%  
CAGR in EPS
7-12%  
CAGR in EPS
Result
Proportion of 
award vested
10.3%
100%a
12.3%
100%a
7-12%  
CAGR in EPS
ROIC gateway 
not met
8-12%  
CAGR in EPS
ROIC gateway 
not met
0%b
0%b
a   CAGR is above the top end of performance measure from the grant 
year to the 2019 annual financial results. The vesting tests took place 
after the ASX announcement of the 2019 annual results.
b    Based on the plan rules, no grants can be vested if return on invested 
capital (ROIC) for the year does not exceed the weighted average 
cost of capital in the year of testing.
InvoCare            Annual Report 2020  | 39
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited continued
Relationship between remuneration and the Company’s performance
The overall level of Executive KMP reward considers the performance of the Group over several years, with at risk remuneration linked to that 
performance. The remuneration approach, elements and mix have delivered an annualised 15% shareholders’ return (being the sum of cash dividends 
and share price growth) between listing in December 2003 and the end of 2020.
Table 3 outlines the Group’s performance delivered over the last five years. It provides details of the key financial performance indicators which are used 
to determine the STI and LTI outcome over the last five years. This table also shows the STI payout percentage to the CEO and the average payout 
percentage to the other Executive KMP.
Table 3 – Key financial performance indicators
Net (loss)/profit after income tax attributable  
to equity holders of InvoCare Limited ($’000)
Operating EBITDA ($’000)
Operating EBIT * ($’000)
Operating net profit after income tax ($’000)
Basic EPS (cents)
Operating EPS (cents)
Full year dividend per share (cents)
Share price at 31 December ($)
Payout % of Cash STI to CEO
Average payout % Cash STI to other Executive KMP
2020
2019
2018
2017
2016
(9,242)
63,752
41,224
97,439
70,949
102,565
144,433
118,998
124,316
115,344
56,367
27,478
(6.9)
20.4
12.5
11.45
27%
27%
105,439
59,202
55.8
51.7
41.0
13.19
62%
57%
89,366
49,496
37.8
45.2
37.0
10.30
32%
35%
N/A
N/A
63,526
57,417
88.8
57.9
46.0
16.10
69%
67%
64.7
52.4
42.5
13.87
91%
80%
*    Operating EBIT was a financial performance indicator only reported from 2018 onwards, no comparatives are provided for the financial years prior to 
2018.
InvoCare            Annual Report 2020  | 40
 
D. Remuneration governance and framework
I. Guiding remuneration principles
The guiding remuneration principle underlying the executive remuneration philosophy is to ensure the Company rewards and recognises the delivery 
of the Group’s strategy, promoting long term sustainable success, aligning management and stakeholder interests and encouraging behaviours 
reflective of the One InvoCare culture. The Company’s remuneration policy follows six guiding principles:
1    Key performance indicators should balance the near-term focus on current year results to drive value creation and the need for sustainable 
outcomes
2    Performance for incentive plan purposes is measured at the level which best aligns with driving accountability for the delivery of the business 
objectives
3    All variable pay should align reward with the stakeholders and encourage a long-term view
4    It should enable the Company to compete effectively to attract and retain talent
5    Reward must be aligned with, and promote the achievement of the Company’s purpose and consistently demonstrate and promote its Values
6    The KMP and ELT total remuneration is benchmarked to comparable positions in comparably sized companies (taking into account sales revenue, 
market capitalisation and industry), with the value of the incentives included in total remuneration based on amounts that can be achieved when 
overall Group performance targets are met
II. The Company’s remuneration governance framework
Board of Directors
People, Culture & Remuneration Committee*
Management
Ensuring the Group’s remuneration 
Approving the Group’s overall remuneration policy 
Implementing of remuneration policies and 
framework is aligned with the Group’s 
and process.
practices.
purpose, core values, strategic 
objectives and risk appetite.
Reporting to the Board on corporate culture within 
Providing information relevant to remuneration 
the Group and making recommendations to the 
decisions and making recommendations to the 
Determining Non-Executive Directors 
Board regarding corporate governance policies to 
PCR Committee with respect to remuneration 
and Executive KMP remuneration. 
support a strong corporate culture.
arrangements.
Monitoring Executive KMP and the 
Reviewing and recommending to the Chair 
Making recommendations to the PCR Committee 
ELT performance and implementation 
arrangements for the Executive KMP and the ELT in 
in relation to the design and implementation of the 
of the Group’s objectives against 
relation to their terms of employment, remuneration 
remuneration strategy and structure.
measurable and qualitative indicators.
and participation in the Group’s incentive programs 
(including performance targets).
Reviewing and recommending to the Board the 
remuneration arrangements for the Chair and  
Non-Executive Directors of the Board, including 
fees, travel and other benefits.
*    The full charter for the PCR Committee is displayed on the Company’s website
III. Use of remuneration advisors
From time to time, the PCR Committee engages external remuneration consultants to provide independent benchmarking data and information 
on best practice and community expectations. This ensures the Company continually reviews, assesses and adapts the remuneration governance 
functions to assist the Board and the PCR Committee in making informed decisions.
During 2020, the PCR Committee commissioned an external consultancy group to provide the following information:
• •  Executive remuneration alternatives in response to COVID-19
• •  Further work on the new LTI plan
No remuneration recommendations as defined by the Corporations Act 2001 were provided by the external consultancy group.
InvoCare            Annual Report 2020  | 41
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited continued
IV. Remuneration framework
TOTAL FIXED REMUNERATION
What is total fixed remuneration 
Base salary, superannuation and any other benefits e.g. motor vehicle.
(TFR)?
How is TFR determined?
TFR (base salary plus fixed cost benefits) is targeted at the median of the market for expected performance 
with the opportunity to earn above median remuneration for exceptional performance. 
TFR is benchmarked to be competitive to attract and retain experienced individuals to drive the Company’s 
strategy. 
Changes to TFR are linked to a combination of rewarding high performance, and market equity.
SHORT TERM INCENTIVE
What is the purpose of the short 
STI aims to provide an incentive for the Executive KMP and the ELT to deliver annual business plans that will 
term incentive (STI) plan?
lead to sustainable superior returns for shareholders. Target based STIs are intended to modulate the cost to 
the Group of employing senior executives, so that risk is shared with the senior executives themselves and the 
cost to the Company is reduced in periods of poor performance. 
This year we have introduced a deferral to the Executive KMP and ELT STI plan with the purpose to aid 
retention and align to market practices. 
The STI plan has been developed to reinforce the Company’s values and behaviours, while supporting a 
commercial mindset and alignment to business objectives.
What is the performance period?
The Group’s financial year from 1 January to 31 December.
What is the award opportunity?
In 2020 target STI as a percentage of TFR was 51.4% for the CEO and 70% for the other Executive KMP.
What key performance  
STI outcome is directly linked to both individual and Group performance against KPIs. The Board has focused 
indicators (KPIs) are measured  
the Executive KMP on four main areas:
for STI to be paid?
• •  Financial performance
• •  Our customers
• •  Our people
• •  Our safety
STI attainment is determined excluding the impact of changes in accounting standards. For further details of 
2020 STI outcomes refer to Table 6 in Section E.III.
What is the relationship between 
performance scales and 
outcomes?
Performance scales
STI outcome
Below threshold
0% paid
Between threshold and target – for the 
50% earned on achievement of threshold level performance, 
financial components, threshold is 95%.
increasing on a straight-line basis to 100% for target level 
Target
performance.
100% paid
Maximum – for financial  
100% earned at target level performance, increasing on a straight-
components only
line basis to 150% earned on achievement of maximum level 
performance.
Is over achievement applicable  
No. Over achievement is only available on the financial components of the STI and this is capped at 150%.
for all the components of the STI?
Is there a gate to  
over achievement?
Yes. Access to over achievement for all financial components is dependent on the Group achieving  
EBITDA target.
Are non-financial components 
Yes. Non-financial components are capped at 100% payment.
capped?
InvoCare            Annual Report 2020  | 42
What are the plan features  
50% of any STI award that exceeds $150,000 will be subject to deferral and will be paid in the form of 
of the deferral?
restricted shares. The shares will be held in trust for 12 months.
What is the deferral period?
There is a one-year deferral period from grant.
How is the number of shares 
The number of shares to be granted will be calculated by dividing the deferred STI amount by the volume 
determined?
weighted average price (VWAP) of shares transacted for the first ten days of the trading window immediately 
after the announcement of the Company’s ASX annual financial results for the STI performance year.
Will participants have access 
Yes. The restricted shares held in trust are entitled to dividends.
to dividends during the deferral 
period?
Is there Board discretion on the 
Yes. The deferred STI will be paid in InvoCare shares, but the Board retains the discretion to deliver the 
payment vehicle used?
deferred STI in cash.
When is STI paid?
Cash STI is payable in the first quarter of each year after the announcement of the Company’s ASX annual 
financial results for the previous year ended 31 December. 
For deferred STI, restricted shares will be allocated in the first quarter of each year after the VWAP price is 
available for the previous year ended 31 December.
Are there any disqualification 
All financial performance data relating to the plan is subject to external audit. 
provisions?
Potential participants may be disqualified from all or part of the plan if their annual performance is determined 
to be below the “on track” rating category in the performance management practices. Should a dispute arise 
regarding a potential disqualification, eligibility will be at the discretion of the CEO, or the Board for the CEO. 
The Company reserves the right to suspend or alter STI payments to any participant due to any action which 
has caused the Group loss or reputational damage. This includes any deferral STI (in the form of restricted 
shares) in the event of fraud, malfeasance, dismissal for cause, or other misconduct.
How is STI treated on cessation of 
In the event of cessation of employment due to resignation or dismissal for cause, all entitlements in relation to 
employment?
the performance period are forfeited. Where an Executive KMP’s employment is terminated by the Company 
LONG TERM INCENTIVE
for any reason other than cause, the relevant executive may receive a pro-rated portion of their STI opportunity 
based on the portion of the performance year served and the STI paid or payable in respect of the immediately 
preceding financial year.
Deferred STI will not vest if the individual resigns or is terminated for cause during the deferral period. The 
Board retains the discretion to allow deferred STI to remain on foot and vested in the normal course for 
approved good leavers. A good leaver will generally be determined by the Board (or its delegate) at the time of 
cessation of employment having regard for the facts and circumstances prevailing at that time.
The Company’s long term incentive (LTI) plan seeks to closely align the interests of the senior executive 
participants with those of investors to ensure participants are rewarded in line with economic value created. 
The following graphic provides a detailed timeline of the key activities of the new 2020 LTI throughout its 
lifecycle. Further details comparing the features of 2020 and 2019 and prior terms and conditions of the LTI 
plan are provided in the question and answer table below.
2019 Initial 
performance 
period  
Baseline
Grant of
performance rights 
and/or options
March 2020
Vesting and 
commencement
of restriction period
March 2023
Performance rights 
and/or options 
exercisable
March 2024
Performance period
Restriction period
2019
2020
2021
2022
2023
2024
Jan Mar
Dec
Jan Mar
Dec
Jan
Mar
Dec
Jan
Mar
Dec
Jan Mar
Dec
Jan Mar
Dec
What is the purpose of the long 
The LTI plan is aimed at attracting, retaining and rewarding high performing executives who contribute to the 
term incentive (LTI) plan?
overall medium and long-term success of the Company.
InvoCare            Annual Report 2020  | 43
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited continued
Who participates in the LTI plan?
Participation is limited to Executive KMP and selected senior management positions by invitation and as 
approved by the Board.
What size of award is granted?
The 2020 LTI target opportunity was 85% of TFR for the CEO and 70% for the other Executive KMP.
How are the grants calculated?
The number of options is calculated based upon the value of LTI to be awarded in options divided by the option 
valuation at the award date. The option value is determined using a Black-Scholes valuation methodology. The 
valuation for allocation excludes dividends and does not incorporate any discount relating to the performance 
and tenure conditions.
The number of performance rights is calculated at the date of issue by dividing the value of LTI to be awarded 
in the form of performance rights by the face value of an InvoCare share. The face value is based on the 
ten-day VWAP for InvoCare shares starting from the first day of the trading window immediately following the 
announcement of the annual financial result.
CHANGES TO THE LTI PLAN
2019
2020
Plan features
The LTI awards are in the form of options and 
Participants are able to choose a mix of options and 
performance rights subject to vesting conditions.  
performance rights but are limited to the following 
The ratio of options and performance rights are  
combinations:
at 75% and 25% for participants.
• •  100% of either options or performance rights
• •  50% each of options and performance rights
• •  25% of one, and 75% of the other
What are the performance  
The performance hurdles for the  
The performance hurdles for the 2020 LTI plan:
hurdles?
2016-2019 LTI plans:
• •  Continued employment condition and
• •  Compound annual growth (CAGR) in normalised 
EPS over the vesting period
EPS is calculated based on “normalised earnings” 
meaning reported profit as adjusted:
• •  To remove the impacts of any gains or losses  
arising from the sale, disposal or impairment  
of non-current assets
• •  To maintain consistency in accounting policies 
across the respective vesting periods for each grant
• •  For LTI awards from February 2018:
•  To reflect constant currency
•  To remove impacts of pre-paid contracts and 
associated funds under management
• •  Continued employment condition and
• •  Two performance hurdles:
•  50% weighting on EPS
•  50% weighting on ROIC
EPS is calculated based on the Operating EPS 
adjusted to reflect constant currency.
ROIC in each year is calculated based on Operating 
EBIT divided by the average invested capital.
Is there a gateway before  
A ‘gateway’ condition must be met before any LTI 
Removal of gateway.
any LTI awards can vest?
awards can vest. The gateway requires a minimum 
level of return on invested capital (ROIC) greater than 
the weight average cost of capital (WACC).
ROIC is a performance hurdle in addition to  
CAGR in EPS.
What are the performance  
Performance is measured over four years:
Performance is measured over three years.
and vesting periods?
• •  Tranche One – 50% vest in year three
• •  Tranche Two – 50% vest in year four
Vesting of the options and performance rights are 
tested on the third and fourth anniversary of their 
grant. Unvested awards at the fourth anniversary of 
the grant are automatically forfeited.
Vesting of the options and performance rights are 
tested at the end of this three year period, subject to a 
further 12 months restriction period.
It also permits for malus in the event of governance 
concerns with Board discretion to be applied 
if performance is impacted by events outside 
management’s control.
InvoCare            Annual Report 2020  | 44
Do we allow for re-testing?
If performance measures are not met on the third 
Re-testing has been removed.
anniversary they are again tested on the fourth 
anniversary.
What are the performance 
Subject to the ROIC gateway condition,  
50% on EPS
conditions?
the EPS performance conditions applying for  
LTI awards are as follows:
For 2018 and 2019:
• •  8% to 12% CAGR in EPS results in  
30% to 100% of LTI vested
For 2016 and 2017:
• •  7% to 12% CAGR in EPS results in  
30% to 100% of LTI vested
• •  6% to 10% CAGR in EPS results in  
30% to 100% of LTI vested
50% on ROIC
• •  10% to 12% average ROIC over the three-year 
period results in 30% to 100% of LTI vested
Are there dividends  
or voting rights?
There are no dividends or voting rights attached to 
There are no voting rights attached to the options and 
the options and performance rights awarded. It is 
performance rights awarded.
only if the options and performance rights vested and 
exercised that there will be any entitlement.
Performance rights are entitled to dividends, if 
determined. Dividends will only be paid, in the form 
of shares, if the performance rights vested and 
exercised.
Why were these  
measures chosen?
CAGR of normalised EPS was selected as the most suitable and reliable measure of organisational performance, 
based on independent advice and analysis by the Board. The reasons for this conclusion include:
• •  The Company is a unique and relatively stable business
• •  EPS growth is aligned with the Company’s strategic objectives and is intended to underwrite appropriate 
dividend returns to shareholders
ROIC was selected as the second performance measure as it is intended to ensure effective capital 
deployment and maintenance of balance sheet strength.
What happens on ceasing 
For the options and performance rights to vest, the employee must be employed at the date of vesting unless 
employment?
the termination of employment has been determined to be a good leaver.
For good leavers, providing a participant has at least three years’ employment with the Company and has 
not engaged in proscribed conduct (meaning serious and wilful misconduct, wilful disobedience, gross 
negligence or incompetence, disqualification under the Corporations Act or serious breaches of contract 
of employment), the Board may at its discretion allow unvested LTI grants to continue to be on foot and 
vest subject to the original terms and performance conditions attached to the relevant grants, regardless of 
whether or not the participant is employed by the Company at the relevant vesting time.
If no determination is made by the Board, all unvested LTI held by the participant will lapse upon termination of 
employment.
The Board has the discretion to determine that any LTI benefit payable in the above termination circumstances 
can be settled in cash.
What happens if a change 
In the event of a change in control or other circumstances where the Board determines it is not practical or 
 of control occurs?
appropriate for the unvested LTI to continue on foot, the Board has the discretion to determine the extent to 
which all or part of any unvested LTI may vest and the specific performance testing to be applied.
Is there a clawback policy 
Payments or vesting related to performance conditions associated with an LTI are subject to a clawback 
included?
policy. The Group will seek to recover all or part of an executive’s incentives that have already been paid to 
ensure the executive has not been inappropriately awarded in circumstances including:
• •  A material misstatement or omission in the Group’s financial statements
• •  Actions or inactions seriously damaging the Group’s reputation or putting the Group at significant risk and/or
• •  A material abnormal occurrence resulting in an unintended increase in the award
InvoCare            Annual Report 2020  | 45
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited continued
When would Board discretion  
Board discretion may be applied to either operating earnings or capital employed in the calculation of EPS or 
be considered?
ROIC. The guiding principle will be to ensure fairness in assessing LTI vesting outcome and alignment with 
shareholder interests.
Any Board discretion applied will be disclosed at the latest when vesting occurs.
InvoCare Share Trading Policy
In accordance with InvoCare’s Share Trading Policy, senior managers are prohibited from trading in 
the Company’s shares other than during specified trading windows, or with approval in exceptional 
circumstances, provided they do not possess inside information. In addition, senior managers are not 
permitted to enter into transactions with their shareholding in the Company which operate to limit the 
economic risk of their shareholding (e.g. margin loans, hedging or cap and collar arrangements), including 
limiting the economic risk of holdings of unvested entitlements associated with LTI securities.
InvoCare            Annual Report 2020  | 46
Directors’ Report
Remuneration report – audited  
Executive KMP remuneration
E. Executive KMP remuneration
I. CEO 2020 remuneration details
a. What was target and actual remuneration in 2020?
The target remuneration for the CEO is set to place a considerable portion of remuneration at risk to align remuneration with both the 
Group’s performance and the individual’s personal influence and contribution to the Group’s performance. The total maximum, target and 
actual remuneration for the CEO for the full year are summarised in the graph below.
Maximum remuneration represents total potential remuneration of TFR, STI and LTI. For STI, the amount includes the 150% achievement for 
financial targets as prescribed by the STI performance targets conditions.
Target remuneration represents total potential remuneration of TFR, STI (achieved at 100% for both financial and non-financial targets and 
reflected through cash and restricted shares) and LTI awarded (at 100% subject to performance and employment conditions to be met).
2020 CEO maximum, target and actual take home
Maximum
Target
Actual take
home*
40.1%
42.3%
38.6%
16.2%
9.6%
34.1%
$2,283,644
14.3%
7.4%
36.0%
$2,165,911
5.4%
56.0%
$2,377,067
0
400,000
800,000
1,200,000
1,600,000
2,000,000
2,400,000
Fixed remuneration
STI - cash
STI - restricted shares
LTI
Total remuneration in $
*    Inclusive of LTI award in 2020 related to 2015 and 2016 grants vested when performance hurdles were tested post 2019 annual results announcement. 
Refer to Table 5 below for further detail.
b. 2020 CEO remuneration breakdown
Total fixed remuneration (TFR)
TFR of $916,206 per annum.
Short term incentive (STI)
Target STI of $470,930 (51.4% of TFR).
The balanced scorecard was based on the following:
• •  Financials 50%
• •  Our customer 20%
• •  Our people 10%
• •  Our safety 20%
The CEO received 27% of target STI for 2020.
100% of this was received in cash.
For further detail on 2020 STI outcome refer to Table 6 below.
Long term incentive (LTI)
Target LTI of $778,775 (85% of TFR).
Of the maximum LTI award, 75% is in options and 25% in performance rights.
For all the grants which were up for performance hurdle testing during 2020, 2015 Tranche Three, 2016 
Tranches Two and Three were 100% vested and 2017 grant hurdles were not met.
For further details on LTI vesting outcomes for 2020 refer to Table 10 in Section E.VI.c below.
InvoCare            Annual Report 2020  | 47
Performance Review12Directors’ Report3Financial Report4Other Information 
Directors’ Report
Remuneration report – audited 
Executive KMP remuneration continued
II. Executive KMP remuneration details – actual received
This section provides details of the cash and value of other benefits 
STI paid in cash and vested LTI exercised or exercisable.  
actually received by the Executive KMP. This is a voluntary disclosure 
Refer to table notes below for further details on how these  
to provide shareholders with increased clarity and transparency in 
amounts were determined.
relation to Executive KMP remuneration.
Director’s discretion was considered in the determination of both the 
Actual pay in Table 5 below represents the pre-tax take home amounts 
2020 STI and 2020 LTI awards. For the Executive KMP who were in 
by each Executive KMP for the financial years ended 31 December 
their roles for the full financial year, the 2020 LTI calculations of EPS 
2020 and 2019. This consists of cash salary, non-monetary benefits, 
and ROIC will be adjusted to take account of the impairment of the  
NZ business and Compass ERP system.
Table 5 - Executive KMP remuneration details – actual pre-tax received
Short-term employee benefits
Post-employment 
benefits
Long-term 
benefits
Share 
 based 
payments
Total
Cash  
salary 1 
$
Short term 
incentive-  
cash 2, a 
$
Non-
monetary 
benefits 1 
$
Super-
annuation 1 
$
Termination 
payments 
$
Long  
service 
leave 
accruals 
$
Shares, 
options and 
perform-
ance  
rights 3 
$
$
Martin Earp
Damien MacRae,  
Deputy CEO commenced  
1 July 2020 (formerly COO) b
Adrian Gratwicke,  
appointed 3 August 2020 c
2020
818,809
126,880
77,075
25,000
2019
794,270
283,776
77,127
25,000
2020
595,750
104,571
4,678
25,000
2019
525,000
127,653
4,730
25,000
2020
272,211
63,652
1,949
10,847
Former Executive KMP ceased during the financial year
Josée Lemoine, resigned 
and ceased as Executive KMP 
effective 3 August 2020
2020
290,148
50,000
3,119
15,925
2019
430,008
120,251
4,730
25,000
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1,329,303
2,377,067
-
-
-
-
1,180,173
729,999
682,383
348,659
130,869
490,061
-
579,989
Footnotes to Table 5
Table notes to Table 5
a   Based on performance in 2020, the PCR Committee determined the 
Executive KMP forfeited an average of 73%, achieving an average of 
27% of their target STI opportunity. Refer to Table 6 below for further 
details.
1    Cash salary, non monetary benefits and superannuation represents 
actual amounts received during the financial year. Cash salary 
excludes the movement of annual leave accruals.
2    STI awarded based on 2020 and 2019 achievement of performance 
b   Damien MacRae was promoted to Deputy CEO on 1 July 2020. 
targets and payable in cash.
His remuneration package was increased accordingly to reflect the 
increased scope of the role and external market positioning.
c   Adrian Gratwicke commenced in the role of CFO on 3 August 2020. 
His remuneration package was commensurate with his skills and 
extensive experience combined with the external market positioning.
 For 2020, 50% of the STI awarded that exceeded $150,000 would 
be subject to deferral and paid in the form of restricted shares. The 
shares would be held in trust for 12 months. Therefore, any deferred 
portion of the 2020 STI is not included as take home pay for 2020.
3    For 2020, LTI awarded related to 2015 and 2016 grants vested 
when performance hurdles were tested post 2019 annual results 
announcement. The vested and exercised/exercisable performance 
rights and options were converted or convertible to InvoCare shares 
during 2020. The value in Table 5 above represents the variable 
weighted average price (VWAP) of InvoCare shares for the financial 
year ended 31 December 2020 times the number of vested and 
exercised/exercisable performance rights and options. The VWAP 
over the period was $11.10.
 For 2019, no LTI vested when performance hurdles were tested post 
2018 annual results announcement.
InvoCare            Annual Report 2020  | 48
 
 
 
III. Executive KMP 2020 STI outcomes
Table 6 below provided details of each Executive KMP’s balance scorecard and the achievements and the financial outcomes during the financial year 
ended 31 December 2020.
Table 6 – Executive KMP 2020 STI outcomes
Executive KMP 
Performance 
target 
Achievement 
%
Target STI  
potential 
$
Actual STI 
awarded  
as a % of  
target  
STI potential 
%
Actual STI  
awarded 
$
STI forfeited as 
a % of target STI 
potential 
%
Financial
Customer
People
Safety
Financial
Customer
People
Safety
Financial
Customer
People
Safety
Martin Earp
Damien MacRae a
Adrian Gratwicke b
Footnotes to Table 6
-
35
-
100
-
35
-
100
-
35
-
100
470,930
27
126,880
73
388,125
27
104,571
73
236,250
27
63,652
73
a    Damien MacRae was promoted to Deputy CEO on 1 July 2020. His target STI potential reflects 45% of current TFR from the 1 January to 30 June 2020 
and 70% of current TFR from 1 July to 31 December 2020, or 57.5% of TFR for the financial year ended 31 December 2020.
b   Adrian Gratwicke’s target STI potential reflects 70% of TFR which was pro-rated to six months in 2020.
InvoCare            Annual Report 2020  | 49
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited 
Executive KMP remuneration continued
IV. Executive KMP remuneration details – statutory basis
Table 7 below discloses the remuneration for Executive KMP calculated in accordance with statutory requirements and Accounting Standards. Refer 
to table notes underneath Table 7 for the relevant statutory and accounting requirements.
Table 7 – Total Executive KMP remuneration – statutory basis
Short-term employee benefits
Post-employment 
benefits
Long-term 
benefits
Cash  
salary 1 
$
Short term 
incentive-  
cash 2 
$
Non-
monetary 
benefits 3 
$
Super-
annuation 4 
$
Termination 
payments 
$
Long 
service 
leave 
accruals 5 
$
Share 
 based 
payments
Shares, 
options and 
perform-
ance  
rights 6 
$
Total
$
Martin Earp a
Damien MacRae,  
Deputy CEO commenced  
1 July 2020 (formerly COO) a
Adrian Gratwicke,  
appointed 3 August 2020 a
2020
875,719
126,880
77,075
25,000
2019
842,702
283,776
77,127
25,000
-
-
(62,453)
101,709
1,143,930
13,097
(232,563)
1,009,139
2020
568,607
104,571
4,678
25,000
428,909
(16,675)
80,951
1,196,041
2019
527,017
127,653
4,730
25,000
2020
297,365
63,652
1,949
10,847
Former Executive KMP ceased during the financial year
Josée Lemoine, resigned 
and ceased as Executive KMP 
effective 3 August 2020 a,b
2020
308,888
50,000
3,119
15,925
2019
431,676
120,251
4,730
25,000
-
-
-
-
8,749
(68,779)
624,370
1,499
137,018
512,330
(24,301)
812
354,443
7,262
(154,260)
434,659
Footnotes to Table 7
Table notes to Table 7
a    The remuneration mix for the Executive KMP based on the 
1  The total cost of cash salary and leave accruals, including annual 
remuneration details in Table 7 above are:
•    Martin Earp: 80% fixed and 20% at-risk  
(2019: 96% fixed and 4% at-risk)
•    Damien MacRae: 84% fixed and 16% at-risk  
(2019: 91% fixed and 9% at-risk)
•   Adrian Gratwicke: 61% fixed and 39% at-risk
•    Josée Lemoine: 86% fixed and 14% at-risk  
(2019: 100% fixed and 0% at-risk)
 2019 remuneration mix had a higher fixed remuneration compared 
to 2020. This was impacted by the negative value of share based 
payments value in 2019. The share based payments value in 2019 
was lower than 2020 due to the performance hurdle forecast being 
partially met at a lower rate in 2019 for all options and performance 
rights whilst in 2018 it was forecast to be met at a higher rate.
b    Josée Lemoine resigned during 2020. No STI was awarded, 
however, in recognition of Ms Lemoine’s contribution to the Company 
during her service and transition support to the incoming CFO, 
a special bonus of $50,000 was paid to her for her assistance in 
completion of all handover duties as agreed.
 Ms Lemoine’s unvested performance rights and options granted 
under the 2017, 2018 and 2019 LTI plans will remain on foot and will 
be subject to the relevant performance hurdles before any vesting 
occurs. No performance rights or options under the 2020 LTI plan 
were granted to Ms Lemoine.
 No termination benefits have been provided to Ms Lemoine on 
cessation of her employment.
leave taken and the increase or decrease in the annual leave provision 
applicable as determined in accordance with the Accounting 
Standard, AASB 119 Employee Benefits.
2  The amount to be settled in cash relating to performance of the  
Group and the individual for the financial year from 1 January to  
31 December. The proportions of STI bonuses awarded and forfeited 
are set out in Table 6 in Section E.III of this Remuneration Report.
3  Non-monetary benefits represent the costs to the Group, including 
any fringe benefits tax, for the provision of fully maintained cars, free 
car parking and other items.
4  Superannuation contributions are paid in line with legislative 
requirements.
5  Long service leave accruals are determined in accordance with 
Accounting Standard, AASB 119 Employee Benefits.
6  The share based payments value in Table 7 above represents the 
amount of sign-on incentive, deferred STI and LTI (in the form of 
unvested shares, options and performance rights) grants made 
in the current and past financial years. They are accounted for in 
accordance with AASB 2 Share-based Payments. Subject to 
meeting the vesting conditions of the grants, the shares, options or 
performance rights will vest, or be forfeited, in future financial years. 
Table 8 below provides the breakdown of share based payments.
InvoCare            Annual Report 2020  | 50
 
 
 
 
Table 8 – Breakdown of share based payments
Deferred STI 
in the form of 
shares 
$
Sign-on 
incentive in 
the form of 
shares 
$
LTI in the  
form of 
shares 
$
LTI in the  
form of 
options 
$
LTI in the  
form of 
performance 
rights 
$
Total share 
based 
payments 
$
Martin Earp
Damien MacRae,  
Deputy CEO commenced  
1 July 2020 (formerly COO)
Adrian Gratwicke,  
appointed 3 August 2020 a,b
2020
2019
2020
2019
2020
Former Executive KMP ceased during the financial year
Josée Lemoine,  
resigned and ceased as Executive 
KMP effective 3 August 2020 b
2020
2019
Footnotes to Table 8
-
-
-
-
-
-
-
-
-
-
-
108,008
-
-
2,275
54,631
44,803
101,709
236,939
(384,191)
(85,311)
(232,563)
-
-
-
-
-
-
80,951
80,951
(51,584)
(17,195)
(68,779)
-
29,010
137,018
406
406
812
(126,305)
(27,955)
(154,260)
a    Adrian Gratwicke received a sign-on incentive in the form of shares held in trust. One third each of the total number of shares granted will be vested on  
1 July 2021, 2022 and 2023 respectively provided that Mr Gratwicke meets the employment condition at the date of vesting.
b    The share based payments for both Adrian Gratwicke and Josée Lemoine are only recognised for the period from the date commenced as or up to the 
date ceasing as Executive KMP.
V. Executive KMP employment terms
The total remuneration package is reviewed annually and the key terms are summarised below.
Role
Martin Earp
Term of 
agreement
Notice period 
(by company or 
by employee)
Post 
employment 
restraints
Termination benefits
1 April 2018 –  
31 March 2021
Six months
12 months
No redundancy payment entitlements. If there are any 
termination entitlements to be paid, they will be limited by 
the current Corporations Act 2001 (Cth) or the ASX Listing 
Rules or both.
Damien MacRae
No expiry date
Six months
12 months
Any payment required under the Fair Work Act 2009 (Cth)
Adrian Gratwicke
No expiry date
Six months
12 months
Any payment required under the Fair Work Act 2009 (Cth)
InvoCare            Annual Report 2020  | 51
Performance Review12Directors’ Report3Financial Report4Other Information 
Directors’ Report
Remuneration report – audited 
Executive KMP remuneration continued
VI. Share based payments
a.  2020 Deferred Employee Share Plan’s grant
As part of the CFO appointment during 2020, Adrian Gratwicke received a one-off sign-on incentive in the form of 30,000 InvoCare shares, which will 
be held in trust within the InvoCare Deferred Employee Share Plan (DESP). The shares will vest in three equal tranches on 1 July 2021, 1 July 2022 and 
1 July 2023, respectively, provided that he is still employed by InvoCare at those dates and the applicable vesting conditions are met as described in 
the DESP rules. Table 9 below provides details of the fair value and maximum value for the sign-on incentive granted.
Table 9 – Fair value and maximum value for sign-on incentive
Grant 
Executive KMP 
Grant date 
Fair value per  
sign-on incentive 
$
Number of  
shares granted 
Performance  
period 
Maximum value to 
be recognised from 
grant date 
$
Adrian Gratwicke
15/06/2020
11.1
30,000
15 June 2020  
to 1 July 2023
333,000
Shares granted 
under DESP
b. LTI plan
The Executive KMP were granted LTI in the form of a combination of options and performance rights (under the Performance Long-term Incentive  
Plan (LTIP)) and shares (under the Deferred Employee Share Plan (DESP), which was replaced by the Performance Long-term Incentive Plan from  
2016 onwards).
The key terms and conditions of the LTI granted are disclosed in Note 20 Share-based remuneration Section B and C.
Refer to Section E.VI.c below for the performance to date of all LTI grants impacting the value of Executive KMP remuneration.
InvoCare            Annual Report 2020  | 52
c.  Performance to date of LTI grants
i.  Performance Long-term Incentive Plan’s grants
Table 10 below summarises the performance to date for the LTI grants under the LTIP since 2016 which impact remuneration in the current or a future 
financial year.
Table 10 – Performance of outstanding LTI granted under LTIP
Grant
Tranche
Performance hurdles a
Tranche One
30% vesting at 7% CAGR 
100% vesting at 12% CAGR
Tranche Two
Pro-rata vesting in between 7% and 12%
February 2019
Tranche Three
0% vesting if less than 7% CAGR
February 2020
Tranche One
30% vesting at 7% CAGR
February 2019
2016 grant  
– three equal 
tranches
2017 grant  
– three equal 
tranches
2018 grant 
– two equal 
tranches
2019 grant 
– two equal 
tranches
Tranche Two
Tranche Three
Tranche One
Tranche Two
Tranche One
Tranche Two
2020 grant  
– one 
tranche, two 
performance 
hurdles
50% of  
2020 grant
50% of  
2020 grant
Footnotes to Table 10
100% vesting at 12% CAGR
Pro-rata vesting in between 7% and 12%
0% vesting if less than 7% CAGR
30% vesting at 8% CAGR
100% vesting at 12% CAGR
Pro-rata vesting in between 8% and 12%
0% vesting if less than 8% CAGR
30% vesting at 8% CAGR
100% vesting at 12% CAGR
Pro-rata vesting in between 8% and 12%
0% vesting if less than 8% CAGR
30% vesting at 6% CAGR
100% vesting at 10% CAGR
Pro-rata vesting in between 6% and 10%
0% vesting if less than 6% CAGR
30% vesting at 10% ROIC
100% vesting at 12% ROIC
Pro-rata vesting in between 10% and 12% 
ROIC
0% vesting if less than 10% ROIC
First testing / 
vesting date
February 2018
Performance  
target at  
grant date
Retesting  
of unvested  
rights
Vesting  
outcome 
%
No retesting is 
required
49.7 cents b 
First test in 2019 
Retest in 2020
First test in 2020
First test in 2019
Retest in 2020
Retest in 2021
First test in 2020 
Retest in 2021
First test in 2021
100
0
100
100
0
0
0
0
0
0
0
65.4 cents b
February 2020
February 2021
February 2021
First test in 2021
57.8 cents c
February 2022
N/A
N/A
February 2022
N/A
N/A
35.9 cents c
February 2023
N/A
N/A
March 2023
46.9 cents c
N/A
N/A
March 2023
N/A
N/A
a   The performance targets are annual compound normalised EPS growth (CAGR) and/or return on invested capital (ROIC) from 1 January of grant year.
b   Including financial performance on funds under management on pre-paid contracts.
c   Excluding financial performance on funds under management on pre-paid contracts.
InvoCare            Annual Report 2020  | 53
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited 
Executive KMP remuneration continued
d.  Fair value and maximum value for LTI grants
Table 11 provides the fair value and the maximum potential value of all outstanding LTI grants at grant date for the Executive KMP.  
If the performance conditions are not met, the minimum value of the LTI will be nil.
Table 11 – Fair value and maximum value for LTI grants
Grant 
Executive KMP 
Grant date 
Number  
of LTI  
granted 
Fair value  
per LTI  
$
Performance  
period 
Maximum value  
to be recognised 
from grant date  
$
Shares granted 
under DESP
Martin Earp
31/03/2015
13.74
17,410
1 January 2015 to 31 December 2019
01/01/2016
01/01/2017
Martin Earp
01/01/2018
Options 
granted under 
LTIP a
Damien MacRae
01/01/2019
01/01/2020
01/01/2018
01/01/2019
2.40
2.93
2.78
2.51
0.58
2.78
2.51
160,313
1 January 2016 to 31 December 2020
133,284
1 January 2017 to 31 December 2021
203,982
1 January 2018 to 31 December 2022
225,923
1 January 2019 to 31 December 2023
272,934
1 January 2020 to 31 December 2022
66,772
1 January 2018 to 31 December 2022
73,954
1 January 2019 to 31 December 2023
Former Executive KMP ceased during the financial year
Josée Lemoine c
01/01/2016
01/01/2017
01/01/2018
01/01/2019
01/01/2016
01/01/2017
Martin Earp
01/01/2018
01/01/2019
01/01/2020
01/01/2018
Performance 
rights granted 
under LTIP b
Damien MacRae
01/01/2019
01/01/2020
Adrian Gratwicke d
15/06/2020
2.40
2.93
2.78
2.51
12.08
14.06
13.91
12.96
9.70
13.91
12.96
9.70
9.70
14,754
1 January 2016 to 31 December 2020
46,075
1 January 2017 to 31 December 2021
49,532
1 January 2018 to 31 December 2022
54,860
1 January 2019 to 31 December 2023
10,617
1 January 2016 to 31 December 2020
9,258
1 January 2017 to 31 December 2021
13,589
1 January 2018 to 31 December 2022
13,072
1 January 2019 to 31 December 2023
14,098
1 January 2020 to 31 December 2022
4,448
1 January 2018 to 31 December 2022
4,279
1 January 2019 to 31 December 2023
26,336
1 January 2020 to 31 December 2022
17,107
15 June 2020 to 3 August 2023
Former Executive KMP ceased during the financial year
Josée Lemoine c
01/01/2016
01/01/2017
01/01/2018
01/01/2019
12.08
14.06
13.91
12.96
2,931
1 January 2016 to 31 December 2020
3,201
1 January 2017 to 31 December 2021
3,300
1 January 2018 to 31 December 2022
3,174
1 January 2019 to 31 December 2023
239,200
384,750
390,521
567,069
567,067
158,302
185,625
185,625
35,410
135,000
137,699
137,699
128,250
130,174
189,023
169,413
136,751
61,875
55,456
255,459
165,938
35,410
45,000
45,900
41,135
Footnotes to Table 11
a   The grant date fair value of the options granted under LTIP was 
c    No LTI was granted to Josée Lemoine for the financial year ended  
determined using Black-Scholes valuation methodology.
31 December 2020.
b   The grant date fair value of the performance rights granted for 2016 to 
2018 under LTIP equalled the ten-day VWAP starting from the first day 
of the trading window immediately following the announcement of the 
full year result. From 2019 grants onwards, the grant date fair value 
of the performance rights granted under LTIP was determined using 
Black-Scholes valuation methodology.
d    The performance period for the 2020 grant to Adrian Gratwicke is 
from 15 June 2020 (i.e., the signing date of the employment condition 
which is deemed to be the commencement date of performance 
period as per AASB 2) instead of 3 August 2020. The performance 
targets are the same as the 2020 grant for other Executive KMP, ie 
50% CAGR on EPS and 50% on ROIC from 1 January 2020.
InvoCare            Annual Report 2020  | 54
e.  Movements in LTI grants
Table 12 provides the movement of all outstanding LTI grants for the Executive KMP during 2020.
Table 12 – Movement of LTI grants
Grant
Executive KMP
Number 
 of LTI held at  
1 January  
2020
Number  
of LTI  
granted  
during 2020
Number of LTI 
vested and 
exercised  
during 2020
Number  
of LTI  
lapsed  
during 2020
Number of  
LTI held at  
31 December 
2020
Shares granted 
under DESP
Options 
granted  
under LTIP
Performance 
rights granted 
under LTIP
Martin Earp
Adrian Gratwicke
Martin Earp a
Damien MacRae
5,804
-
723,502
140,726
Former Executive KMP ceased during the financial year
Josée Lemoine b
Martin Earp
Damien MacRae
Adrian Gratwicke
165,221
42,997
8,727
-
-
(5,804)
30,000
272,934
-
-
14,098
26,336
17,107
-
-
-
-
(7,078)
-
-
Former Executive KMP ceased during the financial year
Josée Lemoine
11,629
-
(1,954)
-
-
-
-
-
-
-
-
-
-
30,000
996,436
140,726
165,221
50,017
35,063
17,107
9,675
Footnotes to Table 12
a  At 1 January 2020 and 31 December 2020, Martin Earp held 53,438 and 160,313 vested and exercisable options, respectively.
b  At 1 January 2020 and 31 December 2020, Josée Lemoine held 4,918 and 14,754 vested and exercisable options, respectively.
VII. Loans to Executive KMP
There were no loans at the beginning or at the end of the financial year ended 31 December 2020 to the Executive KMP. No loans were made available 
to the Executive KMP during 2020.
VIII. The year ahead – What can we expect in 2021?
a.  STI 2021
The Executive KMP 2021 STI opportunity will be subject to key performance conditions and weightings as listed in Table 13.
Table 13 – 2021 STI performance targets
Component
2021 performance targets
CEO – 
weight
CFO – 
weight Why this was chosen?
Financial 
performance
Group EBITDA
30% 
30%  The Company’s key performance metric
Group case volume 
10% 
10%  Case volume is an indicator of revenue growth
Personal financial objective
10%
10% Alignment of KMP’s STI reward with key objectives for the year
Our customer
Net Promoter Score
10%
10% Customer feedback and satisfaction remains core to the service offering
Our people
Employee turnover  
< 12 months tenure
10%
10%
People are the Company’s greatest asset. This encourages greater 
involvement and consideration around all recruitment activity in the regions
Our safety
culture in the workplace. The safety components reflect both a lead and a  
LTIFR
15%
15% The Company continues to reinforce its commitment to a strong safety  
Workplace inspections
5%
5%
lag measure.
Personal
Project objective
10%
10% Alignment of KMP’s STI reward with key objectives for the year
InvoCare            Annual Report 2020  | 55
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited 
Executive KMP remuneration continued
b.  2021 Executive KMP changes announced
i.  
 Olivier Chretien – Managing Director and Chief Executive 
Officer, effective 1 January 2021
ii 
 Martin Earp – Former Chief Executive Officer ceasing 31 
March 2021
Mr Olivier Chretien has been appointed to the position of Chief 
The following provides an overview of final payments upon conclusion 
Executive Officer effective 1 January 2021, and Managing Director 
of Mr Earp’s six year contract in 2021:
effective 4 January 2021.
TFR of $1,025,000 per annum.
Total fixed 
remuneration 
(TFR)
Short term 
incentive (STI)
• •  Fixed remuneration until 31 March 2021
• •  Payment for completion of agreed handover arrangements
• •  Grant of 2021 LTI pro-rated for the period ended 31 March 2021
Target STI of $717,500 (70% of TFR).
• •  Unused accrued annual leave entitlements until 31 March 2021
The STI is based on Mr Chretien’s achievement of 
iii.    Damien MacRae – Former Deputy Chief Executive Officer 
key performance indicators prescribed by InvoCare 
ceasing 5 February 2021
for the relevant financial year.
If Mr Chretien’s STI award exceeds $150,000, 
50% of the value that exceeds this amount will be 
The following provides an overview of final payments upon 
redundancy of Mr MacRae. They included all items in accordance to 
the statutory requirements for his redundancy:
deferred and paid into the Company’s shares held in 
• •  Fixed remuneration until 5 February 2021
trust. There is a one year deferral period from grant. 
The Board retains a discretion to deliver deferred STI 
in cash.
Long term 
incentive (LTI)
Target LTI of $717,500 (70% of TFR).
• •  Remaining contractual notice period from 6 February to 30 June 
2021
• •  Redundancy payments in accordance with statutory requirements
• •  Unused accrued annual leave entitlements until 5 February 2021
Mr Chretien will be eligible to participate in the 
Company’s Long Term Incentive Plan, under 
which he may be granted performance rights and/
or options (subject to shareholders’ approval). 
For the financial year ending 31 December 
2021, the maximum value of Mr Chretien’s LTI 
will be $717,500. Vesting of the LTI is subject 
to performance and continuous employment 
conditions.
Sign-on incentive: Mr Chretien will receive a one-off sign-on incentive 
to the value of $400,000, in the form of InvoCare shares (subject 
to shareholders’ approval). The shares will be allocated and held in 
trust and pursuant to the terms of the InvoCare Deferred Employee 
Share Plan (DESP). The shares will vest two years after Mr Chretien’s 
appointment date provided that he is still employed by InvoCare at 
that date and the applicable vesting conditions as described in the 
DESP rules and accompanying offer letter have been satisfied.
InvoCare            Annual Report 2020  | 56
Directors’ Report
Remuneration report – audited 
Non-Executive Director remuneration
F.  Non-Executive Director remuneration
I.  Fee structure and policy
The following table outlines the Non-Executive Directors (NEDs) fee 
policy and any changes introduced for 2021.
Maximum 
Non-Executive Directors’ base fee for services 
Additional or 
The base fees exclude any remuneration determined 
aggregate 
as Directors is determined within an aggregate 
special duties
by the Directors where a Director performs additional 
fees 
Directors’ fee pool cap, which is periodically 
approved by 
approved by shareholders. At the date of this report, 
shareholders
the pool cap is $1,250,000, being the amount 
approved by shareholders at the AGM held on  
22 May 2015.
Contracts
Upon appointment to the Board, all NEDs receive a 
letter of appointment which summarises the Board 
policies and terms, including compensation, relevant 
to the office of Director.
Non-
The Board reviews NED fees on an annual basis in 
Executive 
line with general industry practice. This ensures fees 
Director fee 
are appropriately positioned in the market to attract 
reviews
and retain high calibre individuals.
or special duties for the Company. If a NED performs 
additional or special duties for the Company, they 
may be remunerated as determined by the Board 
and that remuneration can be in addition to the limit 
mentioned above.
Whilst all Directors have contributed actively to the 
board and special projects beyond the board room 
during the year, these contributions have been made 
as directors and as such have not resulted in any 
additional payments.
Superan-
The fees set out above include superannuation 
nuation
contributions in accordance with relevant statutory 
requirements.
NEDs are entitled to be reimbursed for all reasonable 
Equity 
NEDs may receive options as part of their 
costs and expenses incurred by them in performing 
participation
remuneration, subject only to shareholder approval. 
No options are held by any NED at the date of this 
report.
NEDs of InvoCare Limited are encouraged to acquire 
a minimum equity interest in the Company equivalent 
in value to 50% of their annual Director’s fee applying 
at the time of their appointment as a director of the 
Company, and NEDs are allowed up to three years to 
accumulate the required shareholding.
NEDs equity holdings are set out in Table 16  
in Section G.
Post 
NEDs are not entitled to any compensation on 
employment 
cessation of employment.
benefits
their duties.
NED fee changes 2020
To maintain market equity, the Board determined an 
increase of 3% to the base fee from 1 January 2020 
to the Chairman and the NED roles.
No change to the Chair of the Audit, Risk & 
Committee fee was made in 2020.
Following the half year financial results with the 
impact of COVID-19, it was agreed that NEDs would 
take a 25% reduction to their fees for four months 
from 1 August to 30 November 2020. This reflects 
the continued alignment with all our stakeholders.
NED fee changes 2021
There are no changes to the Board base fees in 
2021. In recognition of the additional workloads for 
Chairs of committees and alignment, the decision 
was made to extend the current Chair fee of $11,560 
for the Audit, Risk & Compliance Committee to the 
Chairs of both the Investment Committee and the 
People, Culture & Remuneration Committee.
Refer to Table 14 for details of 2020 fees including 
reduced NED fees from 1 August to 30 November 
2020 as well as 2021 fees. The aggregation of all 
Board and committee fees for 2020 and 2021, 
respectively, remains below the current pool limit.
InvoCare            Annual Report 2020  | 57
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Remuneration report – audited 
Non-Executive Director remuneration continued
Table 14 – Non-Executive Director fees (inclusive of superannuation)
Board/Committee 
Role 
Per role 
$
2020
Total * 
$
From 1 January 2021
Per role 
$
Total 
$
Board base fee
Chairman
285,691
261,883
285,691
285,691
Non-Executive Directors
142,840
654,683
142,840
714,200
Audit, Risk & Compliance Committee
Chairman
11,560
10,597
Investment Committee
Chairman
People, Culture & Remuneration Committee Chairman
-
-
-
-
11,560
11,560
11,560
11,560
11,560
11,560
Total
927,163
1,034,571
* 
 Following the half year financial results with the impact of COVID-19 the NEDs took a 25% reduction to their fees for four months from 1 August to  
30 November. Therefore, the total annual Board base fee in 2020 column was less than the annual amount per role.
II.  Non-Executive Director’s remuneration details
Table 15 provides the remuneration details for the Non-Executive Directors on the Company’s Board. For any Directors appointed during the  
financial year, their remuneration has been pro-rated from the date of appointment to the end of the financial year. During the financial year ended  
31 December 2020, the Non-Executive Directors took a reduced Board base fee received during the period from 1 August to 30 November 2020. 
Therefore, total remuneration for the financial year ended 31 December 2020 was lower than that for the prior financial year.
Table 15 – Total Non-Executive Director’s remuneration
Short-term 
 employee benefits 
Post- employment 
benefits 
Board and  
committee fees 
$
Superannuation 
$
240,535
253,306
119,577
126,648
119,577
126,648
119,577
126,648
129,254
137,205
119,577
126,648
21,348
24,064
11,420
12,032
11,420
12,032
11,420
12,032
12,279
13,035
11,420
12,032
2020
2019
2020
2019
2020
2019
2020
2019
2020
2019
2020
2019
Total
$
261,883
277,370
130,997
138,680
130,997
138,680
130,997
138,680
141,533
150,240
130,997
138,680
Bart Vogel
Richard Davis
Jackie McArthur
Megan Quinn
Keith Skinner
Robyn Stubbs
InvoCare            Annual Report 2020  | 58
G. Additional information
Table 16 summarises the movement in holdings of InvoCare ordinary shares during the year and the balance at the end of the financial year, both in total 
and held indirectly by related parties of the KMP.
Table 16 – Movement of shareholding interests of Directors in accordance with  
section 205G of the Corporations Act 2001 and the other Executive KMP
Balance as at  
1 January  
2020 
Number
Grant as 
compensation 
Number
Exercise of LTI 
vested during 
2020 
Number
Net other 
changes during 
2020 
Number
Non-
Executive 
Directors
Bart Vogel
Richard Davis
Jackie McArthur
Megan Quinn
Keith Skinner
Robyn Stubbs
Martin Earp
Damien MacRae
Adrian Gratwicke b
Executive 
KMP
16,129
200,000
4,000
-
1,084
7,905
22,671
1,000
-
Former Executive KMP ceased during the financial year
Josée Lemoine
977
Footnotes to Table 16
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12,882
-
-
1,954
3,214
(40,000)
480
-
2,884
-
(17,119)
3,884
-
-
Total shares 
held directly and 
indirectly as at  
31 December 
2020 a 
Number
19,343
160,000
4,480
-
3,968
7,905
18,434
4,884
-
2,931
a    Shares held indirectly are included in the column headed Total shares held at 31 December 2020. Total shares are held directly by the KMP and indirectly 
by the KMP’s related parties, inclusive of domestic partner, dependants and entities controlled, jointly controlled or significantly influenced by the KMP.
b   Adrian Gratwicke commenced as Executive KMP from 3 August 2020 and therefore there were no shares held as at 1 January 2020.
This concludes the Remuneration Report which has been audited.
InvoCare            Annual Report 2020  | 59
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Other statutory matters
Directors
The directors of InvoCare Limited at any time during or since the end of the financial year are as follows. Directors were in office for the entire period until 
otherwise stated.
Name
Bart Vogel
Martin Earp
Richard Davis
Jackie McArthur
Megan Quinn
Keith Skinner
Robyn Stubbs
Role
Chairman
Date of appointment/resignation
Chief Executive Officer and Managing Director
Resigned 4 January 2021
Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Resigned 1 February 2021
Directors appointed subsequent to balance sheet date
Olivier Chretien
Chief Executive Officer and Managing Director
Appointed 4 January 2021
Directorship of other listed companies
Directorship of other listed companies held by the directors in the three years preceding the end of the financial year are as follows.
Name
Company
Period of directorship
Bart Vogel
Martin Earp
Richard Davis
Jackie McArthur
Megan Quinn
Macquarie Telecom Limited
Infomedia Ltd
Salmat Limited
None
Australian Vintage Ltd
Monash IVF Group Limited
Inghams Group Limited
Tassal Group Limited
Blackmores Limited
Qube Holdings Limited
City Chic Collective Limited (formerly known as Specialty Fashion 
Group Limited)
Reece Limited
Keith Skinner
Emeco Holdings Limited
Since 2014
Since 2015
From May 2017 to November 2019
Since 2009
Since 2014
Since 2017
Since 2018
From April 2018 to August 2019
Since 2020
Since 2012
Since 2017
Since 2017
Robyn Stubbs
Aventus Group – Aventus Retail Property Fund and its subsidiaries
Since 2015
Brickworks Limited
Since 2020
Directors appointed subsequent to balance sheet date
Olivier Chretien
None
InvoCare            Annual Report 2020  | 60
Directors’ profiles
Bart Vogel BCom (Hons), FCA, FAICD
Richard Davis BEc
Independent Non-Executive Chairman
Independent Non-Executive Director
Bart Vogel was appointed to the InvoCare Board of Directors  
Richard Davis was appointed to the InvoCare Board of Directors  
on 1 October 2017, and as Chairman of the Board  
on 21 February 2012.
from 1 October 2018.
Richard is the Chair of Investment Committee and serves on the 
Bart serves on the Audit, Risk & Compliance Committee, People, 
People, Culture & Remuneration Committee and Nomination 
Culture & Remuneration Committee and Nomination Committee.
Committee.
Bart’s career includes 20 years in the management consulting 
Richard previously retired as InvoCare’s Chief Executive Officer 
industry, as a partner with Deloitte Consulting, A.T. Kearney and 
and Managing Director on 31 December 2008 after 20 years with 
Bain & Company, focused on the technology and services sectors. 
InvoCare. For the majority of that time, he held the position of Chief 
In his consulting roles, Bart has spent extensive time working in 
Executive Officer and successfully initiated and managed the growth 
global markets with multinational corporates and government 
of the business through a number of ownership changes and over  
bodies. He also spent 13 years in senior executive roles at Asurion 
20 acquisitions, including Singapore Casket Company (Private) 
Australia, Spherion Limited and as the Asia Pacific leader of Lucent 
Limited, the Company’s first international acquisition.
Technologies.
Richard is the Chairman of Australian Vintage Limited and Monash 
Bart is a director of listed companies Infomedia Ltd (serves as 
IVF Group Limited. Richard is also serving as Chairman of Singapore 
Chairman) and Macquarie Telecom Limited. He is also a Director of 
Casket Company (Private) Limited.
BAI Communications and of the Children’s Cancer Institute Australia 
and was a Director of Salmat Limited (delisted on 3 September 2020).
InvoCare            Annual Report 2020  | 61
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Other statutory matters continued
Jackie McArthur BEng MAICD
Megan Quinn GAICD
Independent Non-Executive Director
Independent Non-Executive Director
Jackie McArthur was appointed to the InvoCare Board of Directors  
Megan Quinn was appointed to the InvoCare Board of Directors  
on 1 October 2018.
on 1 October 2018.
Jackie serves on the Audit, Risk & Compliance Committee, 
Megan serves on the Audit, Risk & Compliance Committee, People, 
Investment Committee and Nomination Committee.
Culture & Remuneration Committee and Nomination Committee.
Jackie has over 20 years experience at board and executive levels 
Megan is internationally regarded as a transformation, marketing, 
in strategic planning processes, organisational design, operations, 
retail and business expert and is invited to speak and consult on 
franchising systems, retail, supply chain, logistics, transport, food 
service, innovation, creativity, strategy, building a global brand, 
processing and manufacturing, emerging brand issues and crisis 
business excellence and customer experience for companies, 
management, risk management, corporate social responsibility and 
conferences and media outlets around the world. Named a global 
compliance issues, as well as governance at a global level, across 
game changer and one of Australia’s most powerful women in retail, 
Australia, Asia and globally.
Megan was a co-founder of the world’s premier online luxury fashion 
Most recently she was managing director, Australia and New Zealand, 
retailer, NET-A-PORTER.
of Martin-Brower ANZ, the exclusive distributor to McDonald’s 
Megan is a Director of listed companies City Chic Collective Limited 
restaurants across Australia and New Zealand. Previously, for more 
and Reece Limited. Having previously served on the Board and 
than 13 years, she held various senior executive positions with 
national committee of UNICEF Australia, she is an advocate for the 
McDonalds, both in Australia and overseas, including vice president 
Rights of the Child,and is a passionate ambassador of Fitted For 
of supply chain for Asia Pacific, Middle East and Africa and, in 
Work.
McDonalds Australia, as senior vice president chief restaurant support 
officer and vice president supply chain director.
Jackie is a Director of listed companies Inghams Group Limited, 
Tassal Group Limited and Qube Holdings Limited.
Jackie was the 2016 Telstra NSW Business Woman of the Year and 
overall 2016 Telstra Business Women’s Awards - Corporate and 
Private National Winner. She has completed the INSEAD International 
Executive Program.
InvoCare            Annual Report 2020  | 62
Keith Skinner BCom, FCA, GAICD
Olivier Chretien MEng, MBA, GAICD
Independent Non-Executive Director
Managing Director and Chief Executive Officer
Keith Skinner was appointed to the InvoCare Board of Directors 
Olivier Chretien was appointed as Managing Director and Chief 
 on 1 September 2018.
Keith is the Chair of Audit, Risk & Compliance Committee and serves 
Executive Officer effective from 1 January 2021. Mr Chretien was 
appointed to the InvoCare Board of Directors on 4 January 2021.
on the Investment Committee and Nomination Committee.
Olivier was recently Group Chief Strategy Officer with Ramsay Health 
Keith has a strong record in business management, restructuring, 
finance, accounting, risk and governance. He commenced his career 
as an auditor with Deloitte Australia in 1974, later moving to the firm’s 
Care, where he was in charge of Group Strategy, M&A and Ventures, 
the Australian Pharmacy business, and a Director of the European and 
Asian JV Boards.
Restructuring Services division, and was appointed a partner in 1986. 
Prior to this, Olivier spent 12 years with Wesfarmers. His last role was 
He was a leading practitioner for company turnarounds for over a 
Managing Director, Business Development for the Group, where he 
decade, before becoming Chief Operating Officer of Deloitte Australia 
was also a Director of retail divisional Boards for Coles, Bunnings, 
in 2001.
Since retirement in 2015, Keith has been a Director of a number of 
public and private organisations including Emeco Holdings Limited, 
North Sydney Local Health Board and not for profit organisation 
Kmart and Officeworks. He was previously the Managing Director 
of the Wesfarmers Industrial & Safety division for seven years, with 
more than 4,000 employees and 250 locations across Australia, New 
Zealand, China, Indonesia and the United Kingdom.
Lysicrates Foundation. He has also been Independent Chair of 
Prior to Wesfarmers, he spent nine years with Boston Consulting 
the Audit and Risk Committee of the Australian Digital and Health 
Group in France and Australia, consulting to clients in the 
Agency and has consulted to a number of organisations on strategy 
pharmaceuticals and travel and tourism services industries. He 
execution, restructuring and operational improvement.
started his career in engineering.
Olivier holds an Executive MBA (AMP) from Harvard Business School 
(Boston USA), an MBA from INSEAD (France), and a Master of 
Engineering from Ecole Centrale de Paris (France).
InvoCare            Annual Report 2020  | 63
Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report
Other statutory matters continued
Meetings of Directors
The number of meetings of the Company’s Board of Directors (the Board) and each Board committee held during the financial year ended  
31 December 2020, and the number of meetings attended by each director were as follows.
Board
Audit, Risk & 
Compliance  
Committee
Investment  
Committee
People, Culture 
& Remuneration 
Committee
Nomination  
Committee
Name
Held
Attended
Held
Attended
Held
Attended
Held
Attended
Held
Attended
Bart Vogel
Martin Earp
Richard Davis
Jackie McArthur
Megan Quinn
Keith Skinner
Robyn Stubbs
19
19
19
19
19
19
19
19
19
19
19
19
19
19
4
-
-
4
4
4
-
4
-
-
4
4
4
-
-
-
5
5
-
5
5
-
-
5
5
-
5
5
5
-
5
-
5
-
5
5
-
5
-
5
-
5
8
-
8
8
8
8
8
8
-
8
8
8
8
8
In addition to the formal meetings of directors there were numerous informal meetings of the non-executive directors during the year. Those meetings 
were concerned, for the most part, with succession planning, environmental, social and governance and customer strategy and site visits.
The composition of the Board and Board committees is a minimum of three directors. Board committees consist entirely of independent  
non-executive directors.
Company secretary
Significant changes in the state of affairs
The significant changes in the state of affairs during the financial year 
were as follows:
• •  During April 2020, the Company undertook a fully underwritten 
institutional placement and a Share Purchase Plan which raised 
a total of $270,862,000 in capital net of costs. Part of the capital 
raised was used to reduce borrowings, continue growth projects 
and increase liquidity during the COVID-19 pandemic
• •  During the financial year, the Group acquired the following business 
assets and companies. Further details of these acquisitions are 
provided in Note 18 Business combinations:
•  The business assets of Galaxy Funerals based in Sydney, New 
South Wales. Galaxy Funerals is a specialist business providing 
funeral care to the Chinese community, with religious and  
non-religious backgrounds
•  Family Pet Care Pty Limited which is the provider of pet 
cremation services and has a presence in Western Australia, 
South Australia, Victoria and Southern New South Wales
•  The pet cremation business assets of Pets in Peace which is 
based in Queensland
Other than the matters as stated above, there were no other 
Heidi Aldred BEcon, LLB
Heidi Aldred was appointed as Company Secretary on 15 March 2019. 
significant changes in the state of affairs of the Company during the 
Heidi, a qualified lawyer, has over 20 years experience in secretarial 
financial year.
and general counsel roles in a wide variety of areas with both listed 
and unlisted companies. Her early career included working with 
legal firms Arnold Bloch Leibler and Allens Linklaters (formerly Arthur 
Robinson & Hedderwicks).
InvoCare            Annual Report 2020  | 64
Dividends 
Non-audit services 
Details of dividends paid or determined by the Company during the 
Details of the amounts paid or payable to the auditor for non-audit 
financial year ended 31 December 2020 are set out in Note 4. 
services provided during the financial year by the auditor are outlined 
Subsequent events 
Refer to Note 17 for details of a property sale in January 2021. Other 
than this transaction and the Board’s determination of a final dividend 
of 7.0 cents per share, fully franked, there have been no other matter 
in Note 25 to the financial statements. 
The directors are satisfied that the provision of non-audit services 
during the financial year, by the auditor (or by another person or firm 
on the auditor’s behalf), is compatible with the general standard of 
independence for auditors imposed by the Corporations Act 2001. 
or circumstance arising since 31 December 2020 that has significantly 
The Directors are of the opinion that the services as disclosed in 
affected the Company’s operations, results or state of affairs, or may 
Note 25 to the financial statements do not compromise the external 
do so in future financial years.
auditor’s independence requirements of the Corporations Act 2001 
Indemnification and insurance of officers 
To the extent permitted by law, the Company has indemnified the 
directors and executives of the Company for liability, damages and 
expenses incurred, in their capacity as a director or an executive, for 
which they may be held personally liable, except where there is a lack 
of good faith. 
During the financial year, the Company paid a premium in respect of 
an insurance policy to insure directors and officers of the Company 
against a liability to the extent permitted by the Corporations Act 
2001. The insurance policy specifically prohibits disclosure of the 
nature and liability covered and the amount of the premium paid. 
Environmental regulation and performance 
The Company is committed to the protection of the environment, 
the health and safety of its employees, customers and the general 
public, as well as compliance with all applicable environmental 
laws, rules and regulations in the jurisdictions in which the Company 
operates. The Group is subject to environmental regulation in respect 
of its operations, including some regulations covering the disposal 
of mortuary and pathological waste and the storage of hazardous 
materials. The Company has appropriate risk management systems 
in place at its locations. 
There have been no claims during the year and the directors believe 
the Company has complied with all relevant environmental regulations 
and holds all relevant licences. 
Corporate governance 
The Company and the Board of Directors are committed to achieving 
and demonstrating the highest standards of corporate governance. 
The Board adopts a continuance improvement approach and 
regularly reviews corporate governance and reporting practices. For 
2020, InvoCare’s Corporate Governance Statement reports against 
the 4th Edition ASX Principles and will be published at the time of 
publication of the 2020 Annual Report. 
The 2020 InvoCare Corporate Governance Statement is available on 
the InvoCare website at:  
www.invocare.com.au/investor-relations/corporate-governance 
for the following reasons:
• •  All non-audit services have been reviewed and approved to ensure 
that they do not impact the integrity and objectivity of the auditor
• •  None of the services undermine the general principles relating to 
auditor independence as set out in APES 110 Code of Ethics for 
Professional Accountants issued by the Accounting Professional 
and Ethical Standards Board, including reviewing or auditing the 
auditor’s own work, acting in a management or decision-making 
capacity for the Company, acting as advocate for the Company or 
jointly sharing economic risks and rewards
Auditor’s independence declaration 
A copy of the auditor’s independence declaration as required under 
section 307C of the Corporations Act 2001 is set out immediately 
after the Directors’ Report.
Rounding of amounts
The Company is of a kind referred to in ASIC Corporations (Rounding 
in Financial/Directors’ Reports) Instrument 2016/191, issued by 
the Australian Securities and Investments Commission, relating to 
the “rounding off” of amounts in the directors’ report and financial 
report. Amounts in the reports have been rounded off to the nearest 
thousand dollars (where rounding is applicable) in accordance with 
that instrument.
This report is made in accordance with a resolution of Directors, 
pursuant to section 298(2)(a) of the Corporations Act 2001.
On behalf of the Directors on 24 February 2021.
Bart Vogel Chairman 
Sydney
InvoCare            Annual Report 2020  | 65
Performance Review12Directors’ Report3Financial Report4Other Information 
PricewaterhouseCoopers, ABN 52 780 433 757 One International Towers Sydney, Watermans Quay, Barangaroo, GPO BOX 2650, SYDNEY  NSW  2001 T: +61 2 8266 0000, F: +61 2 8266 9999, www.pwc.com.au Level 11, 1PSQ, 169 Macquarie Street, Parramatta NSW 2150, PO Box 1155 Parramatta NSW 2124 T: +61 2 9659 2476, F: +61 2 8266 9999, www.pwc.com.au   Liability limited by a scheme approved under Professional Standards Legislation. 66Auditor’s Independence Declaration As lead auditor for the audit of InvoCare Limited for the year ended 31 December 2020, I declare that to the best of my knowledge and belief, there have been:  (a)no contraventions of the auditor independence requirements of the Corporations Act 2001 inrelation to the audit; and(b)no contraventions of any applicable code of professional conduct in relation to the audit.This declaration is in respect of InvoCare Limited and the entities it controlled during the period.MW Chiang Sydney Partner PricewaterhouseCoopers 24 February 2021 Financial Report
InvoCare            Annual Report 2020  | 67
Financial Report
Introduction
This is the financial report of InvoCare Limited (the Company) and its 
PAGE  CONTENT
subsidiaries (together referred to as InvoCare or the Group).
InvoCare Limited (ABN 42 096 437 393) is a listed public company 
limited by shares, incorporated and domiciled in Australia. Its 
registered office and principal place of business is:
Level 2, 40 Miller Street 
North Sydney NSW 2060
A description of the nature of the Group’s operations and its principal 
activities is included in the Directors’ Report.
The financial report was authorised for issue by the Directors on  
24 February 2021. The Directors have the power to amend and 
reissue the financial report.
About this report
This financial report’s disclosures are split into five distinct groups 
to enable better understanding of how the Group has performed. 
Accounting policies and critical accounting judgements applied in the 
preparation of the financial statements are shown together with the 
related accounting balance and where the financial statement matter 
is disclosed.
69 
69 
70 
71 
72 
73 
75 
75 
78 
80 
81 
82 
83 
86 
88 
88 
89 
90 
92 
96 
99 
99 
Consolidated financial statements
Consolidated statement of comprehensive income
Consolidated balance sheet
Consolidated statement of changes in equity
Consolidated statement of cash flows
Basis of preparation
Key performance metrics
Note 1. Operating segments
Note 2. Revenue
Note 3. Earnings per share
Note 4. Dividends
Note 5. Expenses
Note 6. Income tax
Note 7. Cash flow information
Significant assets and liabilities
Note 8. Trade receivables
Note 9. Deferred selling costs and revenue
Note 10. Pre-paid contracts
Note 11. Non-current operating assets
Note 12. Intangibles
Capital and risks
Note 13. Financial risk management
106  Note 14. Contributed equity
107  Note 15. Contingencies
108  Note 16. Commitments
108  Note 17. Events after reporting period
109  Business portfolios
109  Note 18. Business combinations
112  Note 19. Interests in subsidiaries
114  Other statutory disclosures
114  Note 20. Share-based remuneration
118  Note 21. Related party transactions
119  Note 22. Parent entity information
120  Note 23. Deed of cross guarantee
122  Note 24. Economic dependence
122  Note 25. Remuneration of auditors
123  Note 26. Other accounting policies
125  Directors declaration
InvoCare            Annual Report 2020  | 68
Financial Report
Consolidated financial statements  
Consolidated statement of comprehensive income
For the year ended 31 December 2020
Revenue from continuing operations
Finished goods, consumables and funeral disbursements
Employee benefits expense
Advertising and public relations expenses
Occupancy and facilities expenses
Motor vehicle expenses
Technology expenses
Other expenses
Depreciation and amortisation expenses
Impairment loss on intangibles
Impairment reversal on cemetery land
Gain on disposal of an associate
Finance costs
Interest income
Net (loss)/gain on undelivered pre-paid contracts
Acquisition related costs
Net gain on disposal of non-current assets
(Loss)/profit before income tax
Income tax expense 
Net (loss)/profit after income tax from continuing activities
Net (loss)/profit after income tax for the year
Other comprehensive income  
Items that may be reclassified to profit or loss
Changes in the fair value of cash flow hedges, net of tax
Total realised loss on early settlement of interest rate swaps reclassified to profit or loss
Net changes to cash flow hedges, net of tax
Changes in foreign currency translation reserve, net of tax
Other comprehensive income/(loss) for the year, net of tax
Total comprehensive (loss)/income for the year, net of tax
(Loss)/profit is attributable to:
Equity holders of InvoCare Limited
Non-controlling interests
Total comprehensive (loss)/income for the year is attributable to:
Equity holders of InvoCare Limited
Non-controlling interests
Notes
2
12
11
10
18
6
2020 
$’000
477,652
(120,514)
(174,764)
(17,725)
(22,533)
(9,473)
(12,736)
(22,289)
97,618
(44,292)
(25,500)
6,000
-
2019 
$’000
500,348
(125,066)
(166,204)
(16,810)
(20,937)
(8,480)
(10,795)
(14,966)
137,090
(36,986)
(24,404)
-
52
(24,929)
(25,671)
1,059
(16,618)
(1,918)
7,383
(1,197)
(7,878)
(9,075)
(9,075)
(320)
2,419
2,099
(1,091)
1,008
(8,067)
(9,242)
167
(9,075)
(8,234)
167
(8,067)
2020 
cents
1,211
45,550
(2,021)
2,352
97,173
(33,285)
63,888
63,888
(1,661)
-
(1,661)
(198)
(1,859)
62,029
63,752
136
63,888
61,893
136
62,029
2019 
cents
Earnings per share for (loss)/profit attributable to the ordinary equity holders of InvoCare 
Limited
Basic earnings per share 
Diluted earnings per share 
3
3
(6.9)
(6.9)
55.8
54.9
The above consolidated statement of comprehensive income should be read in conjunction with the accompanying notes.
InvoCare            Annual Report 2020  | 69
Performance Review12Directors’ Report3Financial Report4Other Information 
 
Financial Report
Consolidated financial statements  
Consolidated balance sheet
As at 31 December 2020
Assets
Current  
assets
Cash and cash equivalents
Trade receivables
Other receivables
Inventories
Pre-paid contract funds under management
Assets held for sale
Deferred selling costs
Deferred contract assets
Total current assets
Non-current 
assets
Trade receivables
Other receivables
Other financial assets
Property, plant and equipment
Right of use asset
Pre-paid contract funds under management
Liabilities Current  
liabilities
Non-current 
liabilities
Equity
Intangibles
Deferred selling costs
Deferred contract assets
Total non-current assets
Total assets
Trade and other payables
Contingent considerations
Lease liabilities
Derivative financial instruments
Current tax liabilities
Pre-paid contract liabilities
Deferred revenue
Provision for employee entitlements
Total current liabilities
Contingent considerations
Borrowings
Lease liabilities
Derivative financial instruments
Deferred tax liabilities
Pre-paid contract liabilities
Deferred revenue
Provision for employee entitlements
Total non-current liabilities
Total liabilities
Net assets
Contributed equity
Reserves
Retained profits
Parent entity interests
Non-controlling interests
Total equity
The above consolidated balance sheet should be read in conjunction with the accompanying notes.
InvoCare            Annual Report 2020  | 70
Notes
7
8
10
9
8
11
11
10
12
9
18
11
10
9
18
13
11
6
10
9
2020 
$’000
118,781
38,757
13,710
44,117
50,268
2,788
3,644
1,541
273,606
29,445
670
4
464,277
144,368
562,863
243,515
34,068
2,525
2019 
$’000
19,560
40,679
9,983
45,117
57,552
5,842
4,480
2,409
185,622
31,477
655
4
426,955
144,001
561,837
210,724
35,448
4,040
1,481,735
1,415,141
1,755,341
1,600,763
60,514
9,265
19,465
600
1,874
44,685
28,632
16,613
181,648
7,909
246,039
146,459
548
32,639
496,624
109,086
2,489
60,810
94
12,934
735
813
48,885
34,913
14,864
174,048
800
357,189
149,967
3,422
34,826
476,498
104,387
2,647
1,041,793
1,129,736
1,223,441
1,303,784
531,900
497,005
9,977
23,495
530,477
1,423
531,900
296,979
219,826
7,728
68,169
295,723
1,256
296,979
Financial Report
Consolidated financial statements  
Consolidated statement of changes in equity
For the year ended 31 December 2020
Attributable to equity holders of InvoCare Limited
2020
Contributed 
equity 
$’000
Share-based 
payment 
reserve 
$’000
Hedging 
reserve 
$’000
Foreign 
currency 
translation 
reserve 
$’000
Retained 
profits 
$’000
Non-
controlling 
interests 
$’000
Total  
equity 
$’000
Balance at 1 January 2020
219,826
2,055
(2,854)
8,527
68,169
1,256
296,979
Total comprehensive income/(loss)  
for the year
Transactions with owners in their  
capacity as owners:
Dividends paid (Note 4)
Employee share plan shares vested during 
the year
Issue of ordinary shares as part of dividend 
reinvestment plan (Note 4)
Issue of ordinary shares, net of transaction 
costs
Transfer of shares from the deferred plan to 
the InvoCare Exempt Share Plan Trust
Employee shares – value of services
Balance at 31 December 2020
497,005
2019
Balance at 1 January 2019
Change in accounting policy
124,140
-
Restated balance at the beginning of the year
124,140
Total comprehensive income for the year
Transactions with owners in their  
capacity as owners:
Dividends paid (Note 4)
Reclassification of equity settled share based 
payments
Employee share plan shares vested during 
the year
Issue of ordinary shares as part of dividend 
reinvestment plan (Note 4)
Issue of ordinary shares, net of transaction 
costs
-
-
-
-
48
(16)
5,918
270,862
351
-
-
-
-
-
-
-
1,257
3,296
246
-
246
-
-
2,353
450
(192)
9,137
85,787
-
-
2,099
(1,091)
(9,242)
167
(8,067)
-
-
-
-
-
-
-
-
-
-
-
-
(29,514)
-
(5,918)
-
-
-
-
-
-
-
-
-
(29,514)
32
-
270,862
351
1,257
(755)
7,436
23,495
1,423
531,900
(1,193)
8,725
58,138
1,241
191,297
-
(1,193)
(1,661)
-
(11,842)
-
(11,842)
8,725
46,296
1,241
179,455
(198)
63,752
136
62,029
-
-
-
-
-
-
-
-
-
-
-
-
(32,742)
(121)
(32,863)
-
-
(9,137)
-
-
-
-
-
-
-
2,353
258
-
85,787
(40)
Employee shares – value of services
312
(352)
Balance at 31 December 2019
219,826
2,055
(2,854)
8,527
68,169
1,256
296,979
The above consolidated statement of changes in equity should be read in conjunction with the accompanying notes.
InvoCare            Annual Report 2020  | 71
Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report
Consolidated financial statements  
Consolidated statement of cash flows
For the year ended 31 December 2020
Notes
Cash flows from 
operating activities
Receipts from customers (including GST)
Payments to suppliers and employees (including GST)
Other revenue
Interest received
Finance costs
Income tax paid
Cash flows from 
investing activities
Net cash flows from operating activities
Proceeds from sale of property, plant and equipment
Purchase of subsidiaries and other businesses including acquisition 
costs, net of cash acquired
Proceeds from sale of subsidiaries and other businesses, net of 
restructuring costs
Purchase of property, plant and equipment and intangibles
Payments to funds under management for pre-paid contract sales
Receipts from funds under management for pre-paid contracts 
performed
Cash flows from 
financing activities
Net cash flows from investing activities
Share capital issue, net of transaction costs
(Payments)/proceeds from share option vested and exercised
Proceeds from borrowings
Repayment of borrowings
Payment for early settlement of interest rate swaps
Proceeds from lease arrangements
Principal elements of lease payments
2020 
$’000
2019 
$’000
505,716
488,008
(421,870)
(393,541)
11,192
95,038
373
6,037
100,504
388
(17,419)
(21,191)
(14,424)
(20,631)
63,568
11,908
59,070
5,565
(40,581)
(15,187)
-
985
(68,136)
(65,289)
(32,169)
(24,976)
45,026
40,842
(83,952)
(58,060)
270,875
85,787
(69)
258
5,000
47,397
(111,761)
(100,500)
(3,115)
-
(11,599)
-
13,598
(9,973)
Dividends paid to InvoCare Limited equity holders
(29,514)
(32,742)
Dividends paid to non-controlling interests in subsidiaries
Net cash flows from financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Effects of exchange rate changes on cash and cash equivalents
-
119,817
99,433
19,560
(212)
(121)
3,704
4,714
14,776
70
Cash and cash equivalents at the end of the year
7
118,781
19,560
The above consolidated statement of cash flows should be read in conjunction with the accompanying notes.
InvoCare            Annual Report 2020  | 72
Financial Report
Basis of preparation
This consolidated financial report is a general purpose financial report 
Critical accounting estimates and judgements
which:
• •  Has been prepared in accordance with the Corporations Act 2001, 
Australian Accounting Standards (AASBs) and Interpretations 
adopted by the Australian Accounting Standards Board, as 
appropriate for for-profit oriented entities and the Australian 
Securities Exchange (ASX) Listing Rules
• •  Complies with International Financial Reporting Standards (IFRS) 
The preparation of a financial report that complies with AASBs 
requires management to make judgements, estimates and 
assumptions.
This can affect the application of accounting policies and the reported 
amounts of assets, liabilities, income and expenses. Actual results 
may differ from these estimates.
adopted by the International Accounting Standards Board
Estimates and underlying assumptions are reviewed on an on-going 
• •  Is presented in Australian dollars ($) which is the functional currency 
basis. Revisions to estimates are recognised prospectively.
of InvoCare
• •  Is prepared under the historical cost basis except for the following 
assets and liabilities, which are stated at their fair value: derivative 
financial instruments; fair value through profit or loss funds 
under management; and liabilities for cash settled share-based 
compensation plans. Recognised assets and liabilities that are 
hedged are stated at fair value in respect of the risk that is hedged. 
Refer to the specific accounting policies within the notes to the 
financial statements for the basis of valuation of assets and 
liabilities measured at fair value
Significant accounting policies have been:
The significant accounting policies highlight information about 
accounting judgements made in applying accounting policies that 
have the most significant effects on reported amounts and further 
information about estimated uncertainties that have a significant risk 
of resulting in material adjustments within the next financial year.
The areas involving a higher degree of judgement or complexity, or 
areas where assumptions and estimates are significant to the financial 
statements are disclosed within the notes following the financial 
information of those transactions or activities.
The COVID-19 pandemic has not significantly increased the 
estimation uncertainty in the preparation of the consolidated financial 
• •  Included in the relevant notes to which the policies relate, while 
statements. A thorough consideration of potential COVID-19 impacts 
other significant accounting policies are discussed in Note 26 
on carrying values of assets and liabilities, contracts and potential 
Other accounting policies
• •  Consistently applied to all financial years presented in the 
consolidated financial statements and by all entities in the Group, 
except as explained in Note 26 Other accounting policies – New 
and revised accounting standards and interpretations not yet 
mandatory or early adopted
liabilities has been made, with no material impact to the financial 
statements, except as recognised in these consolidated financial 
statements.
Current and non-current split
The Group presents assets and liabilities in the consolidated balance 
sheet as current or non-current:
• •  Current assets include assets held primarily for trading purposes, 
cash and cash equivalents and assets expected to be realised in, 
or intended for sale or use in, the course of the Group’s operating 
cycle (that is 12 months). All other assets are classified as  
non-current
• •  Current liabilities include liabilities held primarily for trading 
purposes, liabilities expected to be settled in the course of the 
Group’s operating cycle and those liabilities due within one 
year from the reporting date. All other liabilities are classified as 
non-current where the Group has an unconditional right to defer 
settlement of the liability for at least 12 months after the reporting 
period
InvoCare            Annual Report 2020  | 73
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Basis of preparation continued
Comparatives
Where necessary, comparatives have been reclassified and 
repositioned for consistency with current year disclosures.
The following balance sheet and cash flow items are reclassified 
during the current year:
• •  Deferred contract assets separated from inventories and 
presented on the face of the consolidated balance sheet
• •  Capitalised software reclassified from property, plant and 
equipment to intangibles
• •  Deferred considerations separated from trade and other payables 
and presented on the face of the consolidated balance sheet
• •  Interest paid on lease liabilities reclassified to finance costs on the 
face of consolidated statement of cash flows
Rounding
The Group is of the kind referred to in the ASIC Corporations 
(Rounding in Financial/Directors’ Reports) Instrument 2016/191 
issued by the Australian Securities & Investments Commission.  
In accordance with that instrument, amounts in the financial report 
have been rounded to the nearest thousand dollars, unless otherwise 
indicated.
Non-IFRS information
Some of the financial data in the notes to the financial statements 
as listed below are not disclosures in accordance with the current 
AASBs’ requirements:
• •  EBITDA (earnings before interest, tax, depreciation and 
amortisation) and EBIT (earnings before interest and tax) in  
Note 1 Operating segments
• •  Operating EBITDA and EBIT in key performance metrics section
• •  Voluntary tax transparency code disclosure in Note 6 Income tax
• •  Cash conversion ratio in Note 7 Cash flow information
However, all financial data is based on the information disclosed in the 
audited financial statements and notes to the financial statements of 
InvoCare and follow the recognition requirement of AASBs.
InvoCare            Annual Report 2020  | 74
Financial Report
Notes to the consolidated financial statements  
Key performance metrics
Operating earnings before interest, tax, 
depreciation and amortisation (Operating 
EBITDA) is a key measure used to assess 
the Group’s performance. This section of 
the Financial Report focuses on disclosure 
that enhances a user’s understanding of 
Operating EBITDA.
Operating segment provides a breakdown 
of revenue and profit by the operational 
activity. The key line items of the 
consolidated statement of comprehensive 
income along with their components 
provide detail behind the reported 
balances. Group performance will also 
impact the earnings per ordinary share 
capital and dividend payout.
Finally, the cash flows reflect the core 
results of the Group’s capital management 
strategy and therefore the disclosure 
on these items has been included in this 
section.
Note 1. Operating segments
A. Identification of reportable segments
The Group is organised into three reportable segments:
• •  Australia
• •  Singapore
• •  New Zealand
These reportable segments are based on the internal reports that 
are reviewed and used by the Chief Executive Officer & Managing 
Director (who is identified as the Chief Operating Decision Maker 
(CODM)) in assessing performance and in determining the allocation 
of resources. There is no aggregation of reportable segments.
The reportable segments are identified by management based on the 
countries in which the product is sold or service is provided. Discrete 
financial information about each of these operating segments is 
reported to the CODM and the Board of Directors regularly.
The CODM reviews operating earnings before interest, tax, 
depreciation and amortisation (Operating EBITDA) and operating 
earnings before interest and tax (Operating EBIT).
The accounting policies adopted for internal reporting to the CODM 
are consistent with those adopted in the financial statements.
InvoCare            Annual Report 2020  | 75
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Key performance metrics continued
B. Reportable segments information
2020
Australia 
$’000
Singapore 
$’000
New  
Zealand 
$’000
Other 
$’000
Revenue from external customers
397,756
18,593
50,174
Other revenue (excluding interest income)
8,501
812
1,816
Operating expenses
Adjustment to revenue - pre-paid redemptions*
Adjustment to other revenue - pre-paid redemptions*
Adjustment to operating expenses - pre-paid redemptions*
Operating EBITDA
Depreciation and amortisation
Business acquisition costs
Operating EBIT
Finance costs
Interest income
Non-operating activities (including pre-paid contracts funds under 
management)
Impairment loss on intangibles
Impairment reversal
Income tax expense
Non-controlling interest
Net profit/(loss) after income tax
Total goodwill
Total assets
Total liabilities
(326,809)
(10,013)
(43,212)
79,448
9,392
8,778
3,709
(5,113)
6,351
-
-
-
-
-
-
84,395
9,392
8,778
(37,731)
(1,187)
(5,362)
(1,918)
-
-
44,746
8,205
3,416
(18,445)
1,040
(1)
-
(3,097)
19
(18,040)
(19)
479
(6,176)
6,000
-
-
(6,490)
(1,352)
(167)
-
(19,324)
-
(36)
-
2,468
6,833
(18,543)
171,284
14,365
27,057
1,595,502
46,754
113,085
1,135,264
3,866
84,311
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Total 
$’000
466,523
11,129
(380,034)
97,618
3,709
(5,113)
6,351
102,565
(44,280)
(1,918)
56,367
(21,543)
1,059
(17,580)
(25,500)
6,000
(7,878)
(167)
(9,242)
212,706
1,755,341
1,223,441
*  Adjustment to reclassify the non-operating impacts of performing pre-paid funerals, burial and cremation services to net gain/loss on pre-paid contracts.
InvoCare            Annual Report 2020  | 76
2019
Australia 
$’000
Singapore 
$’000
New  
Zealand 
$’000
Other 
$’000
Revenue from external customers
413,403
20,823
56,033
Other revenue (excluding interest income)
9,176
400
513
Operating expenses
Adjustment to revenue - pre-paid redemptions*
Adjustment to other revenue - pre-paid redemptions*
Adjustment to operating expenses - pre-paid redemptions*
(308,253)
(11,306)
(43,657)
114,326
9,917
12,889
3,855
(4,538)
8,026
-
-
-
-
-
-
-
-
(42)
(42)
-
-
-
Total 
$’000
490,259
10,089
(363,258)
137,090
3,855
(4,538)
8,026
Operating EBITDA
Depreciation and amortisation
Business acquisition costs 
Operating EBIT
Finance costs
Interest income
Non-operating activities (including pre-paid contracts funds under 
management)
Impairment loss on intangibles
Income tax expense
Non-controlling interest
121,669
9,917
12,889
(42)
144,433
(30,775)
(1,201)
(4,997)
(1,984)
-
(37)
88,910
8,716
7,855
(19,561)
(1,309)
(3,552)
1,301
40,739
-
(43)
(20)
-
(31,638)
(1,126)
(136)
-
(47)
(1,368)
(24,404)
(521)
-
-
-
(42)
(2)
-
-
-
-
-
(36,973)
(2,021)
105,439
(24,424)
1,211
39,351
(24,404)
(33,285)
(136)
Net profit/(loss) after income tax
79,615
6,218
(22,037)
(44)
63,752
Total goodwill
Total assets
Total liabilities
119,573
15,514
47,382
-
182,469
1,427,388
47,131
126,105
139
1,600,763
1,156,812
41,774
105,131
67
1,303,784
*  Adjustment to reclassify the non-operating impacts of performing pre-paid funerals, burial and cremation services to net gain/loss on pre-paid contracts.
C. Accounting policy for segment reporting
Operating EBITDA is reconciled to profit after tax as disclosed on the 
consolidated statement of comprehensive income.
Segment revenue, expenses, assets and liabilities are those that are 
directly attributable to a segment and the relevant portion that can 
be allocated to the segment on a reasonable basis. Segment assets 
include all assets used by a segment and consist primarily of operating 
cash, receivables, inventories, property, plant and equipment, right 
of use assets and goodwill and other intangible assets, net of related 
provisions. Segment liabilities consist primarily of trade and other 
creditors, lease liabilities and employee benefits and, in the case of 
Singapore, include an allocation of the long-term borrowings raised 
in Australia to fund the investment in Singapore. New Zealand has 
long-term borrowings which are arranged in New Zealand but with the 
support of Australia.
InvoCare            Annual Report 2020  | 77
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Key performance metrics continued
Note 2. Revenue
A.   Disaggregation of revenue from contracts with customers
The tables below provide detailed disaggregation of revenue derived by the Group.
2020
Funeral services
Memorial Parks
Pet cremations
Rent
Sundry revenue
Australia  
$’000
Singapore 
$’000
New  
Zealand 
$’000 
Total 
$’000
278,699
119,463
4,646
18,593
48,004
345,296
-
-
2,212
121,675
-
4,646
402,808
18,593
50,216
471,617
411
3,039
29
782
121
1,653
561
5,474
Total revenue from continuing operations
406,258
19,404
51,990
477,652
2019
Funeral services
Memorial Parks 
Pet cremations
Rent
Sundry revenue
298,868
117,973
816
20,823
53,576
373,267
-
-
2,528
120,501
-
816
417,657
20,823
56,104
494,584
307
4,616
65
335
13
428
385
5,379
Total revenue from continuing operations
422,580
21,223
56,545
500,348
InvoCare’s New Zealand and Singapore businesses were eligible for government subsidies. The government subsidies were recognised as sundry 
revenue during the financial year ended 31 December 2020.
B.  Critical accounting judgements, estimates and 
The 15 year period is based on a periodically updated actuarial 
assumptions
I.  Significant financing
The Group receives payment from customers for pre-paid funerals, 
burial and cremation services prior to the transfer of the promised 
goods or services to the customer. As the period between receipt of 
the consideration and transfer of the goods or services can exceed 
one year, the Group adjusts deferred revenue using a discount rate. 
The Group determines the discount rate that best reflects the at-need 
funerals price the customers would have paid (that is the cash selling 
assessment of the average period between a customer entering into a 
pre-paid funeral plan and the contract becoming at-need. The actual 
history of a pre-paid cemetery/crematorium contract may differ from 
the profile of a pre-paid funeral plan; however, in the absence of more 
specific data being available, the funeral data has been applied.
The average 15 year period is an assumption only and therefore 
subject to uncertainty. It is possible that there will remain unperformed 
contracts at the end of the 15 year amortisation period, yet all revenue 
will have been recognised. Offsetting this is the likelihood that 
contracts performed during the 15 year period will have unrecognised 
price as if the customer had paid the consideration at the time when 
revenue.
the services are performed or the goods delivered).
II.   Timing of recognition of deferred plaque and 
miscellaneous merchandise revenue
Pre-paid cemetery/crematorium plaque and miscellaneous 
merchandise sales are currently brought to account over an assumed 
15 year period. Unredeemed merchandise sales (included within 
deferred revenue on the balance sheet) total $57,663,000 at  
31 December 2020 (2019: $58,617,000).
Actual redemptions information has been collated for a sample of sites 
in order to determine a more accurate historical pattern of cemetery/
crematorium pre-paid sale redemptions. The information collated 
suggests there is no material misstatement of revenue using the 
assumed 15 years period. The impact of recognising revenue over 
five years less (or five years more) than 15 years would be to increase 
annual revenue by approximately $3,500,000 (2019: $3,300,000) or 
decrease by $1,700,000 (2019: $1,700,000).
InvoCare            Annual Report 2020  | 78
 
C. Accounting policy for revenue recognition
II.    Cemetery and crematorium memorial products 
The Group derives its revenue from the transfer of goods and services 
on delivery of the underlying good or service.
The Group predominately generates revenue through the following 
streams:
(‘memorial products’)
The Group’s deliverables under memorial contracts are:
• •  Interment right – An interment right is the right to be committed in a 
designated space in a cemetery. The specific site is allocated at the 
time of signing the contract. Revenue is recognised when control of 
I.    Funeral services, including pre-paid funerals, burial and 
the interment right and associated memorial passes to the customer.
crematorium services
II.   Cemetery and crematorium memorial products (‘memorial 
products’)
Each of the above goods and services delivered or to be delivered to 
the customers are considered separate performance obligations even 
though for some situations they may be governed by a single legal 
contract with the customer.
Revenue recognition for each of the above revenue streams are as 
follows:
I.    Funeral services, including pre-paid funerals, 
burial and crematorium services
The Group’s performance obligations under funeral services  
contracts are:
• •  At-need funeral services – Revenue is recognised when the 
funeral, burial, cremation and other services are performed or the 
goods supplied
• •  Pre-paid (Pre-need) funerals services – The Group enters 
into pre-paid contracts to provide funerals, burial and cremation 
services or other services in the future. For these contracts, the 
period between payment by the customer and transfer of the 
promised goods or services to the customer can exceed one year
The funds received are placed in trust and are not recognised as 
revenue until the service is performed. As a result, the Group adjusts 
the deferred revenue and pre-paid contract liabilities using a discount 
rate that results in revenue being recognised that approximates the 
cash selling price the customer would have paid if the consideration 
was paid at the same time as the services are provided.
On delivery of a pre-paid funeral service contract, the Group 
recognises the financing component as a component of revenue.
Pre-2018 memorial product contracts 
For memorial product contracts entered into with customers prior to  
1 January 2018, the customer gains control of the interment right on 
full and final settlement.
Post-2018 memorial product contracts 
For contracts entered into from 1 January 2018, the customer gains 
control of the interment right at contract inception, thereby allowing 
revenue to be recognised on delivery.
• •  Headstone/monument/gardens – In a memorial products contract, 
a customer purchases a memorial, such as headstone/heritage 
garden/monument, to be installed on the interment site.  
The memorial may be on site at the time of purchase or may be 
delivered at a future time. Typically, there is a considerable time lag 
between a contract being signed and the delivery of the memorial. 
These items are tracked on a contract by contract basis and 
recognised as revenue upon delivery of products.
• •  Plaques (and other associated smaller merchandise) – These 
products are delivered to the customer on an ‘at-need’ basis 
(generally when the beneficiary has passed away). The revenue 
recognised for plaques and other associated smaller merchandise 
such as ash containers, vases and photos, where actual deliveries are 
not individually tracked, are managed on a portfolio basis given the 
small value of the individual items. The revenue is recognised over a 
15 year period on a straight line basis. The 15 year period represents 
an actuarial estimate of when the contracts will be delivered.
Billing and collection of memorial products contracts can be immediate 
and in full upon contract signing. However, most memorial products 
contracts are paid via instalments over a period of up to five years 
(although the payment periods do vary). The interment right, memorial 
products and plaques are each considered to be distinct performance 
obligations under AASB 15 Revenue from Contracts with Customers 
(AASB 15) as a customer can use the site without a memorial and there 
is not a transformative or integrated relationship between the products. 
The transfer of control of these distinct performance obligations 
determines when revenue should be recognised.
Revenue is measured at the fair value of the consideration received 
or receivable. Amounts disclosed as revenue are net of returns, 
allowances, duties and taxes paid.
Revenue relating to undelivered memorials and merchandise are 
deferred until delivered or made ready for use.
Minor items such as plaques, ash containers and vases where  
actual deliveries are not individually tracked are released to revenue  
over 15 years.
InvoCare            Annual Report 2020  | 79
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Key performance metrics continued
Note 3. Earnings per share
A. Reported period value
Basic earnings per share
Diluted earnings per share
Operating earnings per share
2020 
cents
2019 
cents
(6.9)
(6.9)
20.4
55.8
54.9
51.7
C.  Weighted average number of shares used in 
calculating basic and diluted earnings per share
2020 
Number 
’000
2019 
Number 
’000
Weighted average number of shares used in 
calculating basic earnings per share
133,927
114,189
InvoCare determines the dividends to be paid for any financial periods 
from Operating earnings after tax. Operating earnings is derived from 
Adjustments for calculation of diluted 
earnings per share:
Share options and rights *
-
1,994
Weighted average number of shares used in 
calculating diluted earnings per share
133,927
116,183
*    For the year ended 31 December 2020, the potential ordinary shares 
issued under the Performance Long-Term Incentive Plan of the Group 
were excluded from the calculation because they are anti-dilutive.
D. Accounting policy for earnings per share
Basic earnings per share is calculated by dividing the profit 
attributable to the equity holders of InvoCare Limited by the weighted 
average number of ordinary shares outstanding during the financial 
year, adjusted for any bonus elements in ordinary shares issued during 
the financial year and excluding treasury shares.
Diluted earnings per share adjusts the figures used in the 
determination of basic earnings per share to take into account the 
after income tax effect of interest and other financing costs associated 
with dilutive potential ordinary shares and the weighted average 
number of shares assumed to have been issued at no consideration 
received in relation to dilutive potential ordinary shares.
basic earnings after excluding earnings generated from all non-
operating activities and the financial impacts of pre-paid contracts. 
This is a financial measure which is not prescribed by Australian 
Accounting Standards (AASBs) and represents the earnings under 
AASBs adjusted for specific items as per the table below from the 
statement of comprehensive income.
B.  Reconciliation of earnings used in calculating 
earnings per share
2020 
$’000
2019 
$’000
Net (loss)/profit after income tax
(9,075)
63,888
Less: Non-controlling interests
(167)
(136)
Net (loss)/profit after income tax attributable 
to InvoCare Limited’s equity holders for 
calculating statutory basic and diluted 
earnings per share
Less: Non-operating items 
(9,242)
63,752
Non-operating EBITDA
4,947
7,343
Net loss/(gain) on pre-paid contracts before 
income tax
16,618
(45,550)
Depreciation and amortisation
12
13
Net impairment loss on non-current assets
19,500
24,404
Asset sales gain before income tax
(7,383)
(2,404)
Net finance costs
3,386
1,247
Income tax on non-operating items
(527)
10,261
Operating earnings after income tax for 
calculating operating earnings per share
27,311
59,066
InvoCare            Annual Report 2020  | 80
Note 4. Dividends
A. Dividends paid
2020
Dividends on InvoCare Limited’s ordinary shares
2020 interim dividend
2019 final dividend
2019
2019 interim dividend
2018 final dividend
Cents  
per share 
Total  
amount  
$’000
Tax rate for  
franking credit  
%
Percentage  
franked  
%
5.5
23.5
17.5
19.5
7,894
27,538
35,432
20,428
21,451
41,879
30
30
30
30
100
100
100
100
B.  Dividends determined and not recognised at 
C. Franking credits
year end
On 24 February 2021, the Directors determined a final dividend of 
7.0 cents per share, fully franked, to be paid on 22 April 2021. As this 
occurred after the reporting date, the dividends determined have not 
been recognised in these financial statements and will be recognised 
in future financial statements.
The Company has a Dividend Reinvestment Plan (DRP) that allows 
equity holders to elect to receive their dividend entitlement in the 
form of the Company’s ordinary shares. The price of DRP shares 
is the average market price, less a discount if any (determined by 
2020 
$’000
2019 
$’000
Franking credits available for subsequent 
financial years based on a tax rate of 30%
35,133
39,256
Franking credits available for subsequent financial years include:
• •  Franking credits that will arise from the payment of the amount of 
the provision for income tax at the reporting date
• •  Any franking debits that will arise from the payment of dividends 
recognised as a liability at the reporting date
the directors) calculated over the pricing period (which is at least 
• •  Franking credits that will arise from the receipt of dividends 
five trading days) as determined by the directors for each dividend 
recognised as receivables at the reporting date
payment date.
The Company’s DRP operates by acquiring shares on market at no 
discount. Election notices for participation in the DRP in relation to this 
final dividend must be received by 5 March 2021.
D. Accounting policy for dividends
Dividends are recognised when declared during the financial year.
InvoCare            Annual Report 2020  | 81
Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report
Notes to the consolidated financial statements  
Key performance metrics continued
Note 5. Expenses
Profit before income tax includes the following specific expenses:
A.   Finance costs
C.  Impairment loss – financial assets
2020 
$’000
2019 
$’000
Interest paid and payable
11,122
14,882
Trade receivables
Interest expense on customer advance 
payments
3,232
4,114
D.  Leases expense
2020 
$’000
2019 
$’000
3,598
1,016
Interest expense on lease liabilities
5,297
4,760
Other finance costs
3,156
1,915
Realised loss on early settlement of interest 
rate swaps
2,122
-
24,929
25,671
Expense relating to short term leases
936
569
Expense relating to leases of low value assets 
not included in short term leases
905
1,841
145
714
Interest expense on pre-paid contracts
20,277
20,331
E.   Employee benefits expense
B.  Depreciation, amortisation and impairment of 
non-current assets
Buildings
5,927
4,646
Defined contribution superannuation expense
10,993
10,750
Share-based payments expense
1,192
(206)
Property, plant and equipment
13,723
14,474
F.   Accounting policies 
Right of use assets
Total depreciation
Cemetery land
Leasehold land and buildings
Leasehold improvements
Capitalised software
Brand names
16,384
11,406
The accounting policies on the above specified expenses are located 
36,034
30,526
445
141
384
170
2,642
1,962
3,574
2,508
1,457
1,436
in the notes where the assets or liabilities are disclosed other than 
defined contribution superannuation expense disclosed below. 
Defined contribution superannuation expense
Contributions to defined contribution superannuation plans are 
expensed in the period in which they are incurred.
Amortisation of non-current assets
8,259
6,460
Total depreciation and amortisation
44,293
36,986
Impairment loss on intangibles
25,500
24,404
Impairment reversal of cemetery land
(6,000)
-
Impairment of non-current assets
19,500
24,404
Total depreciation, amortisation and 
impairment
63,793
61,390
InvoCare            Annual Report 2020  | 82
 
 
 
Note 6. Income tax
A.   Income tax expense
D.  Deferred tax liability
Current tax
Deferred tax
2020 
$’000
2019 
$’000
7,232
19,816
(614)
14,326
Under/(over) provided in prior years
1,260
(857)
Income tax expense
7,878
33,285
2020 
$’000
2019 
$’000
The deferred tax liability balances comprised  
temporary differences attributable to:
Amounts recognised in profit and loss:
Cemetery land
30,750
26,626
Property, plant and equipment
2,410
9,013
B.  Reconciliation of income tax expense  
to prima facie tax payable
(Loss)/profit before income tax
(1,197)
97,713
Prima facie tax at 30% (2019: 30%) on (loss)/
profit before income tax
(359)
29,152
Tax effect of amounts which are not 
deductible/(taxable) in calculation of 
taxable income:
Deferred selling costs
Prepayments and other
Brand names
Pre-paid contracts
Provisions
Receivables
Accruals and other
Effect of foreign tax rate differences
(296)
(685)
Deferred revenue
Acquisition costs
465
203
Leased assets
Capital gains not subject to tax as offset 
against capital losses
(405)
(1,284)
Impairment loss on intangibles
5,850
6,833
Capital losses recognised
Amounts recognised directly in equity:
Cash flow hedge reserve
11,938
12,115
485
(947)
2,408
1,900
21,777
28,202
(6,480)
(5,444)
(1,923)
(618)
(2,483)
(2,044)
(19,318)
(26,302)
(6,593)
(5,628)
-
(826)
(332)
(1,221)
32,639
34,826
Non-deductible interest expense
Effect of interest rate swap settlement
Other items (net)
232
1,005
126
-
-
(77)
6,618
34,142
Under/(over) provision in prior years
1,260
(857)
Income tax expense attributable  
to continuing operations
7,878
33,285
C.  Tax expense relating to items of other 
comprehensive income
Cash flow hedges
880
-
The net movement in the deferred  
tax liability is as follows:
Balance at the beginning of the year
34,826
24,314
Net (credit)/charge to statement of 
comprehensive income – current period
(614)
14,326
Net credit to statement of comprehensive 
income – prior periods
(1,939)
(727)
Amounts recognised directly in equity
880
692
Amounts recognised directly in equity –
transition to AASB 16
-
(5,030)
Additions from business combinations
544
-
Effect of movements in exchange rates
(1,058)
1,251
Balance at the end of the year
32,639
34,826
InvoCare            Annual Report 2020  | 83
Performance Review12Directors’ Report3Financial Report4Other Information 
 
 
Financial Report
Notes to the consolidated financial statements  
Key performance metrics continued
E. Tax losses
The Australian Group has nil capital losses (2019: $2,750,000 gross) 
available to offset against capital gains in future years. The capital 
losses carried forward at 31 December 2019, for which a deferred tax 
asset was recognised, were fully utilised against capital gains made 
during 2020. Accordingly no deferred tax asset is recognised at  
31 December 2020 in respect of tax losses.
F. Voluntary tax transparency code disclosure
The Tax Transparency Code (TTC) is a set of principles and minimum 
standards to guide medium and large businesses on public disclosure 
of tax information. The TTC was developed by the Board of Taxation 
and endorsed by the government in the Federal Budget 2016–17.
Adoption of the TTC is voluntary and intended to complement 
Australia’s existing tax transparency measures. The TTC is designed 
to encourage greater transparency within the corporate sector, 
particularly by multinationals, and to enhance the community’s 
understanding of the corporate sector’s compliance with Australian’s 
tax laws.
Companies (including entities treated as companies for Australian 
tax purposes) that are medium or large businesses are encouraged 
to adopt the TTC. For the purpose of TTC, InvoCare is classified as a 
medium business and elected to adopt TTC.
Income tax expense on reported profit was $6,618,000  
(2019: $34,142,000), representing an effective rate of 28.0%  
(2019: 35.1%). An analysis of tax paid, based on tax residency  
status, for Australia and the Group is set out below.
Profit/(loss) before income tax
Tax at nominal rate in relevant country
Increase/(decrease) due to non-temporary differences
Non-deductible acquisition costs
Capital gains offset against capital losses or not subject to tax
Impairment loss on goodwill
Foreign exempt dividends
Non-deductible interest expense
Other items
Increase/(decrease) due to temporary differences
Unrealised pre-paid contract funds under management gains and losses
Impairment of capitalised software
Impairment of cemetery land
Property, plant and equipment temporary differences
Other items
Current income tax paid or payable
Current income tax paid rate *
Current year income tax expense
Effective tax rate
Prior period tax adjustments
Australia
Group
2020 
$’000
2019 
$’000
19,924
113,501
5,977
34,050
465
(517)
-
170
(946)
-
(2,478)
(1,026)
-
165
6,655
1,853
(1,800)
(3,422)
(1,118)
5,780
29.0%
5,060
25.4%
1,427
-
68
(12,128)
-
-
(2,017)
(785)
17,386
15.3%
32,017
28.2%
(771)
2020 
$’000
(1,197)
(1,000)
465
(405)
5,411
-
232
194
6,655
1,853
(1,800)
(3,529)
(844)
7,232
25.8%
6,618
28.0%
1,260
2019 
$’000
97,173
28,467
203
(1,284)
6,833
-
-
26
(12,128)
-
-
(1,834)
(467)
19,816
20.4%
34,142
35.1%
(857)
*  Calculated as the total amount of income tax paid divided by the profit before income tax.
InvoCare            Annual Report 2020  | 84
Governance of tax planning for the Group has been delegated by 
the Board to the Audit, Risk & Compliance Committee (Committee), 
which pursues a non-aggressive tax planning strategy which is 
principled, transparent and sustainable in the long term. It oversees 
the Group’s tax affairs in a pro-active manner that seeks to maximise 
shareholder value, while operating in accordance with the law, and not 
participating in any aggressive tax planning activities. The Committee 
G.  Accounting policy for income tax
The income tax expense or benefit for the period is the tax payable on 
that period’s taxable income based on the applicable income tax rate 
for each jurisdiction, adjusted by the changes in deferred tax assets 
and liabilities attributable to temporary differences, unused tax losses 
and the adjustment recognised for prior periods, where applicable.
receives a regular report on the Group’s tax compliance. Tax planning 
Deferred tax assets and liabilities are recognised for temporary 
initiatives are not implemented until they receive approval from the 
Committee. Tax risks and opportunities are rated according to their 
differences at the tax rates expected to be applied when the assets 
are recovered or liabilities are settled, based on those tax rates that are 
potential impact which determines whether management or the 
enacted or substantively enacted.
Committee has the delegated authority to resolve the matter.
During 2020, capital gains were realised on the sale of land and 
buildings. These capital gains were partially offset against capital 
Deferred tax assets are recognised for deductible temporary 
differences and unused tax losses only if it is probable that future 
taxable amounts will be available to utilise those temporary differences 
losses ($2,750,000 gross) carried forward from the year ended  
and losses.
31 December 2019.
The Group has a limited number of international related party 
arrangements in place. They are:
• •  An Australian subsidiary receives dividends from Singapore Casket 
Company, which is resident in Singapore
• •  The New Zealand group is charged management fees, based on 
time spent, for management, administration, accounting and other 
The carrying amount of recognised and unrecognised deferred tax 
assets are reviewed at each reporting date. Deferred tax assets 
recognised are reduced to the extent that it is no longer probable 
that future taxable profits will be available for the carrying amount 
to be recovered. Previously unrecognised deferred tax assets are 
recognised to the extent that it is probable that there are future taxable 
profits available to recover the asset.
services provided by the Australian operation
Deferred tax assets and liabilities are offset only where there is a 
legally enforceable right to offset; and they relate to the same taxable 
authority on either the same taxable entity or different taxable entities 
which intend to settle simultaneously. Deferred tax balances are 
presented as non-current assets/liabilities on the balance sheet.
Current and deferred tax balances attributable to amounts recognised 
directly in equity are also recognised in equity.
• •  Loans from the Australian group to subsidiaries outside Australia 
are made occasionally under documented loan agreements.  
A loan of NZ$25,000,000 was made by InvoCare Limited to 
InvoCare Holdings New Zealand Limited on 30 April 2020
In addition to income tax paid, the Australian group paid the following 
types of taxes and fees during 2020:
• •  Payroll tax of $6,779,000 (2019: $6,608,000)
• •  Fringe benefits tax of $1,791,000 (2019: $1,663,000)
• •  Land tax on owned buildings of $5,360,000 (2019: $5,246,000),  
to various state governments
• •  Council and water rates paid to various authorities of $3,330,000 
(2019: $3,162,000)
InvoCare            Annual Report 2020  | 85
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Key performance metrics continued
Note 7. Cash flow information
A.   Reconciliation of cash flows from operations 
B. Non-cash investing and financing activities
with net profit after income tax
2020 
$’000
2019 
$’000
Non-cash investing and financing activities for the current and prior 
financial years are:
• •  Acquisition of right of use assets through the changes in 
accounting treatments in accordance with AASB 16 Leases  
(refer to Note 11.B for further details)
• •  Dividends satisfied by the issue of shares under the dividend 
reinvestment plan of $5,918,000 (2019: $9,137,000)
• •  Performance rights and shares issued to employees under the 
Employee Share Trusts Plan and employee share scheme for no 
cash consideration
Net (loss)/profit from ordinary activities after 
income tax
(9,242)
63,752
Adjustments for non-cash items in  
(loss)/profit from ordinary activities
Depreciation and amortisation
44,292
36,986
Impairment loss on intangibles
25,500
24,404
Impairment reversal on cemetery land
Share-based payments expense
Loan establishment costs
Net gain on disposal of property, plant and 
equipment
(6,000)
1,192
890
-
(206)
679
(7,383)
(2,352)
Unrealised loss/(gain) on pre-paid contracts
16,618
(45,550)
Other pre-paid contract movements
15,749
13,909
Interest expense: customer advance 
payments
3,232
4,114
Other non-cash deferred revenue/deferred 
selling costs movements
(26,003)
(19,251)
Business acquisition costs classified in 
investing activities
1,918
2,021
Changes in assets and liabilities, net of the  
effects of purchase and disposal of 
subsidiaries
(Increase)/decrease in trade and other 
receivables
(1,117)
(20,210)
(Increase)/decrease in inventories
(11)
(7,544)
(Increase)/decrease in deferred contract 
assets
(Increase)/decrease in deferred selling 
expenses
Increase/(decrease) in trade and other 
payables
2,383
1,905
2,217
2,222
(896)
(6,075)
Increase/(decrease) in deferred revenue
(1,583)
Increase/(decrease) in income taxes payable
1,061
538
(673)
Increase/(decrease) in deferred taxes
(1,642)
8,847
Increase/(decrease) in provisions
2,393
1,554
Net cash flows from operating activities
63,568
59,070
InvoCare            Annual Report 2020  | 86
C. Net debt reconciliation
D. Cash conversion ratio
The tables set out below provide an analysis of net debt and the 
The cash conversion ratio is one of the key cash performance metrics 
movements in net debt for the current and last financial year.
of the Group, refer to the table below for detail calculation.
Cash 
and cash 
equiv-
alents 
$’000
Borrow-
ings 
$’000
Lease 
liabilities 
$’000
Net  
debts 
$’000
The conversion ratio calculation and the line items as shown in the 
table below are all non-IFRS information. However, all financial data is 
based on the information disclosed in the audited financial statements 
and notes to the financial statements of InvoCare and follow the 
recognition requirements of Australian Accounting Standards. 
19,560
(357,189)
(162,901)
(500,530)
Although the adoption of AASB 15 and AASB 16 have significant 
2020
Net debt as at  
1 January 2020
Cash flows
99,433
106,761
11,599
217,793
financial impacts on the Group, they have had no cash impact.
Additions/variations
Interest expense on 
lease liabilities
Foreign exchange 
adjustments
Net debt as at  
31 December 2020
2019
Net debt as at  
1 January 2019
Recognised due to 
adoption of AASB16
-
-
-
-
(9,631)
(9,631)
(5,297)
(5,297)
Operating cash flows
2020 
$’000
2019 
$’000
63,568
59,070
(212)
4,389
306
4,483
118,781
(246,039)
(165,924)
(293,182)
14,776
(408,245)
-
(393,469)
-
-
(135,629)
(135,629)
Add back: Net finance costs paid
17,046
20,803
Add back: Tax paid
14,424
20,631
Net funds from pre-paid contracts
12,857
15,866
Other cash flows related to pre-paid contracts
1,429
2,406
Ungeared, tax free operating cash flows
109,324
118,776
Operating EBITDA
Cash conversion %
102,565
144,433
107%
82%
Cash flows
4,714
53,103
14,733
72,550
Additions/variations
Interest expense on 
lease liabilities
Foreign exchange 
adjustments
Net debt as at  
31 December 2019
-
-
-
-
(37,245)
(37,245)
E. Cash and cash equivalents
(4,760)
(4,760)
Cash on hand
70
(2,047)
-
(1,977)
Cash at bank
19,560
(357,189)
(162,901)
(500,530)
2020 
$’000
2019 
$’000
126
119
118,655
19,441
118,781
19,560
Cash at bank is non-interest bearing as at 31 December 2019 and 
2020. Therefore, the weighted average interest rate for cash at bank is 
rounded to zero for both 2019 and 2020.
InvoCare            Annual Report 2020  | 87
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Significant assets and liabilities
This section contains the key assets and liabilities in relation to the three main streams 
of businesses, being funeral business (at-need and pre-need) and the cemetery and 
crematoria business. These assets and liabilities include:
• •  Trade and receivables, deferred selling costs and revenue
• •  Pre-paid contracts from the pre-need funeral business
• •  Non-current operating assets, being the land for cemetery, crematoria,  
plant and equipment for supporting the operations and right of use assets
• •  Intangibles recognised for acquired businesses
Note 8. Trade receivables
Current
Trade receivables
Less: loss allowance
Non-current
Trade receivables
Less: loss allowance
2020 
$’000
2019 
$’000
45,230
44,351
(6,473)
(3,672)
38,757
40,679
29,445
31,480
-
(3)
29,445
31,477
A. Loss allowance
The ageing of the impaired trade receivables provided for above are as follows:
Forward aged (12 - 60 months contracts)
Current
Over 30 days past due
Over 60 days past due
Over 90 days past due
Expected credit loss rate
Carrying amount
Allowance for expected  
credit losses
2020 
%
-
0.2
1.5
10.5
39.4
2019 
%
-
0.2
1.0
8.0
21.0
2020 
$’000
36,482
13,718
5,765
3,535
15,175
74,675
2019 
$’000
32,811
20,047
4,556
2,177
16,240
75,831
2020 
$’000
-
27
86
371
5,989
6,473
2019 
$’000
-
40
46
174
3,415
3,675
The movements of loss allowance of trade receivables are as follows:
As at 1 January
2020 
$’000
2019 
$’000
3,675
3,010
Loss allowance recognised during the year
3,667
1,057
Receivables written off as uncollectable
(869)
(392)
As at 31 December
6,473
3,675
InvoCare            Annual Report 2020  | 88
B. Accounting policies
I.  Trade receivables
Trade receivables are amounts due from customers for goods sold or 
services performed in the ordinary course of business. They are initially 
recognised at the amount of consideration that is unconditional. The 
Group holds the trade receivables with the objective to collect the 
contractual cash flows and therefore measures them subsequently at 
amortised cost using the effective interest method.
2020
Note 9. Deferred selling costs and revenue
This note provided details on the movements for the deferred 
selling costs and revenue arising from the sales of pre-paid funeral, 
cremation and burial contracts and undelivered memorials and 
merchandise for the current and prior financial year.
Deferred 
selling 
costs 
$’000
Deferred 
revenue 
$’000
Trade receivables are usually due for settlement no more than  
Balance as at 1 January 2020
39,928
139,300
30 days from the date of recognition, except where extended payment 
terms (up to a maximum of 60 months) have been made available on 
cemetery and crematorium memorial contracts for sale of interment 
rights and associated memorials and other merchandise.
Receivables arising from cemetery and crematorium memorial 
contracts, which are initially expected to be collected over a period 
exceeding twelve months, are recognised as non-current receivables 
and measured as the net present value of estimated future cash 
receipts, discounted at an imputed effective interest rate. Upon initial 
recognition of the contract receivables, any undelivered portion of the 
contracts is included in deferred revenue until delivery.
II.  Loss allowance on trade receivables
Add/(less): Changes during the year
Revenue deferred: Cash received from 
customer instalment payments
Revenue recognised related to transition 
adjustment and instalments received 
during the year:
Cemetery and crematorium memorial 
products
Revenue deferred during the year:
-
9,938
(2,605)
(20,256)
Recognition of significant financing on 
customer advance payments: Cemetery and 
crematoria memorial products
-
1,955
The Group has applied the simplified approach to measuring 
expected credit losses which uses a lifetime expected loss allowance 
Revenue deferred: Cemetery and crematorium 
memorial products
520
4,720
Revenue deferred: Administration fees pre-
paid funeral service contracts
(131)
371
Recognition of significant financing on 
customer advance payments: Administration 
fees pre-paid funeral service contracts
Other movements
-
-
1,277
413
Balance as at 31 December 2020
37,712
137,718
Current
Non-current
3,644
28,632
34,068
109,086
Balance as at 31 December 2020
37,712
137,718
for all trade receivables.
To measure the expected credit losses, trade receivables have been 
grouped based on shared credit risk characteristics and the days  
past due.
When a trade receivable is uncollectible, it is written off against the 
loss allowance account for trade receivables. Subsequent recoveries 
of amounts previously written off are credited against sundry revenue 
in the consolidated statement of comprehensive income.
The occurrence of the pandemic has changed the risk characteristics 
of the Group’s trade receivables. During the year, the Group 
experienced an increase in the number and amount of uncollectible 
trade receivables, due to both the age of the balances and certain 
customers’ financial circumstance. At 31 December 2020, the 
Group’s loss allowance on trade receivables has been increased 
with all of the increase related to the Australian and New Zealand 
Funerals businesses. The increase in provision reflects the Group’s 
assessment of the potential impact of customers’ inability to repay 
debts due to financial hardship caused by the pandemic. The 
Group has implemented a range of initiatives to mitigate any further 
deterioration in the risk characteristics of its trade receivables, 
including requiring the payment of up-front deposits and the 
introduction of key performance metrics focused on collecting 
outstanding trade receivables. These initiatives have resulted in the 
increase in the cash conversion ratio in 2020, however as collection 
of older trade receivables remains challenging, an increased provision 
was recognised.
InvoCare            Annual Report 2020  | 89
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Significant assets and liabilities continued
2019
Deferred 
selling 
costs 
$’000
Deferred 
revenue 
$’000
Balance as at 1 January 2020
42,150
138,754
Note 10. Pre-paid contracts
A.   Statement of comprehensive income impact of 
undelivered pre-paid contracts
2020 
$’000
2019 
$’000
-
11,953
under management
3,659
65,881
Gain on pre-paid contract funds  
Add/(less): Changes during the year
Revenue deferred: Cash received from 
customer instalment payments
Revenue recognised related to transition 
adjustment and instalments received 
during the year:
Cemetery and crematorium memorial 
products
(2,036)
(16,332)
Revenue deferred during the year:
Recognition of significant financing on 
customer advance payments: Cemetery and 
crematoria memorial products
-
2,867
Change in provision for pre-paid  
contract liabilities
(20,277)
(20,331)
Net (loss)/gain on undelivered  
pre-paid contracts
(16,618)
45,550
B.   Movements in pre-paid contract funds under 
management
2020 
$’000
2019 
$’000
619,389
563,587
Revenue deferred on cemetery and 
crematorium memorial products
(209)
(1,002)
Balance as at 1 January
Revenue deferred on administration fees  
Sale of new pre-paid contracts
32,169
24,976
pre-paid funeral service contracts
23
1,614
Recognition of significant financing on 
customer advance payments: Administration 
fees pre-paid funeral service contracts
Other movements
-
-
1,247
199
Initial recognition of contracts paid by 
instalment
3,908
2,494
Redemption of pre-paid contract funds 
following service delivery
(45,026)
(40,842)
Increase/(adjustment) due to business 
Balance as at 31 December 2019
39,928
139,300
combinations
(968)
3,293
Current
Non-current
4,480
34,913
Increase in fair value of contract funds under 
35,448
104,387
management
3,659
65,881
Balance as at 31 December 2019
39,928
139,300
Balance as at 31 December
613,131
619,389
Current
Non-current
50,268
57,552
562,863
561,837
Balance as at 31 December
613,131
619,389
Accounting policies
A.  Deferred selling costs
Direct selling costs applicable to deferred revenue on undelivered 
memorials and merchandise are deferred until the revenue is 
recognised. Direct selling costs applicable to sale of pre-paid funeral, 
cremation, and burial contracts are deferred until the underlying 
service is delivered.
B.  Deferred revenue
Revenue relating to undelivered memorials and merchandise are 
deferred until delivered or made ready for use.
InvoCare            Annual Report 2020  | 90
 
 
C. Movements in pre-paid contract liabilities
E.   Classification of pre-paid funds under 
2020 
$’000
2019 
$’000
management and liabilities
Balance as at 1 January
525,383
510,044
Sale of new pre-paid contracts
32,169
24,976
The current and non-current portions of the pre-paid contract 
assets and liabilities are disclosed separately to more clearly reflect 
the expected pattern of usage associated with the timing of actual 
Initial recognition of contracts paid by 
instalment
3,908
2,494
contract redemptions.
Decrease following delivery of services
(39,460)
(35,800)
F.   Critical accounting judgements, estimates and 
Increase/(adjustment) due to business 
combinations
(968)
3,338
Increase due to significant financing
20,277
20,331
Balance as at 31 December
541,309
525,383
assumptions
I. 
 Fair value measurements – Pre-paid contract 
funds under management
The fair values of the pre-paid contract funds under management are 
44,685
48,885
recognised and measured based on inputs that require judgements 
Current
Non current
496,624
476,498
Balance as at 31 December
541,309
525,383
D.   Nature of contracts under management and 
liabilities
Pre-paid contracts are tripartite agreements, currently entered into 
and performed in Australia, whereby InvoCare agrees to deliver a 
specified funeral service, cremation or burial at the time of need and 
the beneficiary invests the current price of the service to be delivered 
with a financial institution and conditionally assigns the benefit to 
InvoCare.
and estimates. To provide an indication about the reliability of the 
inputs used in determining fair value of the pre-paid contract funds 
under management, the Group has used Level 2 inputs as prescribed 
under the accounting standards. Level 2 input for fair value is 
described as observable inputs either directly (as prices) or indirectly 
(derived from prices) for the asset or liability, other than the unadjusted 
quoted prices in active markets.
II.  Current and non-current split
The Group determines the classification of current and non-current 
portions of pre-paid contract asset and liabilities based on the pattern 
of usage (based on an independent actuarial review) associated with 
the timing of actual contract redemptions. This pattern of usage is 
based on historical data, which is reviewed annually and has remained 
The assignment of the benefit of the invested funds to InvoCare only 
consistent over the past five years.
G. Accounting policies for pre-paid contracts
The Group records the value of the invested funds as an asset and 
revalue the invested funds to fair value at the end of each reporting 
period. The Group initially recognises a liability equal to the value 
of the undelivered service associated with pre-paid contracts and 
adjusts the deferred revenue using a discount rate that results in 
revenue being recognised that approximates the cash selling price the 
customer would have paid if the consideration is paid at the same time 
as the services are provided.
When the service is delivered, the liability is derecognised and 
included in revenue.
becomes unconditional when InvoCare demonstrates that it has 
delivered the service specified. InvoCare receives the investment 
returns as well as the initial investment when the service has been 
delivered.
InvoCare permits, on request, contracts to be paid by instalments 
over periods not exceeding three years. In some instances these 
contracts are never fully paid. If, during the three year period the 
contract becomes at-need, the family is given the option of either 
paying outstanding instalments and receiving the contracted 
services at the original fixed price or using the amount paid as a part 
payment of the at-need service. If the contract is not fully paid after 
three years InvoCare only permits the family to use the amounts paid 
as a partial payment of the at-need services. At the end of the year, 
the total balance of amounts received from instalment payments for 
incomplete contracts was $6,519,397 (2019: $6,863,000).
During the year, the non-cash fair value movements (i.e. investment 
earnings) of $3,659,000 in pre-paid contract funds under 
management (2019: $65,881,000) was less than the non-cash 
growth due to interest expense increases of $20,277,000 in the 
liability for future service delivery obligations (2019: $20,331,000) due 
to lower returns on equities and property revaluations.
InvoCare            Annual Report 2020  | 91
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Significant assets and liabilities continued
Note 11. Non-current operating assets
This note includes the information for the following two categories of non-current operating assets:
• •  Property, plant and equipment
• •  Right of use assets and the related lease liability
A. Property, plant and equipment
2020
Composition as at 31 December 2020
Cemetery 
land 
$’000
Freehold  
land 
$’000
Buildings 
$’000
Leasehold 
land and 
buildings 
$’000
Leasehold 
Improve-
ments 
$’000
Plant and 
equipment 
$’000
Total 
$’000
Cost
122,579
100,478
246,480
4,534
33,574
160,000
667,645
Accumulated depreciation/amortisation
Accumulated impairment
(9,568)
(9,299)
-
-
Net book value
103,712
100,478
172,959
Movement for the year ended 31 December 2020
(73,521)
(3,832)
(9,188)
(97,960)
(194,069)
-
702
-
-
(9,299)
24,386
62,040
464,277
Opening net book value
97,094
102,503
148,459
843
20,187
57,868
426,954
Additions
Additions through business combinations
Disposals
Depreciation/amortisation charge
Impairment reversal
Effect of movement in exchange rates
Transfers from held for sale
1,146
-
-
(445)
6,000
(83)
-
515
-
32,478
-
(2,670)
(2,090)
-
-
-
6,310
15,939
56,388
668
(102)
1,697
2,365
408
(4,454)
(5,927)
(141)
(2,642)
(13,723)
(22,878)
-
-
(1,671)
(1,177)
1,801
1,216
-
-
-
-
(35)
-
-
6,000
(149)
(3,115)
-
3,017
Closing net book value
103,712
100,478
172,959
702
24,386
62,040
464,277
2019
Composition as at 31 December 2019
Cost
121,519
102,503
216,309
4,534
27,166
142,229
614,260
Accumulated depreciation/amortisation
Accumulated impairment
(9,126)
(15,299)
-
-
Net book value
97,094
102,503
148,459
Movement for the year ended 31 December 2019
(67,850)
(3,691)
(6,979)
(84,361)
(172,007)
-
843
-
-
(15,299)
20,187
57,868
426,954
Opening net book value
92,386
101,965
130,825
1,013
14,289
66,723
407,201
Additions
Business combinations
Disposals
Depreciation/amortisation charge
Effect of movement in exchange rates
Transfers to held for sale
Closing net book value
2,037
3,000
-
(384)
30
25
-
21,899
1,390
2,229
(625)
(820)
-
-
-
7,180
21,044
52,160
-
209
6,828
(56)
(15,997)
(17,498)
-
(4,646)
(170)
(1,962)
(14,474)
(21,636)
504
(731)
334
(1,362)
-
-
11
725
137
226
1,016
(1,117)
97,094
102,503
148,459
843
20,187
57,868
426,954
InvoCare            Annual Report 2020  | 92
-
-
-
 
I.  Assets in the course of construction
III. Asset held for sale
The carrying amounts of assets disclosed above include the following 
Asset held for sale represents property identified as surplus to the 
expenditure recognised in relation to property, plant and equipment 
Group’s requirement pursuant to the Network & Brand Optimisation 
which is in the course of construction.
review carried out as part of the Protect & Grow Plan.
Cemetery land improvements
Freehold buildings
Leasehold improvements
Plant and equipment
2020 
$’000
2019 
$’000
31
5,571
6,945
22,262
574
2,164
5,141
19,716
Total assets in the course of construction
12,691
49,713
II.  Impairment
All cemetery and crematorium sites were assessed during the year 
using consistently applied methodology and no changes to the 
impairment provision were deemed necessary except as noted below.
B. Right of use assets and lease liabilities
The Group leases various properties, cemeteries, equipment and 
motor vehicles. Rental contracts are typically made for fixed periods of 
5 to 10 years, with some leases for periods of 30 years.
Extension and termination options are included in a number of 
property leases across the Group. These terms are used to maximise 
operational flexibility in terms of managing contracts. The majority of 
extension and termination options held are exercisable only by the 
Group and not by the respective lessor.
Lease terms are negotiated on an individual basis and contain a wide 
range of different terms and conditions. The lease agreements do 
not impose any covenants, and leased assets may not be used as 
In 2017, the Allambe Gardens Memorial Park was impaired due to a 
security for borrowing purposes.
This section provides information for leases where the Group is a 
lessee. The consolidated balance sheet shows the following types of 
assets and liabilities related to leases:
• •  Right of use assets
• •  Lease liabilities
reassessment of the land available for memorialisation plots. In 2018, 
remediation of the residual land at the Memorial Park commenced. 
The remediation of the residual land was completed in January 
2020, with sales of burial sites in the new Lakeside development 
commencing in 2020. Once all phases of the monumental 
developments are complete, the Lakeside development will ultimately 
result in over 3,000 burial spaces, increasing the lifespan of the park 
by a further 40 years. As a result, a reversal of $6,000,000 of the 
previous impairment has been recognised at 31 December 2020 
(2019: Nil).
The recoverable amount of cash-generating units is based on  
value-in-use calculations. These calculations use cash flow 
projections based on financial estimates approved by management 
based on past performance and future expectations. The cash flows 
cover an initial five-year period and are then extrapolated beyond 
five years using estimated growth rates of 2.5% (2019: 3%) in 
revenue and 2% (2019: 3%) in expenses which are not inconsistent 
with historical trends and forecasts included in reports prepared by 
market analysts. A sensitivity analysis has been conducted on the 
impaired sites by moving the underlying assumptions both up and 
down 10%, considered to be within the reasonably possible range of 
long-term outcomes. This analysis demonstrates that changing the 
assumptions is unlikely to result in a material change in the currently 
recognised impairment losses. The pre-tax discount rate used was 
9.2% (2019: 9.2%), reflecting the risk estimates for the business as  
a whole.
InvoCare            Annual Report 2020  | 93
Performance Review12Directors’ Report3Financial Report4Other InformationProperties 
$’000
Equipment 
$’000
Motor vehicles 
$’000
Financial Report
Notes to the consolidated financial statements  
Significant assets and liabilities continued
I.  Right of use assets
2020
Composition as at 31 December 2020
Cost
Accumulated depreciation
Net book value
Movement for the year ended 31 December 2020
Opening net book value
Additions
Additions through business combinations
Depreciation
Effect of movement in exchange rates
Closing net book value
2019
Composition as at 31 December 2019
Cost
Accumulated depreciation
Net book value
Movement for the year ended 31 December 2019
Opening net book value
Additions
Depreciation
Effect of movement in exchange rates
Closing net book value
II. Lease liabilities on related right of use assets
Current
Non-current
Balance as at 31 December
156,103
(22,924)
133,179
129,359
9,309
6,978
(12,774)
307
133,179
140,536
(11,177)
129,359
121,641
18,895
(11,012)
(165)
129,359
2020 
$’000
19,465
146,459
165,924
721
(365)
356
425
27
-
(96)
-
356
694
(269)
425
590
104
(262)
(7)
425
2019 
$’000
12,934
149,967
162,901
Total 
$’000
171,304
(26,936)
144,368
14,480
(3,647)
10,833
14,217
144,001
130
-
(3,514)
-
10,833
14,350
(133)
14,217
22
14,328
(132)
(1)
9,466
6,978
(16,384)
307
144,368
155,580
(11,579)
144,001
122,253
33,327
(11,406)
(173)
14,217
144,001
InvoCare            Annual Report 2020  | 94
 
 
 
C.  Critical accounting judgements, estimates and 
The cost of improvements to or on leasehold properties is amortised 
assumptions
I.  Estimated impairment of non-financial assets
The Group annually considers if events or changes in circumstances 
indicate that the carrying value of non-financial assets may not be 
recoverable. Similarly, at each reporting date, the non-financial assets 
that suffered a previous impairment are reviewed for possible reversals 
of the impairment. The recoverable amounts are determined based on 
value-in-use calculations which require the use of assumptions. Refer 
to section Note A.II above for details of these assumptions and the 
potential impact to changes to the assumptions.
II.  Determining the lease term
In determining the lease term, management considers all facts and 
circumstances that create an economic incentive to exercise an 
extension option, or not exercise a termination option. Extension 
options (or periods after termination options) are only included in the 
lease term if the lease is reasonably certain to be extended (or not 
over the unexpired period of the lease or the estimated useful life of the 
improvement to the Group, whichever is shorter. The assets’ residual 
values and useful lives are reviewed, and adjusted if appropriate, 
at each balance sheet date. Gains and losses on disposals are 
determined by comparing proceeds with the carrying amount. Gains 
and losses are included in the statement of comprehensive income.
II.  Right of use assets and lease liabilities
InvoCare recognises a right of use asset and a corresponding liability 
at the date at which the leased asset is available for use by the Group. 
Each lease payment is allocated between the liability and finance 
cost. The finance cost is charged to profit or loss over the lease 
period so as to produce a constant periodic rate of interest on the 
remaining balance of the liability for each period. The right of use asset 
is depreciated over the shorter of the asset’s useful life and the lease 
term on a straight line basis.
Assets and liabilities arising from a lease are initially measured on a 
present value basis. Lease liabilities include the net present value of 
terminated). The Group has assessed it is reasonably certain that it will 
the following lease payments:
exercise its option to renew all leases.
• •  Fixed payments (including in-substance fixed payments), less any 
The assessment is reviewed if a significant event or a significant 
lease incentives receivable
change in circumstances occurs which affects this assessment and 
that is within the control of the Group.
D. Accounting policies
I.  Property, plant and equipment
Property, plant and equipment are carried at historical cost less 
• •  Amounts expected to be payable by the Group under residual 
value guarantees
• •  Exercise price of a purchase option if the Group is reasonably 
certain to exercise that option
• •  Payments of penalties for terminating the lease, if the lease term 
reflects the Group exercising that option
depreciation or amortisation. Historical cost includes expenditure that 
The lease payments are discounted using the interest rate implicit in 
is directly attributable to the acquisition of the items.
the lease. If that rate cannot be determined, the Group’s incremental 
Subsequent costs are included in the asset’s carrying amount or 
recognised as a separate asset, as appropriate, only when it is 
probable that future economic benefits associated with the item 
borrowing rate is used, being the rate that the Group would have to 
pay to borrow the funds necessary to obtain an asset of similar value in 
a similar economic environment with similar terms and conditions.
will flow to the Group and the cost of the item can be measured 
Right of use assets are measured at cost comprising the following:
reliably. Repairs, maintenance and minor renewals are charged to 
the statement of comprehensive income during the financial period in 
which they are incurred.
Cemetery land is carried at cost less accumulated depreciation and 
impairment write-downs. The Group sells interment and inurnment 
rights while retaining title to the property. Cemetery land is amortised, 
as the right to each plot or space is sold, to write off the net cost of the 
land over the period in which it is utilised and an economic benefit has 
been received. Other freehold land is not depreciated or amortised.
Depreciation of other assets is calculated using the straight line 
method to allocate their cost or revalued amounts, net of their residual 
values, over their estimated useful lives, as follows:
• •  Buildings: 40 years
• •  Plant and equipment: 3-10 years
• •  Amount of the initial measurement of lease liability
• •  Any lease payments made at or before the commencement date 
less any lease incentives received
• •  Any initial direct costs
• •  Restoration costs
Payments associated with short term leases and leases of low-value 
assets (less than $10,000) are recognised on a straight line basis as 
an expense in profit or loss. Short term leases are leases with a lease 
term of 12 months or less. Low-value assets comprise information 
technology equipment and small items of office equipment.
InvoCare            Annual Report 2020  | 95
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Significant assets and liabilities continued
Note 12. Intangibles
2020
Composition as at 31 December 2020
Cost
Accumulated amortisation
Impairment
Net book value
Movement for the year ended 31 December 2020
Opening net book value
Additions
Goodwill 
$’000
Brand  
name 
$’000
Capitalised 
software 
$’000
Total 
$’000
256,066
19,748
45,351
321,165
-
(13,349)
(14,765)
(28,114)
(43,360)
-
(6,176)
(49,536)
212,706
6,399
24,410
243,515
182,469
6,465
21,790
210,724
-
-
12,011
12,011
Additions through business combinations
51,676
1,491
366
53,533
Amortisation charge
Impairment loss
Effect of movement in exchange rates
Closing net book value
2019
Composition as at 31 December 2019
Cost
Accumulated amortisation
Impairment
Net book value
Movement for the year ended 31 December 2019
Opening net book value
Additions
Additions through business combinations
Finalisation of prior period acquisitions
Disposals
Amortisation charge
Impairment loss
Effect of movement in exchange rates
Closing net book value
-
(1,457)
(3,574)
(5,031)
(19,324)
-
(6,176)
(25,500)
(2,115)
(100)
(7)
(2,222)
212,706
6,399
24,410
243,515
206,949
18,549
32,897
258,395
-
(12,084)
(11,107)
(23,191)
(24,480)
-
-
(24,480)
182,469
6,465
21,790
210,724
197,541
7,258
18,377
223,176
-
7,210
1,550
(275)
-
629
-
(9)
5,921
-
-
-
5,921
7,839
1,550
(284)
-
(1,436)
(2,508)
(3,944)
(24,404)
847
-
23
-
-
(24,404)
870
182,469
6,465
21,790
210,724
InvoCare            Annual Report 2020  | 96
 
A. Impairment test for goodwill
B. Goodwill
Impairment tests are performed annually, or more frequently if events 
or circumstances indicate that the carrying amount may not be 
recoverable.
For the Group’s Australian-based operations, goodwill cannot be 
allocated on a non-arbitrary basis to individual cash generating 
unit (CGU) due to the significant history of numerous acquisitions, 
especially during the years 1993 to 1999, 2018 to 2020, and resulting 
post-acquisition business integration activities and operational 
changes over many years. New Zealand and Singapore operations 
are separate CGU and the associated goodwill arising from their 
acquisition have been allocated to the individual New Zealand or 
Singapore CGU. As a result, the lowest level within the Group at which 
goodwill is monitored for management purposes comprises the 
grouping of all CGUs within a country of operation. The recoverable 
amounts of the total of Australia, New Zealand and Singapore CGUs 
I. 
Impairment of New Zealand CGU
Recoverable amount testing for the period ended 31 December 2020 
has identified the New Zealand CGU as being impaired.
As at 31 December 2020, an impairment charge of $19,324,000 
of goodwill has been applied as the carrying amount of goodwill, 
property, plant & equipment, right of use assets and brand names 
exceeded its recoverable amount within the New Zealand business 
CGU. The disruption caused by COVID-19 and the subsequent 
restrictions imposed by the New Zealand government have hampered 
the Group’s ability to operate to planned expectations previously 
used to assess the recoverable amount of this business. While some 
progress had been made to improve the business, the reassessment 
of recoverable value has resulted in a further impairment charge of 
$19,324,000 of goodwill for the year ended 31 December 2020.
are based on value-in-use calculations. These calculations use cash 
New Zealand is a very traditional market that is fragmenting on price 
flow projections based on approved financial estimates covering a 
as customer demand has shifted to lower value packages rather 
five year period. Cash flows beyond the five year period have been 
than larger traditional funeral services. This change in consumer 
extrapolated using estimated growth rates. The assessment also 
behaviour was previously experienced in Australia prompting the 
considered the reasonable possible long term shift in key assumptions 
NBO strategy and it was mitigated by the Group’s ability to leverage 
which may potentially cause an impairment to arise.
brands such as Simplicity and Value Cremations. The pandemic has 
accelerated the change in New Zealand, as restrictions on the number 
of funeral attendees and economic pressure on household incomes 
has contributed to customers choosing a simpler funeral service for 
their loved ones. The Simplicity brand provides some mitigation to 
the impact of this change on customer preference. Notwithstanding 
the impairment, the Group remains confident that the quality of our 
frontline team in New Zealand will continue to provide excellent service 
to our client families.
The remaining goodwill acquired through business combinations or 
territory acquisitions has been allocated to a reportable segment for 
impairment testing (refer Note 1).
II.  Sensitivity – New Zealand CGU
Each of the sensitivities below assumes that a specific assumption 
moves in isolation, while other assumptions are held constant.  
A change in one of the key assumptions could be accompanied by 
a change in another assumption, which may increase or decrease 
the net impact. A reasonable possible shift in these key assumptions 
would result in the following outcomes:
• •  Terminal growth rate decreased by 0.5%: $4,800,000  
(2019: $6,007,000) additional impairment
• •  Post-tax weighted average cost of capital increase by 0.3%: 
$3,789,000 (2019: $4,713,000) additional impairment
InvoCare            Annual Report 2020  | 97
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Significant assets and liabilities continued
C.  Key assumptions used for value-in-use 
E.   Critical accounting judgements, estimates and 
calculations
assumptions
Budgeted cash flows have been based on past performance and 
The Group annually considers if events or changes in circumstances 
expectations for the future. The growth rates of 2.5% (2019: 3%) in 
indicate that the carrying value of goodwill or cash-generating units 
revenue, 2% (2019: 3%) in expense and 1% (2019: 1%) in volume 
may not be recoverable. Similarly, at each reporting date, cash-
growth projections are not inconsistent with historical trends and 
generating units that suffered a previous impairment are reviewed 
forecasts included in reports prepared by market analysts. In the 
for possible reversals of the impairment. The recoverable amounts 
calculation of the terminal value, the long term annual growth rate 
are determined based on value-in-use calculations which require the 
of the real gross domestic product (GDP) of the country is used as a 
use of assumptions. Refer to section C. above for details of these 
basis for the terminal growth rate. For goodwill, these assumptions are 
assumptions and the potential impact to changes to the assumptions.
based on the CGU to which the goodwill is attributed.
The pre-tax discount rate used for assessing the carrying value of 
F.  Accounting policies
goodwill in each CGU was as follows:
Australian operations
Singapore operations
New Zealand operations
2020 
%
2019 
%
9.2
9.2
9.2
9.2
10.0
10.0
I.  Goodwill
Goodwill arises on acquisition of business/subsidiary. Goodwill 
acquired in business combinations is not amortised. Instead, goodwill 
is tested for impairment annually or more frequently if events or 
changes in circumstances indicate that it might be impaired, and 
is carried at cost less accumulated impairment losses. Impairment 
losses on goodwill are taken to profit or loss and are not subsequently 
These discount rates reflect the risk estimates for each business as  
reversed if the related assets subsequently increases in value.
a whole.
Sensitivity analysis indicates significant headroom exists in the  
value-in-use calculations for Australia and Singapore CGUs 
compared to the carrying value of goodwill. There is no reasonable 
possible long term shift in key assumptions considered likely which 
will cause impairment of either of these two CGUs.
D. Capitalised software
I. 
Impairment of Oracle cloud ERP (Compass)
The Group has been on a three year enterprise resource planning 
(ERP) and digital transformation journey, with the journey set to 
continue with a second phase of enhancements and transitioning 
the Memorial Parks business onto the Oracle cloud ERP platform 
(referred to as Compass), including providing a digital interface for 
our customers and suppliers. The Group remains committed to 
Compass. There have been some challenges through the journey 
with some lessons learnt from the early phases of the implementation. 
The Group has continued to enhance and update functionality 
of Compass in 2020. These enhancements have resulted in the 
replacement of certain functionality and significant improvements 
in certain modules to ensure the asset is operating as intended. 
A detailed analysis of the modules, integrations and functionality 
of Compass has identified some modules as having indicators of 
impairment at 31 December 2020. As a result, an impairment charge 
of $6,176,000 of capitalised software has been recognised.
II.  Trademarks and brand names
Trademarks and brand names recognised through business 
acquisitions have a finite useful life and are carried at cost less 
accumulated amortisation and impairment losses. Amortisation 
is calculated using the straight line method to allocate the cost of 
trademarks and brand names over their estimated useful lives of ten 
years.
III. Capitalised software
Capitalised software is carried at historical cost less accumulated 
amortisation and impairment write-downs. Historical cost includes 
expenditure that is directly attributable to the acquisition of the 
software. Amortisation is calculated using the straight line method to 
allocate the cost of software over its estimated useful life of ten years.
IV.  Impairment of assets
Assets that have an indefinite useful life are not subject to amortisation 
and are tested annually for impairment or half yearly only if events 
or changes in circumstances indicate that the carrying amount 
may not be recoverable. Assets that are subject to depreciation or 
amortisation are reviewed for impairment indicators every six months. 
An impairment loss is recognised for the amount by which the asset’s 
carrying amount exceeds its recoverable amount. The recoverable 
amount is the higher of an asset’s fair value less costs to sell and 
value-in-use. For the purposes of assessing impairment, assets are 
grouped at the lowest levels for which there are separately identifiable 
cash flows (cash-generating units).
InvoCare            Annual Report 2020  | 98
Financial Report
Notes to the consolidated financial statements  
Capital and risks
The Group’s activities expose it to a variety of financial risks. The Group’s overall financial 
risk management strategy focuses on the unpredictability of financial markets and seeks 
to minimise adverse effects on the Group’s financial performance. This section contains 
disclosures of financial risks the Group is exposed to and how the Group manages those risks.
The capital management, impact of contingencies, commitments, and events subsequent to 
reporting period are also considered in this section.
Note 13. Financial risk management
The Group operates in different jurisdictions and markets. Strategic risk management is carried out by the Board of Directors. The Audit, Risk & 
Compliance Committee, which operates under policies approved by the Board, is responsible for operational and financial risk management. These 
policies provide written principles for overall risk management, as well as policies covering specific areas such as interest rate risk and currency risk.
The table below summarises the key risks identified, exposures, and management of exposures.
Risk identified
Definition
Exposures
Management of exposures
Market risk –  
The risk that the value of a 
• •  Financial assets: mainly cash at bank
• •  Fixed interest rate borrowings
interest rate
financial asset or liability or 
cash flow associated with the 
financial asset or liability will 
fluctuate due to changes in 
market interest rates
• •  Financial liabilities: mainly borrowings, pre-
paid contract liabilities, lease liabilities
• •  Derivative financial instruments, mainly 
interest rate swaps
• •  Further information for interest rate risk 
exposure and hedging effectiveness is 
provided in section A below 
• •  Managing to the hedge limits in respect of 
the policies as approved by the Board
• •  Speculative trading is not permitted
Market risk – 
The risk in local currency 
• •  Foreign currency earnings
• •  Physical financial instruments, including 
foreign currency
terms that the value of a 
• •  Net investments in foreign operations
financial commitment or a 
recognised asset or liability, 
will fluctuate due to changes 
in foreign currency exchange 
rates
• •  Foreign currency borrowings
• •  Further information on foreign currency risk 
exposures is provided in section B below
Market risk – 
The risk that the investment 
price
returns of funds under 
• •  Investment returns of the funds under 
management of pre-paid contracts
management on pre-paid 
contracts impact future 
income
• •  Majority of the funds under management is 
placed with the Over Fifty Guardian Friendly 
Society (OFGFS)
• •  Further information on pricing risk exposures 
is provided in section C below
natural hedges from matching foreign assets 
and liabilities
• •  Speculative trading is not permitted
• •  Maintain Board representation in OFGFS
• •  Monitor the investment strategy of OFGFS 
and the investment assets mix
Credit risk
The risk that a counterparty 
• •  Recoverability of receivables
• •  The Group’s policy is to only deal with banks 
will not be able to meet its 
• •  Recoverability of other financial assets and 
obligations in respect of a 
cash deposits
financial instrument, resulting 
in a financial loss to the Group
• •  Further information on credit risk exposures 
is detailed in section D below
and financial institutions with minimum 
independent credit ratings
• •  Operations of the Group results in no 
concentration of customers in any particular 
region or sector enhanced
• •  Enhanced alternative payment methods for 
customers in regional areas
Liquidity risk
The risk of having insufficient 
• •  Insufficient levels of committed credit 
• •  Maintaining sufficient levels of cash 
funds to settle financial 
facilities
liabilities as and when they 
• •  Settlement of financial liabilities
fall due
• •  Further information on liquidity risk 
exposures is detailed in section E below
and committed credit facilities to meet 
financial commitments and working capital 
requirements
• •  Timely review and renewal of credit facilities
InvoCare            Annual Report 2020  | 99
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Capital and risks continued
The Group holds the following financial assets and liabilities.
The interest rate swaps position and the coverage on outstanding 
2020 
$’000
2019 
$’000
bank borrowings as at end of the financial years are set out in the table 
below.
Financial assets
Cash and cash equivalents
118,781
19,560
Trade receivables
68,202
72,149
Pre-paid contract funds under management
613,131
619,389
Other financial assets
Financial liabilities
Trade and other payables
Contingent considerations
Borrowings
Lease Liabilities
4
4
800,118
711,102
60,514
60,810
17,174
894
246,039
357,189
165,923
162,901
Derivative financial instruments
1,148
4,157
Bank borrowings a
Effective average interest rate as at  
31 December
Interest rate swaps position as at  
31 December
2020 
%
2019 
%
3
4
Weighted average fixed interest rate payable
2.49
2.34
Weighted average variable interest rate 
receivable
0.12
1.03
Interest rate swaps coverage on outstanding bank borrowings
Australia
New Zealand
Singapore b
490,798
585,951
Combined Australia and New Zealand
39
40
Nil
30
93
87
Nil
91
A.   Interest rate risk exposure  
(cash flow and fair value)
The Group’s main interest rate risk arises from long term borrowings. 
All bank borrowings are initially at variable interest rates determined by 
a margin over the reference rate based on the Group’s leverage ratio. 
Borrowings issued at variable rates expose the Group to cash flow 
interest rate risk. The Group’s policy is to keep 75% of debt, measured 
by individual currency, on fixed interest rates over the next 12 months 
by entering into interest rate swap contracts. The policy, however, 
provides flexibility to reduce the level of coverage in low interest rate 
currency or when the interest rate outlook is relatively benign. The 
Group has entered into interest rate swap contracts under which it 
receives interest at variable rates and pays interest at fixed rates.
In addition to bank borrowings, the Group also entered into a note 
purchase agreement in February 2018 that is denominated in 
Australian dollars at a fixed interest rate. This assists in minimising the 
Group’s overall interest rate risk.
a    The effective average interest rate includes swaps and margins but 
excluding establishment fees.
b    Due to the relative stability of Singapore interest rates, Singapore 
denominated debt has been allowed to stay at floating rates.
Hedging for interest rate risk exposure
Hedge effectiveness is determined at the inception of the hedge 
relationship, and through periodic prospective effectiveness 
assessments to ensure that an economic relationship exists between 
the hedged item and hedging instrument.
The Group enters into interest rate swaps that have similar critical 
terms as the hedged item, such as reference rate, reset dates, 
payment dates, maturities and notional amount. The Group does not 
hedge 100% of its loans; therefore the hedged item is identified as a 
proportion of the outstanding loans up to the notional amount of the 
swaps. As all critical terms matched during the year, the economic 
relationship was 100% effective.
Hedge ineffectiveness for interest rate swaps is assessed by 
performing a qualitative assessment of effectiveness. If changes 
in circumstances affect the terms of the hedged item such that the 
critical terms no longer match exactly with the critical terms of the 
hedging instrument, the Group uses the hypothetical derivative 
method to assess effectiveness.
Hedge ineffectiveness may occur due to:
• •  The credit value/debit value adjustments on the interest rate swaps 
which is not matched by the loans
• •  Differences in critical terms between the interest rate swaps and 
loans
InvoCare            Annual Report 2020  | 100
 
The following variable rate bank borrowings and interest rate swap contracts are outstanding at the reporting date.
Variable borrowings
Interest rate swaps (notional principal)
Net exposure to cash flow interest rate risk
2020
2019
Weighted average 
interest rate  
%
2.71
2.49
Weighted average 
interest rate  
%
3.94
2.34
Balance  
$’000
114,308
(44,723)
69,585
The notional principal amounts and swap liability periods of expiry of the interest rate swap contracts are as follows.
Less than one year
One to two years
Two to three years
Three to four years
Nominal value
Swap liability
2020 
$’000
30,681
14,042
-
-
2019 
$’000
74,400
54,000
49,000
25,000
2020 
$’000
600
548
-
-
44,723
202,400
1,148
Balance  
$’000
259,600
(202,400)
57,200
2019 
$’000
984
1,340
1,143
690
4,157
These contracts require settlement of net interest receivable or 
payable each 90 days. The settlement dates coincide with the dates 
on which interest is payable on the underlying debt.
As a consequence, the Group is exposed to interest rate risks on that 
B.  Foreign currency risk exposure
The Group rarely undertakes significant commercial transactions 
in currencies other than in the functional currency of the operating 
subsidiaries in New Zealand and Singapore.
portion of total borrowings not swapped to fixed rates and to potential 
Foreign currency risks arise from recognised assets and liabilities 
movements in the margin due to changes in the Group’s leverage 
ratio. Where possible, borrowings are made in the same country 
as the operation being funded to provide a natural hedge against 
currency volatility. Where this is not possible, other techniques, such 
as foreign currency bank accounts, are used to mitigate the profit and 
loss volatility due to currency movements.
Due to the use of floating to fixed interest rate swaps, the Group has 
fixed interest commitments and the changes in the fair value of the 
that are denominated in a currency other than the Group’s functional 
currency, the Australian dollar. The major foreign currency risk relates 
to the investments in subsidiaries in New Zealand and Singapore. This 
exposes the Group to foreign currency risk on the assets and liabilities.
Borrowings have been made by the New Zealand subsidiary and by 
the Group in Singapore dollars to provide a natural hedge against the 
risk of changes in exchange rates in New Zealand and Singapore. 
The borrowings in Singapore dollars are therefore a hedge of a net 
future cash flows of these derivatives are recognised in equity to the 
investment in a foreign subsidiary.
extent that the derivative remains effective in accordance with AASB 9 
Financial Instruments.
The interest rate swap contracts were all judged to be effective at 
31 December 2020 and the movements in the fair value of these 
instruments have been quarantined in equity.
The overall impact and sensitivities of the interest bearing assets and 
liabilities and related derivatives of the Group has been summarised in 
section G Summarised sensitivity analysis in this note.
The Group has no significant unhedged foreign exchange exposures 
at 31 December 2020. Therefore, there was no ineffectiveness to be 
recorded from net investments in foreign entity hedges.
The Group’s exposure to foreign currency risk at the end of the 
reporting period, expressed in Australian dollars, was as follows.
New Zealand dollars
Singapore dollars
2020 
$’000
2019 
$’000
2020 
$’000
2019 
$’000
Borrowings
50,000
72,000
35,000
37,100
Derivatives
678
1,334
-
-
InvoCare            Annual Report 2020  | 101
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Capital and risks continued
C. Price risk exposure
The Group is the ultimate beneficiary of pre-paid contract funds under 
management (Invested Funds) invested in various pre-paid contract 
trusts, as described in Note 10.D. There are a significant number of 
trusts in existence with various investment profiles.
Other than disclosed above, the Group does not hold any investments 
in equities or commodities and is therefore not subject to price risk.
Based on the asset allocation as at 31 December 2020 and  
31 December 2019 the following changes in investment returns are 
Accordingly, the Group’s future income is sensitive to the price risk 
reasonably probable.
relating to the investment returns of these funds under management. 
These funds are invested in a range of asset classes with different 
price risk variables including cash, fixed interest, Australian and 
international equities, hybrids and direct and indirect property. The 
return on these funds (net of the increase in the liability to deliver the 
future services) are recognised in the statement of comprehensive 
income.
88% of the funds are managed by the Over Fifty Guardian Friendly 
Society (OFGFS) which is controlled by a five-member independent 
Board with two InvoCare representatives. Non OFGFS funds primarily 
invested in capital guaranteed funeral bonds managed by a range of 
APRA regulated institutions.
The OFGFS Board has appointed an Investment Committee (GIC) 
which is responsible for the management of the Invested Funds in 
accordance with an approved Investment Policy Statement (IPS). 
The IPS provides guidance on the ongoing prudent and efficient 
management of the investment arrangements. The principle objective 
of the Invested Funds is to maximise returns without exceeding risk 
levels specified in the Investment Guidelines. By pursuing these 
objectives, the Invested Funds are expected to provide a long-term 
rate of return sufficient to meet the original plus subsequent increases 
in retail prices of delivering the promised funeral services after 
considering all Invested Funds expenses and tax.
The GIC regularly sets a target asset allocation to ensure investment 
activity sits within the stated risk profile and to also ensure that other 
limits specified in the IPS are being met. External consultants are 
engaged to review the risk and return forecasts on a regular basis and 
recommend amendments to the target asset allocation if required.
Normally funds are invested for extended periods, with the median life 
of a pre-paid funeral contract being circa nine years. Liquidity risk is 
considered low with the flow of funds from the sale of new contracts 
exceeding redemptions in most years. The fund can therefore take 
a long-term view on its investment horizon and absorb short term 
fluctuations in returns caused by market volatility.
The asset allocation at year end of pre-paid contract funds under 
management is as follows.
Equities
Property
Cash and fixed interest (includes hybrid 
securities)
2020 
%
2019 
%
40
28
32
43
27
30
Asset class
Equities  
(plus or minus 10%)
Property  
(plus or minus 3%)
Cash and fixed 
interest (no price risk)
2020
2019
Increase 
$’000
Decrease 
$’000
Increase 
$’000
Decrease 
$’000
20,819
(20,819)
26,875
(26,875)
4,305
(4,305)
4,993
(4,993)
-
-
-
-
25,124
(25,124)
31,868
(31,868)
D. Credit risk exposure
Credit risk is managed on a Group basis. Credit risk arises from cash 
and deposits with banks and financial institutions, derivative financial 
instruments, as well as credit exposures to customers, including 
outstanding receivables and committed transactions. For banks and 
financial institutions, only independently rated parties with a minimum 
rating of AA- are accepted.
Credit risks in relation to customers are highly dispersed and without 
concentration on any particular region or sector. The trade receivables 
are non-interest bearing. Funeral homes attempt to collect deposits at 
the time the service is commissioned both as a sign of good faith and 
in order to cover out-of-pocket expenses. Cemetery and crematorium 
products are generally not delivered prior to the receipt of all or 
substantially all of the amounts due.
The Group applies the simplified approach to measuring expected 
credit losses which uses a lifetime expected loss allowance for all 
trade receivables.
To measure the expected credit losses, trade receivables have been 
grouped based on shared credit risk characteristics and the days past 
due. The expected loss rates are based on the payment profiles of 
sales over a period of rolling 24 months before the financial year end 
31 December 2020. Refer to Note 8 for details of loss allowance and 
movement for the financial year.
The Group’s own collection activity, which varies based on the 
nature and relative age of the debt, is routinely applied to all past due 
accounts. When these activities do not result in a successful recovery 
of the debt, it is referred to external debt collection agencies.
Trade receivables are written off when there is no reasonable 
expectation of recovery. Indicators which include amongst others, 
is the failure of the debtor to engage in a repayment plan with the 
InvoCare            Annual Report 2020  | 102
Group. Once all attempts to recover the debt have been exhausted, 
As at 31 December 2020, the details of the facilities available, drawn 
then a debt is considered to be in default and written off. Subsequent 
down, unused by facilities are disclosed in the table below.
recoveries of amounts previously written off are credited against 
sundry revenue in the consolidated income statement.
E.  Liquidity risk exposure
Prudent liquidity management implies maintaining sufficient cash and 
marketable securities, the availability of funding through an adequate 
amount of committed credit facilities and the ability to close out 
market positions. Due to the relatively stable nature of the Group’s 
business, management aims to maintain a large portion of committed 
Total facilities available
Working capital facility  
– expiring within one year
Unsecured loan facility  
– expiring in two to five years
credit lines on a long term basis.
Drawn down as at 31 December
On 19 June 2020, InvoCare completed the extension to February 2023 
of its $200,000,000 three-year revolving debt facility, which was due 
to expire in February 2021.
This $200,000,000 debt facility is currently undrawn.
Working capital facility  
– expiring within one year
Unsecured loan facility *  
– expiring in two to five years
During April and May 2020, the Group completed an Institutional 
Placement and a Share Purchase Plan and raised a total of 
Unused as at 31 December
$274,034,000, gross of transaction costs. The net proceeds of the 
capital raised are to be utilised to reduce net debt, increase liquidity 
and balance sheet flexibility to support the business during the current 
uncertain environment and to fund growth initiatives.
With the reduction in net debt post capital raised, the covenant ratios 
of the Group continued to be met as per the facilities agreements as at 
31 December 2020.
The facilities agreements covenants ratios are calculated on a rolling 
12-month basis and are:
Working capital facility  
– expiring within one year
Unsecured loan facility *  
– expiring in two to five years
2020 
$’000
2019 
$’000
7,440
9,638
448,702
450,000
456,142
459,638
-
3,297
248,717
359,600
248,717
362,897
7,440
6,341
199,985
90,400
207,425
96,741
* 
 As at 31 December, the balance of the long-term borrowings – 
unsecured loan facility outstanding after loan establishment costs is 
as set out in the table below.
• •  Net debt to bank adjusted operating EBITDA must be no greater 
Long-term borrowings outstanding as at 31 December
than 3.5 times
• •  EBITDA to net interest must be great than 3.0 times
Unsecured loan facility  
– expiring in two to five years
248,717
359,600
Less: Loan establishment costs
(2,678)
(2,411)
246,039
357,189
In order to comply with the Group’s Treasury Policy, the repayment of 
the $200,000,000 tranche resulted in the early settlement of several 
interest rate swaps to ensure the Group remained within its policy 
bands and was not ‘over hedged’. The early settlement of the interest 
rate swaps resulted in a loss of $2,122,000 recognised through profit 
and loss during the half year ended 31 December 2020. Refer to  
Note 5.A.
InvoCare            Annual Report 2020  | 103
Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report
Notes to the consolidated financial statements  
Capital and risks continued
The table below analyses the Group’s financial liabilities into the relevant maturity groupings based on their contractual terms as at the reporting date. 
Trade and other payables, lease liabilities and borrowings are non derivative liabilities.
2020
Trade and other payables
Contingent considerations
Lease liabilities
Borrowings
Derivatives
2019
Trade and other payables
Contingent considerations
Lease liabilities
Borrowings
Derivatives
Less than  
one year 
$’000
Two to  
three years 
$’000
More than  
three years 
$’000
60,514
9,265
19,465
-
600
60,810
500
12,934
-
984
-
7,909
36,486
146,039
548
-
394
28,639
257,189
2,483
-
-
109,973
100,000
-
-
-
121,328
100,000
690
Total 
$’000
60,514
17,174
165,924
246,039
1,148
60,810
894
162,901
357,189
4,157
F. Fair value measurement
The Group’s financial assets and liabilities are measured at fair value at the end of each reporting period. They are measured or disclosed at fair value, 
using a three level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:
• •  Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date
• •  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly
• •  Level 3: Unobservable inputs for the asset or liability
The following table gives information about how the fair value of financial assets and liabilities are determined, including the valuation technique and 
inputs used. For the Group’s financial assets and liabilities not measured at fair value, their carrying amount provides a reasonable approximation of 
their fair values.
Financial assets 
or liabilities
Fair value 
hierarchy
Valuation technique
Significant 
unobservable 
inputs
Relationship of unobservable 
inputs to fair value
Pre-paid 
contract 
funds under 
management
Derivative 
financial 
instruments
Level 2
The fair value is calculated based on the number 
Not applicable
Not applicable
of units multiplied by the unit price of the funds 
which administers the invested funds. 
The unit price of the funds is based on the fair 
value of the underlying investments, which 
include equities, cash, fixed interest deposits and 
property.
Level 2
The fair value is calculated as the present value 
Not applicable
Not applicable
of the estimated future cash flows based on 
observable yield curves
Contingent 
Level 3
The fair value is calculated based on the 
Forecast 
The estimated fair value would 
consideration
contracted terms of performance measures,  
performance 
increase/decrease if the forecast 
eg revenue, EBITDA or net profit
measures per the 
performance measures per the 
contracts
contracts were higher/lower. Refer 
to Note 18. C for further details
There were no transfers between levels during the reporting period.
InvoCare            Annual Report 2020  | 104
 
G. Summarised sensitivity analysis
The following table summarises the sensitivity of the Group’s financial assets and financial liabilities to interest rate risk and foreign exchange risk net of 
applicable income tax.
2020
Financial assets
Interest rate risk
Foreign exchange risk
-100 basis point
+100 basis point
-10%
+10%
Carrying 
amount 
$’000
Profit/ 
(loss) 
$’000
Equity 
$’000
Profit/ 
(loss) 
$’000
Equity 
$’000
Profit/ 
(loss) 
$’000
Equity 
$’000
Profit/ 
(loss) 
$’000
Equity 
$’000
Cash and cash equivalents
118,781
(831)
Trade receivables
68,202
-
Pre-paid contract funds under 
management
613,131
(188)
Other financial assets
4
Financial liabilities
Trade and other payables
Contingent considerations
Lease liabilities
Borrowings
Derivatives
(60,514)
(17,175)
(165,924)
(246,039)
(888)
(1,148)
-
Total increase/ (decrease)
(1,907)
2019
Financial assets
Cash and cash equivalents
Trade receivables
19,560
72,149
(137)
-
Pre-paid contract funds under 
management
619,389
(4,567)
Other financial assets
4
Financial liabilities
Trade and other payables
Contingent considerations
Lease liabilities
Borrowings
Derivatives
(60,810)
(894)
(162,901)
(357,189)
(400)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
626
626
-
-
-
-
-
-
-
-
831
-
188
-
-
-
-
888
-
1,907
137
-
4,567
-
-
-
-
400
-
-
-
-
-
-
-
-
(626)
(626)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
(179)
-
(179)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
(520)
520
147
(1,114)
-
1,114
-
-
-
-
-
-
-
-
147
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
(325)
-
(637)
637
266
(5,178)
-
5,178
(4,157)
-
1,424
-
(1,424)
Total increase/ (decrease)
-
(5,104)
1,424
5,104
(1,424)
(325)
-
266
-
InvoCare            Annual Report 2020  | 105
Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report
Notes to the consolidated financial statements  
Capital and risks continued
Note 14. Contributed equity 
Ordinary shares – fully paid
Treasury shares – fully paid
A. Ordinary shares
2020  
Number   
‘000
144,061
(1,175)
142,886
2019 
Number   
‘000
117,185
(1,225)
115,960
2020  
Number   
‘000
2019 
Number   
‘000
Movement during the financial year
Balance as at 1 January
117,185
110,256
Shares issued for Dividend Reinvestment Plan*
Shares issued for Institutional Placement and Share Purchase Plan
Balance as at reporting date
527
26,349
144,061
664
6,265
117,185
2020   
$‘000
511,293
(14,288)
497,005
2020   
$‘000
234,513
5,918
270,862
511,293
2019   
$‘000
234,513
(14,687)
219,826
2019 
$‘000
139,589
9,137
85,787
234,513
Ordinary shares entitle the holder to participate in dividends and the proceeds on winding up of the Company in proportion to the number of and 
amounts paid on the shares held. On a show of hands every holder of ordinary shares present at a meeting in person or by proxy, is entitled to one vote, 
and upon a poll each share is entitled to one vote.
*    Since 2006, the Company activated its Dividend Reinvestment Plan under which equity holders of ordinary shares may elect to have all or part of their 
dividend entitlements satisfied in ordinary shares rather than by being paid in cash.
B. Treasury shares
Movement during the financial year
Balance as at 1 January
Disposal of shares – vested share rights/options
Disposal of shares – transfer to EESP's members
2020  
Number   
‘000
2019 
Number   
‘000
2020 
$‘000
2019 
$‘000
(1,225)
(1,261)
(14,687)
(15,449)
19
31
12
24
48
351
450
312
Balance as at reporting date
(1,175)
(1,225)
(14,288)
(14,687)
Treasury shares are shares in InvoCare Limited that are held by the InvoCare Deferred Employee Share Plan Trust for the purpose of issuing shares 
under the InvoCare Deferred Employee Share Plan, as set out in Note 20.
InvoCare            Annual Report 2020  | 106
 
 
 
   
 
 
C. Capital management
The Group’s capital management objectives and strategies seek 
• •  Maintaining an optimal leverage ratio: The optimal capital structure, 
to maximise total shareholder returns, while maintaining a capital 
which has the lowest cost of capital, is indicatively at a leverage 
structure with acceptable debt and financial risk.
The capital management goals can be broadly described as:
• •  Manage the amount of equity and the expectation of returns – 
including dividend distribution policy, dividend reinvestment and 
share buy-back policies
ratio (i.e. Net debt/Adjusted operating EBITDA) of no higher 
than a range between 3.0 times and 3.5 times but preferably 
lower than 3.0 times with an interest cover ratio of greater than 
4.0 times. A liquidity buffer of at least $25 million should be 
maintained. Where the capacity exists, debt financing will be used 
for small acquisitions and capital expenditure. In the absence 
• •  Maintain debt and gearing that is prudent, cost effective, 
of opportunities to invest in growing the business, the Group 
supports operational needs and provides flexibility for growth and 
will consider applying excess debt capacity to make returns to 
development
shareholders
• •  Avoid excessive exposure to interest rate fluctuations and debt 
• •  Maintaining floating to fixed base interest rate swaps for at least 
refinancing risk
75% of debt principal in Australia and New Zealand
The goals are actively managed by the use of quantifiable measures. 
These measures and relevant comments are as follows:
• •  Maximising shareholder returns: Earnings per share (EPS)  
is a key measure and for 2020, basic EPS was (6.9 cents)  
• •  Managing refinancing risk: By spreading the tenor of the debt 
available to the Group minimises its exposure to the risks that all the 
debt will become due at a single point of time
(2019: 55.8 cents). Operating EPS, which excludes restructuring 
D. Accounting policy for ordinary shares
costs, gains and losses on the disposal or impairment of  
non-current assets and on undelivered pre-paid contracts and 
non-controlling interests and disposal of subsidiaries, was  
20.4 cents (2019: 51.7 cents). Importantly, senior management  
of the Group have long-term incentives linked to EPS growth, thus 
aligning employee and shareholder interests. Total compound 
annual shareholder return, being the sum of cash dividends and 
share price growth, has exceeded 15% per annum since the 
Company listed in December 2003, except for 2008 when global 
Ordinary shares are classified as equity. Incremental costs directly 
attributable to the issue of new shares are shown in equity as a 
deduction, net of tax, from the proceeds.
Note 15. Contingencies
There were no unrecognised contingent assets as at  
equity market values declined, although InvoCare’s share price did 
31 December 2020 and 31 December 2019.
not fall as significantly as the rest of the market
The Group had the following guarantee that are determined as 
• •  Maintaining a minimum ordinary dividend payout ratio of between 
contingent liabilities at 31 December 2020:
• •  Bank guarantees given for leased premises of subsidiaries to a 
maximum of $2,870,000 (2019: $3,261,000)
• •  Deed of cross guarantee by a number of the entities within the 
Group. Refer to Note 22 for further details of the bank guarantee
60% to 80% of operating earnings after tax. For each of the years 
since listing, the Group has distributed ordinary dividends in 
excess of this payout ratio. The aggregate of the interim and final 
2020 dividends represents a payout ratio of 61% (2019: 79%) of 
operating earnings after tax
• •  Confirming compliance with the debt covenant ratios, as defined in 
the facility agreements, through bi-annual calculations. The Group 
has complied with its banking covenants as follows:
•  Interest cover (EBITDA/Net interest expense) must be greater 
than 3.0 times
•  Leverage ratio (Net debt/Adjusted operating EBITDA) must not 
be greater than 3.5 times
InvoCare            Annual Report 2020  | 107
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Capital and risks continued
Note 16. Commitments
Note 17. Events after reporting period 
As at reporting date, the Group has the following capital and other 
On 27 January 2021, a property classified as held for sale at  
commitments which are not recognised as liabilities.
31 December 2020 was sold for $7.4 million resulting in a gain of  
A.   Capital commitments
$6.3 million. 
Other than the above transaction and the dividend determined as 
2020 
$’000
2019 
$’000
disclosed in Note 4, no other matter or circumstance has arisen since 
31 December 2020 that has significantly affected, or may significantly 
affect the Group’s operations, the results of those operations, or the 
Group’s state of affairs in future financial years.
Contracted and conditionally contracted - within one year
Building extensions and refurbishments
301
4,969
Leasehold improvements
Plant and equipment purchases
1,112
511
70
434
B.  Other commitments
Within one year
Documentary letters of credit
104
35
C.  Operating lease commitments
The Group leases premises, motor vehicles and sundry office 
equipment under non-cancellable operating leases with terms 
generally from one to five years. The Rookwood Crematorium lease 
expires in 2025. The Great Southern Garden of Remembrance lease 
expires in 2047 with an option to renew for a further 50 years.
From 1 January 2019, the Group has recognised right of use assets 
for these leases, except for short term and low value leases, see  
Note 11. B. Right of use assets for further information.
Contracted non-cancellable operating leases committed at reporting 
date but not recognised as liabilities or payable are provided in the 
table below.
Within one year
One to five years
2020 
$’000
669
137
806
2019 
$’000
1,723
711
2,434
InvoCare            Annual Report 2020  | 108
 
Financial Report
Notes to the consolidated financial statements  
Business portfolio
This section provides 
information on how the Group 
structure affects the financial 
position and performance of 
the Group as a whole. The 
disclosures detail the types 
of entities and transactions 
included in the consolidation 
and those excluded.
Note 18. Business combinations
A.   Acquisitions for the year ended 31 December 2020
I. 
 Summary of acquisitions
During the year ended 31 December 2020, the Group acquired three 
businesses. A summary of the purchase consideration, goodwill and identifiable 
assets and liabilities acquired for all the acquisitions are presented below.
The accounting for these acquisitions is provisional as at 31 December 2020.
Subsidiaries/businesses acquired are:
• •  Galaxy Funerals
• •  Family Pet Care Pty Limited
• •  Pets in Peace
The purchase consideration, fair value of identifiable net assets acquired,  
and goodwill are disclosed below.
a.  Total purchase consideration paid/payable
2020
Cash consideration
Contingent consideration
Deferred consideration
Total purchase consideration
b. 
Identifiable assets and liabilities acquired
2020
Cash and cash equivalents
Inventories
Other current assets
Property, plant and equipment
Right of use assets
Identifiable intangibles
Lease liabilities
Borrowings
Other liabilities
Deferred tax liability
Total net identifiable assets acquired
Goodwill
Galaxy Funerals  
$’000
Family Pet Care  
Pty Limited 
$’000
Pets in Peace 
$’000
591
5,333
-
5,924
32,806
8,465
438
41,709
5,130
2,982
-
8,112
Galaxy Funerals  
$’000
Family Pet Care  
Pty Limited 
$’000
Pets in Peace 
$’000
-
-
-
59
431
-
(431)
-
(18)
-
41
5,883
364
1,010
1,320
1,695
4,539
1,857
(4,470)
(17)
(1,876)
(544)
3,878
37,831
-
-
10
611
2,008
-
(2,301)
-
(178)
-
150
7,962
Total 
$’000
38,527
16,780
438
55,745
Total 
$’000
364
1,010
1,330
2,365
6,978
1,857
(7,202)
(17)
(2,072)
(544)
4,069
51,676
The goodwill recognised is attributable to the location, workforce and the profitability of the acquired businesses. It will not be deductible for tax 
purposes.
If new information obtained within one year from the acquisition date about facts and circumstances that existed at the acquisition date identifies 
adjustments to the above amounts, then the acquisition accounting will be revised.
InvoCare            Annual Report 2020  | 109
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Business portfolio continued
c. 
 Financial performance of acquired businesses
2020
Revenue
Net profit after income tax
Galaxy Funerals  
$’000
Family Pet Care  
Pty Limited 
$’000
Pets in Peace 
$’000
1,670
484
2,360
238
420
213
Total 
$’000
4,450
935
If all the acquisitions had occurred on 1 January 2020, consolidated revenue and profit after tax for the year ended 31 December 2020 would have 
increased by approximately $25,065,000 and $3,495,000, respectively.
d.  Total purchase consideration – cash flows
2020
Galaxy Funerals  
$’000
Family Pet Care  
Pty Limited 
$’000
Pets in Peace 
$’000
Outflow of cash to acquire subsidiary/businesses, net of cash acquired
Cash consideration
Less: Cash balances acquired
Add: Acquisition related costs *
Add: Payment of deferred consideration  
(Broulee Memorial Gardens)
Net cash outflows – investing activities
591
-
32,806
(364)
5,130
-
Total 
$’000
38,527
(364)
1,918
500
40,581
* 
 Acquisition-related costs totalling $1,918,000 (as shown on the consolidated statement of comprehensive income) are not able to be allocated to 
individual transactions as they include the costs of operating a Mergers and Acquisitions team in addition to costs arising directly attributable to the 
acquisitions.
B.  Acquisitions for the year ended  
31 December 2019
C.  Fair value measurement – contingent 
consideration
For all three acquisitions settled during the prior year ended 31 
December 2019, the accounting for all of them has been finalised 
during 2020. There have been no material changes to the financial 
information disclosed for each acquisition. Refer to 2019 Annual 
Report for further details of those acquisitions.
For some of the businesses acquired, consideration paid/
payable consists contingent component (classified as contingent 
consideration as shown on face of the consolidated balance sheet) 
pending for the achievement of the agreed financial performance of 
the acquired businesses. The contingent consideration are measured 
and disclosed at fair value. This section provided details on how fair 
value is determined, including the valuation technique (only Level 3: 
Unobservable inputs for the contingent consideration) and inputs 
used and the movement for the financial period.
Level 3
Contingent consideration – current
Contingent consideration – non-current
2020 
$’000
9,265
7,909
17,174
2019 
$’000
94
800
894
InvoCare            Annual Report 2020  | 110
I. 
 Valuation techniques for fair value measurements 
categorised within level 3
The contingent consideration arose on the business combination 
(refer to earlier sections within this note). The fair value was 
determined using an independent expert and is estimated based 
on a multiple of forecast earnings before interest, tax, depreciation 
and amortisation (EBITDA) of the acquired business over a two year 
period. Any settlement of contingent consideration will be in the form 
of cash. Any variation at the time of settlement will be recognised as 
income or expense in profit or loss.
II.    Critical accounting judgements, estimates 
and assumptions – fair value of contingent 
consideration
The Group’s contingent consideration liability is measured at fair 
D. Accounting policies for business combination
The purchase method of accounting is used to account for all 
acquisitions of assets (including business combinations) regardless 
of whether equity instruments or other assets are acquired. Cost 
is measured as the fair value of the assets given, shares issued or 
liabilities incurred or assumed at the date of exchange.
Identifiable assets acquired and liabilities and contingent liabilities 
assumed in a business combination are measured initially at their fair 
values at the acquisition date. The excess of the cost of acquisition 
over the fair value of the Group’s share of the identifiable net assets 
acquired is recorded as goodwill. If the cost of acquisition is less 
than the fair value of the net identifiable assets of the subsidiary 
acquired, the difference is recognised directly in the statement 
of comprehensive income, but only after a reassessment of the 
value at the end of each reporting period. The information provided 
identification and measurement of the net assets acquired.
below is about how the fair value of this financial liability is determined, 
including the valuation technique and inputs used.
• •  Fair value hierarchy: level 3
• •  Valuation technique: the fair value is calculated based on a multiple 
of forecast EBITDA of the business over a two year period
Where settlement of any part of cash consideration is deferred, the 
amounts payable in the future are discounted to their present value 
as at the date of acquisition. Any variations in the initial estimates of 
deferred consideration and the final amount payable are remeasured 
through the statement of comprehensive income.
• •  Significant unobservable inputs: forecast EBITDA of the business 
The present value of contingent consideration is classified as a 
and the discount rate
• •  Relationship of unobservable inputs to fair value: the estimated fair 
financial liability and is subsequently remeasured to fair value with 
changes in fair value recognised in profit or loss.
value would increase/decrease if the forecast EBITDA or discount 
The acquisition-related costs are recorded in the statement of 
rate were higher/lower
comprehensive income.
III.  Level 3 – Contingent consideration
Movements in level 3 – contingent consideration during the current 
and previous financial year are set out below.
Balance at 1 January
2020 
$’000
2019 
$’000
894
1,394
Contingent consideration relating to business 
combinations
16,780
500
Payments during the financial year
(500)
(1,000)
Balance at 31 December
17,174
894
The carrying value of contingent consideration might be impacted by 
the changes in discount rate or the forecast EBITDA of the businesses 
acquired during the financial year. The impact to the carrying value for 
the following unobservable inputs are as follows:
• •  Profitability adjustments to EBITDA: a 5% decrease in the 
profitability per year over the two year period would decrease the 
contingent consideration by $839,000
InvoCare            Annual Report 2020  | 111
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Business portfolio continued
Note 19. Interests in subsidiaries
A. Interests in subsidiaries
Set out below are the Group’s principal trading subsidiaries at 31 December 2020. Unless otherwise stated, the subsidiaries as listed below have 
share capital consisting solely of ordinary shares, which are held directly by the Group, and the proportion of ownership interests held equals to the 
voting rights held by the Group. The country of incorporation or registration is also their principal place of business. The principal activities of all these 
subsidiaries are funeral services provider.
Name of subsidiaries
InvoCare Australia Pty Limited
Bledisloe Australia Pty Limited
InvoCare PetCare Limited
Family Pet Care Pty Limited
InvoCare New Zealand Limited
William Morrison Funeral Director*
Singapore Casket Company (Private) Limited
Country of 
incorporation
Australia 
Australia 
Australia 
Australia 
New Zealand 
New Zealand 
Singapore 
Ownership interest held
2020 
%
100
100
100
100
100
-
100
2019 
%
100
100
-
-
100
100
100
*    On 31 December 2020, William Morrison Funeral Director was amalgamated into InvoCare New Zealand Limited.
Shares in subsidiaries are carried at cost and relate to InvoCare 
Limited’s ownership interest in InvoCare Australia Pty Limited, 
InvoCare PetCare Pty Limited, Family Pet Care Pty Limited, InvoCare 
(Singapore) Pty Limited, InvoCare New Zealand Limited and InvoCare 
Hong Kong Limited. All shares held are ordinary shares.
InvoCare Australia Pty Limited, InvoCare PetCare Pty Limited, 
Family Pet Care Pty Limited, InvoCare (Singapore) Pty Limited and 
Bledisloe Australia Pty Ltd have been granted relief from the necessity 
B. Significant restrictions
Other than those imposed by the legislative provisions in the 
respective country of incorporation, for the subsidiaries listed above, 
the Group has no significant restriction on its ability to access or use 
assets and settle liabilities.
C. Subsidiaries with non-controlling interests
to prepare financial reports in accordance with ASIC Corporations 
One subsidiary, Macquarie Memorial Park Pty Limited, has  
Instrument 2016/785 issued by the Australian Securities & 
Investments Commission. For further information refer to Note 23.
non-controlling interests of 16.86% (2019: 16.86%). During the  
year dividends totalling $Nil were paid to non-controlling interests  
(2019: $121,000).
D. Employee share trust
The Group has formed a trust to administer the InvoCare Exempt 
Employee Share Plan and the InvoCare Deferred Employee Share Plan.
InvoCare            Annual Report 2020  | 112
E.  Accounting policies
I.  Subsidiaries
Subsidiaries are all entities (including employee share trust) over which 
the Group has control. The Group controls an entity when the Group is 
exposed to, or has rights to, variable returns from its involvement with 
the entity and has the ability to affect those returns through its power 
to direct the activities of the entity.
II.  Consolidation of subsidiaries
Subsidiaries are fully consolidated from the date on which control 
is transferred to the Group. They are deconsolidated from the date 
that control ceases. The purchase method of accounting is used to 
account for the acquisition of subsidiaries by the Group (refer to  
Note 18.D).
Intercompany transactions, balances and unrealised gains on 
transactions between Group companies are eliminated. Unrealised 
losses are also eliminated unless the transaction provides evidence 
of the impairment of the asset transferred. Accounting policies 
of subsidiaries have been changed where necessary to ensure 
consistency with the policies adopted by the Group.
Non-controlling interests in the results and equity of non-wholly 
owned subsidiaries are shown separately in the consolidated 
statement of comprehensive income and balance sheet, respectively.
III. Employee share trust
The employee share trusts are consolidated, as the substance of the 
relationship is that the trusts are controlled by the Group. Shares held 
by the InvoCare Deferred Employee Share Plan Trust are disclosed as 
treasury shares and deducted from contributed equity.
IV.  Foreign currency translation on subsidiaries
The results and financial positions of all the Group entities (none of 
which has the currency of a hyperinflationary economy) that have 
a functional currency different from the presentation currency are 
translated into the presentation currency as follows:
• •  Assets and liabilities for each balance sheet presented are 
translated at the closing rate at the date of that balance sheet
• •  Income and expenses for each statement of comprehensive 
income are translated at average exchange rates
• •  All resulting exchange differences are recognised in other 
comprehensive income
On consolidation, exchange differences arising from the translation 
of any net investment in foreign subsidiaries, and of borrowings 
and other financial instruments designated as hedges of such 
investments, are recognised in other comprehensive income. When 
a foreign operation is sold or any borrowings forming part of the 
net investment are repaid, a proportionate share of such exchange 
differences will be recognised in the statement of comprehensive 
income, as part of the gain or loss on sale where applicable.
Goodwill and fair value adjustments arising on the acquisition of a 
foreign subsidiary are treated as assets and liabilities of the foreign 
subsidiaries and translated at the closing rate.
InvoCare            Annual Report 2020  | 113
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Other statutory disclosures
This section provides information on other 
disclosures which are required by various 
accounting standards and reporting 
requirements.
Note 20. Share-based remuneration
The ultimate objective of share-based remuneration is to align the 
participants with delivery of shareholder value. Long term incentives, 
with appropriate performance hurdles, align participants to the longer 
term strategies, goals and objectives of the Group, and provide 
greater incentive for senior employees to have broader involvement 
and participation in the Group beyond their immediate role. Equity 
participation also assists the Group to attract and retain skilled and 
experienced senior employees.
The obligations under share-based payment arrangements are 
settled by either issuing new ordinary shares in the Company or 
acquiring ordinary shares of the Company on market. Overseas 
participants receive cash equivalent to the value of the equity awarded 
that vests.
Trading in the Company’s ordinary shares awarded under the share-
based remuneration arrangements is governed by the Company’s 
Share Trading Policy. The policy restricts employees from trading in 
the Company’s shares when they are in a position to be aware, or 
are aware, of price sensitive information. The policy also implements 
blackout periods which prohibit trading in the Company’s shares in 
the lead up to the Group’s half year and annual result announcements, 
unless Board express approval is obtained.
The arrangements are governed by the terms of the Company’s three 
Plan Rules.
Four plans are currently in operation. They include:
• •  A plan which is available to eligible employees who meet the 
employment conditions:
•  Exempt Employee Share Plan (EESP) – in the form of shares to 
the maximum value of $1,000 instead of cash salary
• •  Three plans which are only available to nominated employees:
•  Long-term Incentive Plan (LTIP) – in the forms of options 
and performance rights or cash equivalent, they will vest if the 
performance and employment conditions are both met
•  Deferred Employee Share Plan (DESP) – in the form of shares 
or share appreciation rights (SARs) for overseas employees 
which will vest when employment condition is met
•  Service Based Equity Plan (SEP) – in the form of rights or cash 
equivalent, they will vest if the employment condition is met
InvoCare            Annual Report 2020  | 114
A. Exempt Employee Share Plan
• •  Performance hurdle(s):
Australian based permanent employees with more than six months 
service and a salary less than $180,000 per annum and casual staff 
with more than two years service routinely working at least 40% of 
a full time equivalent are annually offered the opportunity to acquire 
•  For 2016 to 2019 grants: only compound annual growth (EPS 
CAGR) target: Normalised EPS b growth above the base year. 
Vesting of options and performance rights is conditional on 
meeting a minimum level of return on invested capital (ROIC a)
$1,000 worth of InvoCare Limited shares through a salary sacrifice 
•  For grants from 2020 onwards: 50% grant on EPS CAGR target 
arrangement as permitted by Australian Taxation Legislation.  
and 50% grant on ROIC target
During 2020, 351 employees accepted the offer and at  
31 December 2020 a further $185,000 was remaining to be  
collected via payroll deductions.
• •  Vesting scale:
•  For 2016 and 2017 grants, only EPS CAGR target: Below 7% 
EPS CAGR: Nil; At 7%: 30%; Between 7% and 12%: straight 
line pro-rata vesting between 30%-100%; At or above 12%: 
B. Long-term Incentive Plan
100%
LTIP was introduced during 2016. The plan permits settlement in 
•  For 2018 and 2019 grants, only EPS CAGR target: Below 8% 
either equity or cash, at the Board’s discretion. The plan provides 
EPS CAGR: Nil; At 8%: 30%; Between 8% and 12%: straight 
options and performance rights to senior management team, so 
line pro-rata vesting between 30%-100%; At or above 12%: 
employees are incentivised to maximise shareholder value in the 
100%
longer term.
The key terms and conditions of this plan:
• •  In the form of options and performance rights to be granted as 
approved by the Board
• •  Both options and performance rights are granted for nil 
consideration
•  For grants from 2020 two performance target (50% EPS CAGR 
and 50% ROIC): Below 6% EPS CAGR: Nil; At 6% EPS CAGR: 
30%; Between 6% and 10% EPS CAGR: straight line pro-rata 
vesting between 30%-100%; At or above 10% EPS CAGR: 
100%; Below 10% ROIC: Nil; At 10% ROIC: 30%; Between 10% 
and 12% ROIC: straight line pro-rata vesting between  
30%-100%; At or above 12% ROIC: 100%
• •  Allocation between options and performance rights is:
• •  Dividend entitlement:
•  Set by the Board for senior management team in the ratio of 
75%:25% for options and performance rights, respectively
•  For other participants in the ratio of 50%:50% based on the 
contractual arrangement or election
•  From 2020 grant onwards, the ratio between options and 
performance rights are based on election by all participants
• •  Upon vesting:
•  For 2016 to 2019 grants: Not entitled to any dividends
•  For grants from 2020 onwards: performance rights entitled 
to dividends in the form of DRP and only become vested and 
exercisable into InvoCare shares should performance hurdles of 
performance rights vest at the performance testing time
• •  Not entitled to voting rights during the vesting period
• •  Upon termination of employment, all unvested options and 
•  For Australian participants, each option (after paying the options 
performance rights will be forfeited
price) and performance right entitle the participant to subscribe 
for one InvoCare ordinary share
•  For overseas participants, each option (after paying the options 
price) and performance right entitle the participant to receive 
• •  Clawback and malus: the Board, at its sole discretion, may 
determine that all or part of any vested and unvested options or 
performance rights may be forfeited in certain circumstances
a    ROIC means return on invested capital and is calculated by dividing 
cash equivalent value of one InvoCare ordinary share at the 
the operating earnings by the average invested capital
market value at date of vesting
• •  Performance testing timing:
•  For 2016 and 2017 grants, each grant is divided in three equal 
tranches and the first testing date of the three tranches are in 
the second, third and fourth year anniversary following the grant 
year with last retesting in the fifth year anniversary
•  For 2018 and 2019 grants, each grant is divided in two equal 
tranches and the first testing date of the two tranches are in the 
third and fourth year anniversary following the grant year
b    Normalised EPS means constant currency EPS adjusted to exclude 
the after tax impacts of funds under management movements, the 
gain or loss on the sale, disposal or impairment of non-current assets, 
non-cash movements in derivative financial instruments reported 
in profit before tax and impacts of changed accounting policies 
because of changes of accounting standards from the base year. For 
2020 grant onwards, EPS is calculated based on operating earnings 
(normalised for non-operating items)
The fair value of the options and performance rights at grant date is 
estimated using Black-Scholes Pricing model. The model takes into 
account the exercise price, the term of the option, the share price at 
•  For grants from 2020 onwards, the grant has only one test in the 
grant date and expected price volatility of the underlying share, the 
third year anniversary following the grant year
expected dividend yield and the risk-free interest rate for the term of 
the option.
InvoCare            Annual Report 2020  | 115
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Other statutory disclosures continued
The following information related to the options and performance rights issued under the LTIP.
Grant date 
Expiry date 
Options
1/01/2016
1/01/2026
22/02/2016
22/02/2026
1/01/2017
1/01/2027
22/02/2017
22/02/2027
1/01/2018
1/01/2028
1/01/2019
1/01/2029
1/03/2020
1/03/2028
Performance rights
1/01/2016
1/01/2026
22/02/2016
22/02/2026
1/01/2017
1/01/2027
22/02/2017
22/02/2027
1/01/2018
1/01/2028
1/01/2019
1/01/2029
1/03/2020
1/03/2035
3/08/2020
1/08/2035
Fair value at 
grant date 
Balance at the 
start of the year  
Number
Granted 
Number
Vested 
Number
Lapsed 
Number
Balance at the  
end of the year 
Number 
$2.40
$2.40
$2.93
$2.93
$2.78
$2.51
$0.58
$12.08
$12.08
$14.06
$14.06
$13.91
$12.96
$9.70
$9.70
363,842
20,946
384,779
16,221
605,974
795,028
-
2,186,790
34,904
2,983
37,321
3,380
55,494
70,089
-
-
-
-
-
-
-
-
513,820
513,820
-
-
-
-
-
-
105,068
17,107
(2,591)
-
-
-
-
-
-
-
-
-
-
-
(15,936)
-
361,251
20,946
384,779
16,221
605,974
779,092
513,820
(2,591)
(15,936)
2,682,083
(11,946)
(213)
-
-
-
-
-
-
-
-
-
-
-
(2,766)
-
-
22,958
2,770
37,321
3,380
55,494
67,323
105,068
17,107
311,421
The value of the options and performance rights exercised is based on the VWAP for the year ended 31 December 2020 and was $11.10  
(2019: $14.08).
204,171
122,175
(12,159)
(2,766)
InvoCare            Annual Report 2020  | 116
C. Deferred Employee Share Plan
D. Service Based Equity Plan
This plan, introduced in 2007, is settled by the transfer of InvoCare 
The Service Based Equity Plan (SEP) introduced in 2020 is settled by 
ordinary shares to participants upon vesting. The plan is used to 
the transfer of InvoCare ordinary shares to participants upon vesting. 
recognise, reward and retain key talent in critical roles at the middle 
The plan is used to recognise, reward and retain key talent in critical 
management level. Eligible employees participate in the plan based 
roles at the middle management level. Eligible employees participate 
on nomination only.
in the plan based on nomination only.
Prior to 2015, the senior management who participated in this plan 
The key terms and conditions of this plan include:
were required to meet both performance and employment conditions 
in order for the shares to vest. The last Tranche,  being Tranche 3 of the 
2015 grant fully vested as a result of performance testing performed 
• •  Granted in the form of rights as approved by the Board
• •  Rights are granted for nil consideration
at the end of February 2020. Unvested grants from 2016 onwards 
• •  To vest, the participant must meet ongoing employment conditions
remain in place with employment conditions only for vesting.
• •  Each grant of rights is divided into six equal tranches
Due to the impact of COVID-19, the Board determined there would be 
• •  The vesting date of the six tranches are every six months from the 
no grants under the DESP for 2020 other than the commitments due 
grant date
to employment contractual requirements.
• •  Entitled to receive any dividends that may become payable during 
The key terms and conditions of this plan include:
the vesting period and are payable as additional shares only on 
• •  Granted in the form of shares as approved by the Board
• •  Shares are granted for nil consideration
• •  To vest, the participant must meet ongoing employment conditions
• •  Each grant of shares is divided into three equal tranches
• •  The vesting date of the three tranches are:
date of vesting
• •  Dividend entitlement will be calculated and converted into the 
equivalent number of rights based on the Dividend Reinvestment 
Plan rules
• •  Upon vesting:
•  For Australian participants, each right entitles the participant to 
•  Tranche 1 – completion of 36 months employment from  
subscribe for one InvoCare ordinary share
grant date
•  For overseas participants, each right entitles the participant to 
•  Tranche 2 – completion of 48 months employment from  
receive cash equivalent value of one InvoCare ordinary share at 
grant date
the market value at date of vesting
•  Tranche 3 – completion of 60 months employment from  
• •  Upon termination of employment, all unvested rights and any 
grant date
cumulative dividend (in the form of rights) will be forfeited
• •  Entitled to receive any dividends that may become payable on the 
shares during the vesting period
• •  Entitled to voting rights of the shares during the vesting period
• •  Upon termination of employment, all unvested shares will be 
forfeited
InvoCare            Annual Report 2020  | 117
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Other statutory disclosures continued
The following information relates to the rights issued under the SEP and shares held in the share plan trust under DESP.
Grant date 
Expiry date 
Fair value at 
grant date 
Balance at the 
start of the year  
Number
Granted 
Number
Vested 
Number
Lapsed 
Number
Balance at the  
end of the year 
Number 
Rights - ongoing employment condition only
1/09/2020
1/09/2035
19/10/2020
1/09/2035
$9.70
$10.50
Shares - ongoing employment condition only
1/03/2015
1/03/2020
1/03/2016
1/03/2031
1/03/2017
1/03/2032
1/03/2018
1/03/2028
1/03/2019
21/02/2029
1/03/2020
1/03/2035
15/06/2020
1/07/2035
$13.74
$12.08
$14.06
$13.91
$14.46
$10.70
$11.10
Shares - performance and ongoing employment conditions
1/01/2015
1/01/2030
22/02/2015
22/02/2025
31/03/2015
31/03/2030
23/08/2018
23/08/2028
$13.74
$13.74
$13.74
$13.74
-
-
-
135,948
14,000
149,948
117
3,367
7,665
13,136
29,617
-
-
53,902
10,866
1,358
5,804
1,354
19,382
-
-
-
-
-
1,758
30,000
31,758
-
-
-
-
-
-
-
-
(117)
(3,367)
(3,888)
(4,277)
-
-
-
-
-
-
-
-
(115)
(574)
(553)
-
-
(11,649)
(1,242)
(10,864)
(1,358)
(5,804)
(1,354)
(19,380)
(2)
-
-
-
(2)
135,948
14,000
149,948
-
-
3,662
8,285
29,064
1,758
30,000
72,769
-
-
-
-
-
The value of the options and performance rights exercised is based on the VWAP for the year ended 31 December 2020 and was $11.10  
(2019: $14.08).
Note 21. Related party transactions
A. Key management personnel compensation
B. Parent entity
2020 
$
2019 
$
The ultimate parent entity within and for the Group is InvoCare Limited.
Short-term employee benefits
3,330,600 3,316,765
Post-employment benefits
156,079
160,227
Other long-term benefits
Termination benefits
Share based payments
(101,930)
29,108
428,909
-
C. Transactions with subsidiaries
All transactions that have occurred among the subsidiaries within the 
Group have been eliminated for consolidation purposes.
320,490
(455,602)
D. Transactions with other related parties
4,134,148 3,050,498
The contributions to superannuation funds on behalf of employees are 
disclosed in Note 5.E.
InvoCare            Annual Report 2020  | 118
 
 
Note 22. Parent entity information
A. Summary financial information
C. Contingent liabilities
The financial information provided in the table below is only for 
Other than the guarantees as disclosed in section B above, there were 
InvoCare Limited, the parent entity of the Group.
no unrecognised contingent liabilities as at 31 December 2020 and  
2020 
$’000
2019 
$’000
31 December 2019.
Statement of comprehensive income
D.  Capital commitment – property, plant and 
Profit after income tax
59,662
66,079
equipment
Total comprehensive income
61,279
65,024
The parent entity has no capital commitments for the acquisition  
Balance sheet
Current assets
Total assets
Current liabilities
Total liabilities
Equity
44,936
2,015
866,746
653,989
1,582
2,353
165,779
256,760
of property, plant or equipment at 31 December 2020 and  
31 December 2019.
E. Tax consolidation group
InvoCare Limited (the head entity) and its wholly-owned Australian 
subsidiaries implemented the tax consolidation legislation from  
1 January 2004.
Contributed equity
497,005
219,826
On adoption of the tax consolidation legislation, the entities in the tax 
Share-based payments reserve
3,296
2,055
Cash flow hedges reserve
(359)
(1,976)
consolidated group entered into a tax sharing and funding agreement 
which, in the opinion of the directors, limits the joint and several liability 
of the wholly-owned subsidiaries in the case of a default by the head 
Foreign currency reserve
1,080
1,080
entity.
Retained profits
Total equity
199,945
176,244
700,967
397,229
B. Guarantees entered into by the parent entity
The parent entity provided the following guarantees during the year 
ended 31 December 2020 and 31 December 2019:
This agreement was updated on 5 June 2007 and provides that the 
wholly-owned subsidiaries will continue to fully compensate InvoCare 
Limited for any current tax payable assumed and be compensated 
by InvoCare Limited for any current tax receivable and deferred tax 
assets relating to unused tax losses or unused tax credits that are 
transferred to InvoCare Limited under the tax consolidation legislation.
The amounts receivable or payable under the tax funding agreement 
are due upon receipt of the funding advice from the head entity, 
• •  Bank guarantees given for leased premises of subsidiaries to a 
which is issued as soon as practicable after the end of each financial 
maximum of $2,870,000 (2019: $3,261,000)
year. InvoCare Australia Pty Limited, as permitted by the tax funding 
• •  Under the terms of a General Security Trust Deed executed 
on 16 February 2018 the parent entity, InvoCare Limited, and 
its material wholly-owned subsidiaries (the Guarantors) have 
individually guaranteed to the financiers the due and punctual 
payment in full of any liabilities or obligations provided under the 
terms of the Syndicated Facility Agreement and the Note Purchase 
Agreement both dated 16 February 2018. The Guarantors have 
also indemnified the financiers against any loss or damage suffered 
by the financiers arising from any failure by a borrower or any 
Guarantor to satisfy the obligations
agreement, acts on behalf of InvoCare Limited for the purpose of 
meeting its obligations to make tax payments, or receive refunds, 
and reimburses, or is compensated by, that entity through the 
intercompany loan account for amounts of tax paid, or received, 
except for the tax allocated to that entity.
F.   Accounting policy applicable to parent entity
The accounting policies of the parent entity are consistent with those 
of the Group, except for the following:
• •  Investments in subsidiaries are accounted for at cost, less any 
impairment, in the parent entity
• •  Dividends received from subsidiaries are recognised as other 
income by the parent entity and its receipt may be an indicator of an 
impairment of the investment
InvoCare            Annual Report 2020  | 119
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Other statutory disclosures continued
Note 23. Deed of cross guarantee
A.  Consolidated statement of comprehensive 
InvoCare Limited, InvoCare Australia Pty Limited and InvoCare 
(Singapore) Pty Limited entered into a Deed of Cross Guarantee 
on 11 December 2006 under which each company guarantees the 
debts of the others. Effective from 15 June 2011, Bledone Pty Ltd 
and Bledisloe Australia Pty Ltd became parties to this Deed of Cross 
Guarantee. Effective from 19 February 2021, InvoCare PetCare Pty 
Limited and Family Pet Care Pty Limited became parties to this Deed 
of Cross Guarantee. By entering into the deed, the wholly-owned 
income of the Closed Group
2020 
$’000
2019 
$’000
Revenue from continuing operations
387,544
400,261
Finished goods, consumables and funeral 
disbursements
(96,351)
(95,930)
Employee benefits expense
(143,212)
(132,503)
subsidiaries have been relieved from the requirement to prepare a 
Advertising and public relations expenses
(11,921)
(9,106)
Occupancy and facilities expenses
(18,985)
(14,741)
Financial Report and Directors’ Report under ASIC Corporations 
Instrument 2016/785 issued by the Australian Securities & 
Investments Commission.
The above companies represent a “Closed Group” for the purposes of 
Motor vehicle expenses
Technology
the ASIC Corporations Instrument, and as there are no other parties to 
Other expenses
the Deed of Cross Guarantee that are controlled by InvoCare Limited, 
they also represent the “Extended Closed Group”.
Set out below is a consolidated statement of comprehensive 
income, summary of movements in consolidated retained profits and 
consolidated balance sheet for the year ended 31 December 2020 of 
the Closed Group.
Depreciation, impairment and amortisation 
expenses
Impairment of loss on intangibles
Impairment reversal of cemetery land
Finance costs
Interest income
(8,125)
(7,066)
(10,951)
(10,795)
(18,811)
(11,087)
79,188
119,033
(34,630)
(29,176)
(6,175)
6,000
-
-
(38,573)
(17,959)
1,539
1,092
Net gain on undelivered pre-paid contracts
2,691
45,550
Acquisition related costs
Inter-segment revenue
(1,918)
(1,984)
1,317
1,810
Net gain on disposal of non-current assets
7,520
2,189
Profit before income tax
Income tax expense
16,959
120,555
(7,296)
(29,827)
Net profit after income tax for the year
9,663
90,728
Other comprehensive income 
Items that may be reclassified to profit and loss
Changes in fair value of cash flow hedges,  
net of tax
(1,240)
(1,055)
Total realised loss on early settlement of 
interest rate swaps reclassified to profit or loss
1,611
(1,055)
Net changes to cash flow hedges, net of tax
371
(1,055)
Changes in foreign currency translation 
reserve, net of tax
(1,595)
(1,248)
Other comprehensive income for the year,  
net of tax
(1,224)
(2,303)
Total comprehensive income for the year,  
net of tax
8,439
88,425
InvoCare            Annual Report 2020  | 120
 
B.  Summary of movements in consolidated 
retained profits of the Closed Group 
2020 
$’000
2019 
$’000
Current liabilities
Trade and other payables
Retained profits as at 1 January
193,201
144,401
Contingent consideration
Profit after income tax for the year
9,663
90,728
Lease liabilities
Dividends paid
(35,432)
(41,928)
Derivative financial instruments
Retained profits as at 31 December
167,432
193,201
Pre-paid contract liabilities
Deferred revenue
2020 
$’000
2019 
$’000
51,482
52,865
9,171
-
16,786
11,418
512
735
44,532
48,715
28,627
34,909
C.  Consolidated balance sheet of the  
Provision for employee benefits
15,463
13,626
Closed Group
Current assets
Cash and cash equivalents
107,219
7,920
Trade receivables
Other receivables
Inventories
15,894
35,172
15,041
7,576
40,000
40,688
Total current liabilities
Non-current liabilities
Contingent consideration
Borrowings
Lease liabilities
166,573
162,268
7,909
800
199,285
295,228
121,252
114,632
Derivative financial instruments
-
2,088
Pre-paid contract funds under management
50,268
57,551
Deferred tax liabilities
35,951
35,766
Asset held for sale
Deferred selling costs
Deferred contract assets
Total current assets
Non-current assets
2,333
3,981
3,644
4,481
1,541
2,409
235,940
159,778
Pre-paid contract liabilities
496,624
476,498
Deferred revenue
69,391
69,579
Provision for employee entitlements
2,444
5,528
Total non-current liabilities
932,856 1,000,119
1,099,429 1,162,387
663,291
405,475
497,005
219,826
(1,146)
(7,552)
167,432
193,201
663,291
405,475
Total liabilities
Trade and other receivables
64,042
62,132
Net assets
Shares in subsidiaries
246,778
246,778
Property, plant and equipment
423,397
353,630
Right of use asset
118,667
121,784
Pre-paid contract funds under management
562,863
561,837
Intangible assets
Deferred selling costs
Deferred contract assets
95,357
43,682
13,151
14,201
2,525
4,040
Total non-current assets
1,526,780 1,408,084
Total assets
1,762,720 1,567,862
Equity
Contributed equity
Reserves
Retained profits
Total equity
InvoCare            Annual Report 2020  | 121
Performance Review12Directors’ Report3Financial Report4Other Information 
 
Financial Report
Notes to the consolidated financial statements  
Other statutory disclosures continued
Note 24. Economic dependence
Note 25. Remuneration of auditors
The parent entity depends on dividend and interest income from, and 
During the year the following fees were paid or payable for services 
management fees charged to, its subsidiaries to source the payment 
provided by the auditor of the parent entity, InvoCare Limited, its 
of future dividends and fund its operating costs and debt service 
related practices and non-related audit firms.
obligations as borrower under the bank loan facility agreements. The 
parent entity’s financial position is sound. Adequate cash resources 
are available to enable it to meet its obligations as and when they fall 
due, through either drawing on unused finance facilities, which at the 
reporting date amounted to $207,425,000 as outlined in Note 13.E., 
or by on-demand repayment of intercompany advances.
A. Audit services
PricewaterhouseCoopers  
– Australian firm
2020 
$
2019 
$
Audit and review of financial reports
525,121
450,621
PricewaterhouseCoopers  
– non-Australian firm
Audit and review of financial reports
22,443
24,788
Non-PricewaterhouseCoopers  
– Singaporean firm
Audit and review of financial reports
32,152
32,743
Total remuneration for audit services
579,716
508,152
B. Non-audit services
PricewaterhouseCoopers  
– Australian firm
Assurance services
Taxation services
Other Services
PricewaterhouseCoopers  
– non-Australian firm
Taxation services
Other services
Non-PricewaterhouseCoopers  
– Singaporean firm
22,400
29,050
11,500
58,500
-
7,250
49,033
35,687
1,633
-
Other services
11,476
12,389
Total remuneration for non-audit services
96,042
142,876
It is the Company’s policy to employ PricewaterhouseCoopers 
on assignments additional to their statutory audit duties where 
PricewaterhouseCoopers’ expertise and experience with the Group 
are important and auditor independence is not compromised. These 
assignments are principally tax advice and advisory services, or where 
PricewaterhouseCoopers is awarded assignments on a competitive 
basis. It is the Company’s policy to seek competitive tenders for any 
major consulting projects.
InvoCare            Annual Report 2020  | 122
 
Note 26. Other accounting policies
IV.  Trade and other payables
A.   New or amended accounting standards and 
interpretations adopted
Trade and other payables represent liabilities for goods and services 
provided to the Group prior to the end of the financial year which had 
not been settled at balance date. The amounts are unsecured and are 
usually paid within 60 days of recognition.
The Group has adopted all of the new or amended Accounting 
Standards and Interpretations issued by the Australian Accounting 
V.  Borrowings
Standards Board (AASB) that are mandatory for the current reporting 
Borrowings are initially recognised at fair value, net of transaction 
period.
• •  Conceptual Framework for Financial Reporting and AASB 2019-1 
Amendments to Australian Accounting Standards–References to 
the Conceptual Framework
B. Other accounting policies applicable
I.  Foreign currency translation
a.  Functional and presentation currency
Items included in the financial statements of each of the Group’s 
entities are measured using the currency of the primary economic 
environment in which the entity operates (the functional currency). The 
consolidated financial statements are presented in Australian dollars, 
which is InvoCare Limited’s functional and presentation currency.
b.  Transactions and balances
Foreign currency transactions are translated into the functional 
currency using the exchange rates prevailing at the dates of the 
transactions. Foreign exchange gains and losses resulting from the 
costs incurred. Borrowings are subsequently measured at amortised 
cost. Any difference between the proceeds (net of transaction 
costs) and the redemption amount is recognised in the statement of 
comprehensive income over the period of the borrowings using the 
effective interest rate method.
Borrowings are classified as current liabilities unless the Group has an 
unconditional right to defer settlement of the liability for at least twelve 
months after the balance sheet date.
VI. Derivative financial instruments
The Group uses derivative financial instruments, interest rate 
swaps, to hedge its risks associated with exchange and interest rate 
fluctuations. Derivatives are initially recognised at fair value on the  
date a derivative contract is entered into and are subsequently  
re-measured to their fair value at each reporting date. The accounting 
for subsequent changes in fair value depends on whether the 
derivative is designated as a hedging instrument, and if so, the nature 
of the item being hedged. The Group designates certain derivatives 
as either:
settlement of such transactions and from the translation at year end 
• •  Hedges of the risks associated with the cash flows of recognised 
exchange rates of monetary assets and liabilities denominated in 
assets and liabilities and highly probable forecast transactions 
foreign currencies are recognised in the income statement, except 
(cash flow hedges)
when they are deferred in equity as qualifying cash flow hedges and 
qualifying net investment hedges or are attributable to part of the net 
• •  Hedges of a net investment in a foreign operation
The Group documents at inception the relationship between hedging 
instruments and hedged items, as well as its risk management 
objective and strategy for undertaking various hedge transactions. 
The Group also documents its assessment of whether the derivatives 
that are used in hedging transactions have been, and will continue to 
be, highly effective in offsetting changes in fair values or cash flows or 
hedged items.
The fair value of interest rate swap contracts is calculated as the 
present value of the estimated future cash flows. The full fair value of a 
hedging derivative is classified as a non-current asset or liability when 
the remaining maturity of the hedged item is more than twelve months; 
it is classified as a current asset or liability when the remaining maturity 
of the hedged item is less than twelve months.
investment in a foreign operation.
II.  Inventories
Inventories comprising of funeral merchandise and memorialisation 
property items in the cemeteries and crematoria and pets cremations 
business, primarily held for the purpose of trading, are sold, 
consumed or realised as part of the normal operating cycle even when 
they are not expected to be realised within twelve months, and are 
classified as current.
Inventories are stated at the lower of cost and net realisable value. 
Cost comprises direct materials and, where appropriate, a proportion 
of variable and fixed overhead. Costs are assigned to individual items 
of inventory predominantly on the basis of weighted average cost. Net 
realisable value is the estimated selling price in the ordinary course of 
business less the estimated costs necessary to make the sale.
III. Deferred contract assets
Deferred contract assets represent items to be delivered related to the 
pre-2018 memorial product contracts. These contract assets will be 
unwind to cost of goods sold as the performance obligations of these 
contracts are met.
InvoCare            Annual Report 2020  | 123
Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report
Notes to the consolidated financial statements  
Other statutory disclosures continued
Hedges that meet the criteria for hedge accounting are accounted for 
VII. Employee benefits
as follows:
a.   Cash flow hedges
a.   Wages and salaries, annual leave and sick leave
Liabilities for wages and salaries, including non-monetary benefits and 
The effective portion of changes in the fair value of derivatives that are 
annual leave expected to be settled within 12-months of the reporting 
designated and qualify as cash flow hedges is recognised in equity in 
date are recognised in other payables and provision for employee 
the hedging reserve. The gain or loss relating to the ineffective portion 
benefits in respect of employees’ services up to the reporting date and 
is recognised immediately in the statement of comprehensive income 
are measured at the amounts expected to be paid when the liabilities 
within finance costs.
are settled, including appropriate on-costs.
Amounts accumulated in equity are recycled in the statement of 
b.   Long service leave
comprehensive income within finance costs in the periods when the 
hedged item affects profit or loss (for instance when the forecast sale 
that is hedged takes place).
When a hedging instrument expires, is sold or terminated, or when 
a hedge no longer meets the criteria for hedge accounting, any 
cumulative gain or loss existing in equity at that time remains in 
equity and is recognised when the forecast transaction is ultimately 
recognised in the statement of comprehensive income.
The liability for long service leave is recognised in the provision for 
employee benefits and is measured as the present value of expected 
future payments to be made in respect of services provided by 
employees up to the reporting date, including appropriate on-costs. 
Consideration is given to expected future wage and salary levels, 
experience of employee departures and periods of service. Expected 
future payments are discounted using market yields at the reporting 
date on corporate bonds with terms to maturity and currency that 
match, as closely as possible, the estimated future cash outflows.
When a forecast transaction is no longer expected to occur, the 
cumulative gain or loss that was reported in equity is immediately 
c.   Bonus plans
transferred to the statement of comprehensive income.
The Group recognises a liability in other payables and an expense 
b.   Hedges of a net investment
Hedges of a net investment in a foreign operation, including a hedge 
of a monetary item that is accounted for as part of the net investment, 
are accounted for in a similar way to cash flow hedges. Gains or losses 
for bonus plans when there is no realistic alternative but to settle the 
liability and at least one of the following conditions is met:
• •  There are formal terms in the plan for determining the amount  
of the benefit
on the hedging instrument relating to the effective portion of the hedge 
• •  The amounts to be paid are determined before the time of 
are recognised directly in equity while any gains or losses relating to 
completion of the financial report
the ineffective portion are recognised in the income statement. On 
disposal of the foreign operation, the cumulative value of any such 
gains or losses recognised directly in equity is transferred to the 
income statement.
• •  Past practices give clear evidence of a constructive obligation
VIII.   New Accounting Standards and Interpretations 
not yet mandatory or early adopted
There are no Australian Accounting Standards and Interpretations 
that have recently been issued or amended but are not yet mandatory, 
that have been early adopted by the Group for the annual reporting 
period ended 31 December 2020.
InvoCare            Annual Report 2020  | 124
 
Financial Report
Directors’ declaration
In the Directors’ opinion:
• •  The financial statements and Notes 1 to 26 are in accordance with 
the Corporations Act 2001, including:
•  Complying with Accounting Standards, the Corporations 
Regulations 2001 and other mandatory professional reporting 
requirements
•  Giving a true and fair view of the Company’s and the Group’s 
financial position as at 31 December 2020 and of their 
performance for the financial year ended on that date
• •  There are reasonable grounds to believe that the Company will be 
able to pay its debts as and when they become due and payable
• •  At the date of this declaration, there are reasonable grounds to 
believe that the members of the Extended Closed Group identified 
in Note 23 will be able to meet any obligations or liabilities to which 
they are, or may become, subject by virtue of the deed of cross 
guarantee described in Note 23
Basis of preparation on page 73 confirms that the financial statements 
also comply with International Financial Reporting Standards as 
issued by the International Accounting Standards Board.
The Directors have been given the declarations by the Chief Executive 
Officer and Chief Financial Officer required by section 295A of the 
Corporations Act 2001.
This declaration is made in accordance with a resolution of the 
Directors.
Bart Vogel Chairman 
Sydney  24 February 2021
InvoCare            Annual Report 2020  | 125
Performance Review12Directors’ Report3Financial Report4Other InformationPricewaterhouseCoopers, ABN 52 780 433 757 One International Towers Sydney, Watermans Quay, Barangaroo, GPO BOX 2650, SYDNEY  NSW  2001 T: +61 2 8266 0000, F: +61 2 8266 9999, www.pwc.com.au Level 11, 1PSQ, 169 Macquarie Street, Parramatta NSW 2150, PO Box 1155 Parramatta NSW 2124 T: +61 2 9659 2476, F: +61 2 8266 9999, www.pwc.com.au Liability limited by a scheme approved under Professional Standards Legislation. 126Independent auditor’s report To the members of InvoCare Limited Report on the audit of the financial report Our opinion In our opinion: The accompanying financial report of InvoCare Limited (the Company) and its controlled entities (together the Group) is in accordance with the Corporations Act 2001, including: (a)giving a true and fair view of the Group's financial position as at 31 December 2020 and of itsfinancial performance for the year then ended(b)complying with Australian Accounting Standards and the Corporations Regulations 2001.What we have audited The Group financial report comprises: ●the consolidated balance sheet as at 31 December 2020●the consolidated statement of comprehensive income for the year then ended●the consolidated statement of changes in equity for the year then ended●the consolidated statement of cash flows for the year then ended●the notes to the consolidated financial statements, which include significant accounting policiesand other explanatory information●the directors’ declaration.Basis for opinion We conducted our audit in accordance with Australian Auditing Standards. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial report section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Group in accordance with the auditor independence requirements of the Corporations Act 2001 and the ethical requirements of the Accounting Professional & Ethical Standards Board’s APES 110 Code of Ethics for Professional Accountants (including Independence Standards) (the Code) that are relevant to our audit of the financial report in Australia. We have also fulfilled our other ethical responsibilities in accordance with the Code. Performance Review12Directors’ Report3Financial Report4Other Information127 Our audit approach An audit is designed to provide reasonable assurance about whether the financial report is free from material misstatement. Misstatements may arise due to fraud or error. They are considered material if individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial report. We tailored the scope of our audit to ensure that we performed enough work to be able to give an opinion on the financial report as a whole, taking into account the geographic and management structure of the Group, its accounting processes and controls and the industry in which it operates. Materiality Audit scope Key audit matters ●For the purpose of our auditwe used overall Group materiality of $3.3 million,which representsapproximately 5% of theGroup’s average profit beforetax of the past three yearsadjusted for impairment.●We applied this threshold,together with qualitative considerations, to determinethe scope of our audit and the nature, timing and extent ofour audit procedures and toevaluate the effect ofmisstatements on the financialreport as a whole.●We chose Group profit beforetax because, in our view, it isthe benchmark against whichthe performance of the Group is most commonly measured.Due to fluctuations in profitand loss from year to year, wechose a three year average.Impairment is adjusted as it isan infrequently occurring itemimpacting the consolidatedstatement of comprehensiveincome.●We selected 5% which iswithin the range of acceptablequantitative profit related materiality thresholds.●Our audit focused on wherethe Group made subjectivejudgements; for example,significant accountingestimates involvingassumptions and inherentlyuncertain future events.●The Group comprises businesses operatingpredominately in Australia, New Zealand and Singaporewith the most financiallysignificant operations beingAustralia.●We focused our audit on thefinancial information of theAustralian operations giventheir financial significance tothe Group.●We performed specific risk-focused audit procedures overthe Singapore and NewZealand operations.●Amongst other relevant topics,we communicated the followingkey audit matters to the Auditand Risk Committee:−Estimated recoverableamount of goodwill for theNew Zealand operations−Accounting for pre-paidfuneral contracts●These are further described inthe Key audit matters section of our report.128 Key audit matters Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the financial report for the current period. The key audit matters were addressed in the context of our audit of the financial report as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. Further, any commentary on the outcomes of a particular audit procedure is made in that context.  Key audit matter How our audit addressed the key audit matter Estimated recoverable amount of goodwill for the New Zealand operations Refer to note 12 Under Australian Accounting Standards, the Group is required to test goodwill annually for impairment, irrespective of whether there are indications of impairment. This assessment is inherently complex and judgemental as the Group is required to:      ●forecast the operational cash flows of the cashgenerating units of the Group●determine discount rates and terminal growthrateswhich are used in the discounted cash flow model used to assess impairment (the model).      The Group recognised a $19.3 million goodwill impairment charge relating to New Zealand operations in the year ended 31 December 2020. We considered this a key audit matter because significant judgement is required by the Group in estimating the recoverable amount of goodwill relating to the New Zealand operations. We focused our efforts on developing an understanding and testing the overall calculation and methodology of the Group’s impairment assessment.      In obtaining sufficient audit evidence, our procedures included, amongst others: ●assessing whether the cash generating units(CGUs) to which goodwill is allocated areconsistent with our knowledge and understandingof New Zealand operations and internal reporting●developing an understanding of how the Groupidentified the relevant methods, assumptions orsources of data, and the need for changes in them,that are appropriate for determining therecoverable amount in the context of theAustralian Accounting Standards ●evaluating whether judgements made in selectingthe method, significant assumptions and data fordetermining the estimate give rise to indicators ofpossible bias by the Group●comparing the cash flow forecasts to the Group’smost up-to-date budgets●assessing the Group’s historical ability to forecastfuture cash flows by comparing budgets withreported actual results for the past year●testing the mathematical calculations within themodel●comparing the terminal growth rate applied in themodel to external information sources●evaluating the reasonableness of the disclosuresagainst the requirements of Australian AccountingStandards.PwC valuations experts assisted us in performing these procedures where appropriate. Performance Review12Directors’ Report3Financial Report4Other Information129 Key audit matter How our audit addressed the key audit matter Accounting for pre-paid funeral contracts Refer to note 10 The Group enters into pre-paid funeral contracts whereby it agrees to deliver a specified funeral, cremation or burial service at the time of need. The beneficiary invests the current price of the service to be delivered with a financial institution and conditionally assigns the benefit to the Group. For each pre-paid funeral contract, the Group records an asset for the value of the funds invested (funds under management) and a liability to deliver the services. As at 31 December 2020, the Group had recorded $613.1 million of funds under management and   $541.3 million of contract liabilities. We considered pre-paid funeral contracts to be a key audit matter due to the: ●size of the asset and liability balances●significant financing component within thecontracts, as a result of significant time differencesthat may arise between receipt of cash fromcustomers and the subsequent recognition ofrevenue on the delivery of services (redemptiondate).For the asset value invested, we performed the following procedures amongst others: ●agreeing a sample of balances recorded by theGroup to statements and confirmations receivedfrom independent custodians●testing the valuation of the invested funds undermanagement by comparing a sample of underlyinginvestments to relevant unit prices using marketpricing data and custodian confirmations. For the liability recognised, we performed the following procedures amongst others: ●comparing the date and value of a sample ofcontracts to that recorded by the Group●assessing the reasonableness of the significantfinancing component recognised during the yearby comparing the amount to our own calculations●selecting a sample of redeemed contracts(recognised revenue) to assess whether theGroup’s performance obligation under the pre-paid funeral contracts had been satisfied. Thisincluded comparing the relevant original contractsto service delivery documents and investmentreturns●evaluating the reasonableness of the disclosures against the requirements of Australian AccountingStandards.Other information The directors are responsible for the other information. The other information comprises the information included in the annual report for the year ended 31 December 2020, but does not include the financial report and our auditor’s report thereon. Prior to the date of this auditor's report, the other information we obtained included the director's report. We expect the remaining other information to be made available to us after the date of this auditor's report. Our opinion on the financial report does not cover the other information and we do not and will not express an opinion or any form of assurance conclusion thereon. In connection with our audit of the financial report, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial report or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed on the other information that we obtained prior to the date of this auditor’s report, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. When we read the other information not yet received, if we conclude that there is a material misstatement therein, we are required to communicate the matter to the directors and use our professional judgement to determine the appropriate action to take. 130 Responsibilities of the directors for the financial report The directors of the Company are responsible for the preparation of the financial report that gives a true and fair view in accordance with Australian Accounting Standards and the Corporations Act 2001 and for such internal control as the directors determine is necessary to enable the preparation of the financial report that gives a true and fair view and is free from material misstatement, whether due to fraud or error. In preparing the financial report, the directors are responsible for assessing the ability of the Group to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so. Auditor’s responsibilities for the audit of the financial report Our objectives are to obtain reasonable assurance about whether the financial report as a whole is free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Australian Auditing Standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial report. A further description of our responsibilities for the audit of the financial report is located at the Auditing and Assurance Standards Board website at: https://www.auasb.gov.au/admin/file/content102/c3/ar1_2020.pdf. This description forms part of our auditor's report. Report on the remuneration report Our opinion on the remuneration report We have audited the remuneration report included in pages 36 to 59 of the directors’ report for the year ended 31 December 2020. In our opinion, the remuneration report of InvoCare Limited for the year ended 31 December 2020 complies with section 300A of the Corporations Act 2001. Responsibilities The directors of the Company are responsible for the preparation and presentation of the remuneration report in accordance with section 300A of the Corporations Act 2001. Our responsibility is to express an opinion on the remuneration report, based on our audit conducted in accordance with Australian Auditing Standards.  PricewaterhouseCoopers Sydney Partner 24 February 2021 MW Chiang Other Information
Shareholder Information
As at 24 March 2021
The following information is presented in compliance with ASX Listing Rules 4.10  
(as relevant). The information is current as at 24 March 2021.
1.  Corporate Governance Statement
The 2020 Corporate Governance Statement can be found on the Company’s website at 
www.invocare.com.au/investor-relations/.
2.  Securities on issue
Shares and options as at 24 March 2021
Ordinary shares on issue
Unquoted options on issue
3.  Voting rights
Number
144,060,733
2,682,083
For fully paid ordinary shares – On a show of hands every member present at a meeting in 
person or by proxy shall have one vote and upon a poll shall have one vote for each share 
represented.
For unquoted options – No voting rights apply unless and until the unquoted options are 
converted to fully paid ordinary shares. 
4.  Distribution of quoted ordinary shares and small holdings 
Range
100,001 and over
10,001 to 100,000
5,001 to 10,000
1,001 to 5,000
1 to 1,000
Total
Unmarketable parcels
Fully paid ordinary shares
%
Number of holders
73,905,231
19,841,791
14,732,703
29,172,320
6,408,688
144,060,733
15,451
51.30
13.77
10.23
20.25
4.45
100.00
48
957
2,063
12,347
13,883
29,298
732
InvoCare            Annual Report 2020  | 132
 
     
5.  Top 20 registered shareholders 
Name
HSBC Custody Nominees (Australia) Limited  
J P Morgan Nominees Australia Pty Limited  
BNP Paribas Noms Pty Ltd  
Continue reading text version or see original annual report in PDF format above